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This thesis aims to examine the validity of existing tools recommended for outcome prediction
after abdominal aortic aneurysm (AAA) rupture and to design and validate a novel risk scoring
instrument. It also aims to examine the utility of novel predictive variables. Finally, it examines
the functional outcomes achieved by survivors of aneurysm rupture.
Existing risk models and predictive variables for outcome were validated on a retrospective
cohort of consecutive patients with ruptured AAA. These data were also used to design a novel
prognostic index for outcome prediction. A prospective cohort of consecutive patients was used
to further validate these scoring systems, examine novel prognostic variables and determine
functional outcome.
Existing risk scoring instruments for patients with ruptured AAA lack validity. Analysis of
preoperative variables in patients with ruptured AAA shows that absolute surgical futility cannot
be predicted. However, in-hospital hypotension (<90mmHg), reduced Glasgow Coma Scale (<15)
and anaemia (<9g/dL) are associated with perioperative death. When these risk factors are equally
weighted and combined to create a novel risk scoring instrument (Edinburgh Ruptured Aneurysm
Score-ERAS), three discriminatory tiers of risk are demonstrable. The validity of this risk
instrument is confirmed on prospective data. Examination of novel perioperative prognostic
variables shows that elevated cardiac troponin I, with or without clinically apparent cardiac
dysfunction, is predictive of death after ruptured AAA repair. However, although ruptured AAA
are associated with an early elevation in inflammatory biomarkers, these do not appear to confer
additional prognostic value. Furthermore, for the first time, prospective study shows that patients
who survive ruptured AAA repair achieve a good recovery in terms of functional outcome within
six months of operation.
Surgical futility cannot be predicted prior to operation in patients with AAA. However, the ERAS
shows potential as a preoperative prognostic index in patients with ruptured AAA.
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lJntroduction
There is no disease more conducive to clinical humility than aneurysm ofthe aorta.
Sir William Osier
1.1. Overview
This thesis examines the outcomes of patients with ruptured abdominal aortic
aneurysm (AAA). As the incidence of this condition continues to increase, survival
has remained essentially unchanged over the past 30-years It has been suggested
that the only means by which to improve perioperative mortality after aneurysm
rupture may be to operate only on patients with reasonable operative risk.
The majority of vascular surgeons in the UK employ a selective policy when faced
with patients with ruptured AAA . Thereby, clinicians must frequently make the
decision whether to palliate or to operate on a given patient. To date this remains a
largely subjective decision. There is an array of reports on risk scoring and outcome
prediction aimed at informing such decision-making. However, all of these tools lack
adequate validation and their use cannot be robustly supported in clinical practice.
Furthermore, there remain many misconceptions concerning variables that may
influence outcome after ruptured AAA that are largely based on anecdotal evidence
and inadequate knowledge.
In this introductory chapter, the relevant clinical and pathophysiological background
and previous published literature in the field will be discussed.
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1.2. Abdominal aortic aneurysm
The normal diameter of the aorta varies with age, sex and bodyweight3. It decreases
in size as it leaves the thorax and enters the abdomen, tapering to its iliac bifurcation.
However, the infrarenal aorta enlarges progressively with age. An aortic aneurysm
may be defined as a permanent localised dilatation of at least a 50% increase in
diameter compared to the expected normal diameter of the aorta 4. If the maximum
normal diameter of the aorta is considered to be 2.1cm, aneurysmal dilatation is said
to occur when the diameter exceeds 3.0cm.
The abdominal aorta comprises of three histologically distinct tissue layers: an
intima, media, and adventitia. True aneurysms represent a dilatation of all three
layers of the vessel wall. The abdominal aorta is the most commonly affected artery
and accounts for 90% of all aneurysms. Of these, 95% will originate below the level
of the renal arteries. The aortic arch, thoracic aorta and thoracoabdominal aorta are
involved in approximately 10% of aneurysms 5.
The morphology or shape of aneurysms may be classified as saccular or fusiform,
although this description represents a continuous spectrum. Saccular aneurysms only
affect a small portion of the aortic circumference while fusiform lesions involve the
entire circumference of the vessel.
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1.3. Epidemiology
Ruptured abdominal aortic aneurysm (AAA) accounts for around 10 000 deaths each
year in the United Kingdom6. This represents a similar number of deaths caused by
gastric, oesophageal and prostatic malignancies 7. Over the past 20-years, hospital
based admissions and mortality from AAA in the UK have continued to rise 8'9.
These trends have also been reported in Europe, Australia and the USA l0"12.
Knowledge of the prevalence of AAA has implications for the planning and
organisation of health-care resources. In determining the prevalence of AAA, the
frequently asymptomatic nature of the disease is a major confounding factor. Data on
prevalence stem from four sources: autopsy surveys, routine mortality and hospital
in-patient statistics and population-screening surveys. It should be noted that all of
these sources have their limitations and potential for bias; screening surveys offer,
potentially, the most accurate estimate of prevalence.
The prevalence of screen detected AAA in men in England is reported to be between
1.3 and 12.7 per cent 13. This variation is accounted for by differing criteria for the
definition of AAA and the age group screened. If the criterion of aortic diameter
>29mm is used as the definition for AAA, the prevalence ranges between 2.9 and 7.6
per cent l3. The prevalence ofAAA amongst women in this country, though less well
documented, is much lower and is reported to be around 1.3 per cent 14. These
figures are in keeping with data from other European and North American series l5'16.
Interestingly, data from autopsy based surveys yield similar results. The prevalence
4
of AAA at autopsy in the UK has been reported at 2.3 per cent in men and 1.6 per
cent in women. 17
Scottish hospital records data have reported the overall incidence of asymptomatic
AAA to be around 63.6 cases per 100 000 per year 18. Similar studies from North
America, Australia and Western Europe report incidences of between 3.0 and 117.2
per 100 000 people per year 15-19'20. Variation in these figures is attributable to the
differing data sources utilised: hospital records, death certificates and autopsy reports
13. However, all studies report a consistent increase with time in the age-adjusted
incidence of AAA. Such a finding may be accounted for in part by increasing AAA-
related hospital admissions due to greater awareness, improved methods of diagnosis
and a lower threshold for surgical intervention. Nevertheless, it is suggested that a
real increase in AAA incidence has occurred at a time when other cardiovascular
o
diseases have been declining .
The reported incidence of ruptured AAA ranges from 1 to 21 per 100 000 people per
year 13. Here too, a steady increase in incidence has also been identified. This finding
is unrelated to population age flux, as the age-standardised mortality has also risen.
Although it is possible that increased awareness has led to an increase in the citation
of AAA as a cause of death, it is felt that there has been a true increase in the
incidence of aneurysm rupture.
Recent work has examined trends in hospital related admissions and AAA related
mortality in Scotland. Between 1981 and 2000, 42.3 per cent of the 10 822 deaths
from aortic aneurysm in Scotland were attributed to the abdominal aorta. Age-
adjusted mortality rates for AAA increased 2.6-fold from 2.62 deaths per 100 000 in
1981 to 6.82 per 100 000 in 2000 (Fig. 1.3.2) 8. Unlike previous studies that have
considered trends in AAA during the period of introduction of ultrasonography and
computed tomography, there have been no significant advances in the diagnosis of
aortic aneurysm over the past 10-15 years to account for these increases. Hospital
admissions for AAA also rose threefold, with increases in both elective admissions
(from 3.05 to 7.80 per 100 000) and emergency admissions (from 7.44 to 11.23 per
100 000).
Figure 1.3.1. 3-Dimensional reconstruction of intact AAA
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Fig. 1.3.2. Age-adjusted mortality rates for abdominal aortic aneurysm in men and
women in Scotland between 1981 and 2000 8
7
There were consistently more emergency admissions than elective, although the
proportion of elective admissions did increase with time. Surgical workload
increased dramatically during the study period, from 130 operations for AAA in
1981 to 528 in 2000. It was also noted that there was a large increase in the
o
proportion of patients over 75 years undergoing emergency surgery .
These data imply that the incidence of AAA has increased over the past 20 years in
Scotland. This is unlikely to be due to changes in detection and diagnosis, or ageing
of the population. The increase in incidence of both elective and emergency
admission suggests that a genuine and persistent rise in the incidence of AAA has
occurred.
8
1.4. Aetiology and risk factors
The cause of aneurysms remains unclear. Historically, aneurysmal change was
thought to be underpinned by atherosclerosis. However, because of histological and
epidemiological differences it is now recognised that atherosclerosis is a coexistent
secondary phenomenon and the majority of AAA (90%) are thought to represent a
degenerative or non-specific process 21.
Abdominal aortic aneurysms exhibit familial clustering. This raises the possibility of
both genetic and environmental aetiological factors. Genes encoding for type III
collagen, matrix metalloproteinases and protease inhibitors and plasminogen
activator inhibitor have all been reported to play some role in AAA development or
expansion 22'23. However, no specific genes have been convincingly implicated to
date and it is inferred that susceptibility to the development ofAAA is an irreversible
process with multiple genetic and environmental risk factors. Genetic influences are
attributed to a few gene polymorphisms with large effects 22.
North American and European data suggests that there is a four-fold increase in risk
of having an AAA for the brother of a patient having an AAA 24'25. Familial
abdominal aortic aneurysms are more common when the index case is female and
rupture is said to occur at a younger age and more often than with sporadic
aneurysms 26'27.
Established independent risk factors for AAA included male gender, age,
hypertension, hyperlipidaemia and smoking 28~30. In particular, the relationship
between tobacco use and AAA development is striking. Aneurysms are four-times
9
more prevalent amongst smokers than non-smokers and the comparative relative
risks of chronic cigarette smokers developing an AAA are three-fold greater than
their risk of developing coronary artery disease 29,31 ■ For these reasons, it is thought
that smoking is the foremost environmental risk factor for aneurysm development
and growth.
Figure 1.4.1. Large asymptomatic AAA
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1.5. Pathology
Abdominal aortic aneuryms are characterised histologically by destruction of elastin
and collagen in the tunica media and tunica adventitia, smooth muscle cell apotosis
with thinning of the medial wall, infdtration of lymphocytes and macrophages, and
neovascularization 32. Four pathological mechanisms are thought to play central roles
in AAA development: Proteolyis of connective tissue, inflammation, biomechanical
33
stress and genetic influences .
Proteolysis:
Macrophage and aortic smooth muscle cell derived matrix metalloproteinases
(MMPs) and other proteases are secreted into the extracellular matrix and are integral
to aneurysm formation 34'35. Though MMPs are expressed and active during normal
physiological aortic remodeling, they mediate degradation of elastin and collagen
within the aortic media and internal lamina in AAA pathogenesis 36. A shift in the
balance between MMPs and their inhibitors moves away from normal remodeling
activity towards pathological elastin and collagen degradation. Factors initiating and
propagating proteolyis in the aorta remain unclear37.
Inflammation
Transmural lymphocyte and macrophage infiltration is a histological characteristic of
32AAA . An inflammatory cytokine cascade released by these cells is thought to
stimulate protease activation. The chemotactic trigger responsible for this cellular
migration remains uncertain, although it has been proposed that aortic elastin
11
degradation products, interstitial collagen or oxidized low-density lipoprotein, may
37
be an antigenic and chemotactic stimulus for macrophages .
Other factors stimulating a vascular inflammatory response include Chlamydia
pneumoniae, Treponema pallidum, Cytomegalovirus, and Herpes Simplex Virus. It is
hypothesized that these agents may initiate the proteolytic cascade resulting in matrix
degradation 38'39. Interestingly, Chlamydia pneumoniae has been demonstrated in as
many as 55% of aneurysms and antibody titers have been directly correlated with
aneurysm expansion, while doxycycline treatment has resulted in reduced rates of
aneurysm expansion 40"42.
Biomechanics
The aortic wall contains smooth muscle, elastin, and collagen arranged in concentric
layers in order to withstand arterial pressure. Elastin is the principal load-bearing
element in the aorta while collagen provides tensile strength and helps maintain the
structural integrity of the vascular wall 43. The normal aorta displays a reduction in
•5*7
the elastin to collagen ratio as it passes from the thorax into the abdomen . Thus,
the abdominal aorta has less elastin and as a consequence, less load-bearing potential
than the aortic arch.
Matrix metalloproteinase-9 expression and activity is increased in the abdominal
aorta compared with aortic arch and thoracic aorta. Activation of these proteases is
also thought to be brought about by the disruption of normal laminar flow seen in the
infra renal aorta 44. Furthermore, the attenuation of the vasa vasorum in the infrarenal
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aorta is proposed to contribute to relative hypoxia of the vessel stimulating MMP
activity. These factors are all thought to contribute to the predisposition of the
infrarenal aorta to develop aneurysmal change .
Genetics
As already discussed, though multifactorial genetic influences are involved in AAA
development, the polymorphisms responsible for aneurysm pathogenesis remain
elusive. Similarly, the phenotypic expression of these traits is uncertain. It is
proposed that an abnormality of the primary structures of elastin and collagen or a
mutation, directly or indirectly, affecting protease and protease-inhibitor activity are
implicated .




1.6. Biology ofAAA rupture
The concept that aortic rupture occurs when wall stress exceeds the tensile strength
of the aneurysm wall is now recognised to be an oversimplification of the
mechanisms at play. This is reinforced by the observation that even small aneuryms
may rupture 5. Recent work has proposed that the tensile strength of aneurysmal
aortic wall is heterogeneous. It is felt that enhanced enzyme activity within the aortic
wall results in focal areas of weakness or 'hotspots' that are susceptible to rupture at
relatively low wall stress 46.
It should be noted that although elastin degradation is an important characteristic in
aortic dilatation, it is the proteolytic degradation of collagen, predominantly in the
adventitia, that predisposes to aortic rupture. This may be considered the final
common pathway in the progression to rupture 47. The role of
matrixmetalloproteinases in AAA evolution has already been alluded to. However,
they are thought to play a role in aneurysm rupture too. While MMP-2 is implicated
in the expansion of small AAA, MMP-9 activity is closely related to large
aneurysms. Matrixmetalloproteinase-9 levels are reported to be six fold greater in
ruptured compared to intact AAA . It has also been observed that MMP-9 levels are
much higher at the site of aneurysm rupture when compared to a distant, intact area
ofAAA wall 49. These findings lend weight to the hypothesis that areas of increased
MMP activity result in focal hotspots of aneurysm wall that are vulnerable to
46
rupture .
The role of the immune response in AAA rupture remains controversial. Though its
effect may culminate in promoting connective tissue breakdown and smooth muscle
apoptosis, it may also exert a reparative influence mediated by anti-inflammatory
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cytokines that inhibit macrophage activation and MMP expression 47'50. Further
confounding evidence stems from the observation of rapid AAA growth and even
rupture in patients receiving chemotherapy regimens 51. Similar findings have also
been noted in patients who receive immunosuppressive regimens following organ
transplantation . Recent work on Natural Killer (NK) T-cells has shown that
patients with an AAA have significantly higher percentages of peripheral blood NK
cells when compared to both arteriopaths and normal controls 53. Furthermore
Natural Killer cells from patients with an AAA display increased cytotoxicity
towards both an NK-sensitive target cell line and human aortic smooth muscle cells
. Increased NK cytotoxicity could be a contributing factor in the generation or
potentiation of inflammation in patients with an AAA.
Intraluminal thrombus develops in the majority of AAA and it has been suggested
that it plays a part in aneurysm rupture. Again, the precise relationship between
thrombus and aneurysm rupture is uncertain. Patients with ruptured AAA display
evidence of acute haemorrhage within mural thrombus and this may be a causal
relationship 54. Alternatively, an extensive interface of thrombus reduces oxygen
delivery from the true lumen to the aortic wall 55. This may result in inflammation
with associated proteolysis and a reduction in local wall tensile strength predisposing
to rupture 47. The constituents of thrombus also include inflammatory cells that are
capable of mediating proteolytic enzyme release and activation 56. This is supported
57
by the observation of elevated levels of plasmin at the thrombus-aortic interface .
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Relative hypoxia of the aortic wall may also compromise the integrity of
extracellular matrix synthesis 1. Cell culture work on aortic endothelial cells has
shown that hypoxic conditions result in reduced collagen synthesis 59. Moreover, the
collagen synthesised is abnormal due to the need for oxygenation in the
hydroxylation of proline 60.
The biology of aneurysm rupture remains far less certain than the pathogenesis of
aneurysms themselves. The concepts that have been discussed are likely to interact in
the common pathway that culminates in AAA rupture. These influences may be
amenable to therapeutic manipulation as a means of slowing or arresting the progress
towards rupture.
Figure 1.6.1. Macroscopic pathological specimen of ruptured AAA
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1.7. Cardiac injury
Coexistent coronary artery disease (CAD) in patients with peripheral vascular
disease is well documented. It is reported that perioperative myocardial ischemia
occurs in 20% to 40% of patients undergoing vascular surgery; of whom 50%
develop adverse events 60. In the Cleveland Clinic study, hemodynamically
significant CAD was demonstrated in more than a third of patients with AAA 61.
Cardiac injury may be precipitated by the insults of anaesthesia related hypotension,
blood loss, fluid shifts, aortic cross-clamping and ischaemia-reperfusion injury. In
the context of ruptured aneurysms, death and postoperative morbidity in patients who
undergo technically successful repair of a ruptured aneurysm is commonly attributed
to the development ofmyocardial infarction 62. However, the detection of clinically
signficiant perioperative cardiac injury and its prognostic implications remain
unclear.
Cardiac events have been traditionally diagnosed on clinical, electrocardiographic
(ECG) and biochemical criteria. The diagnosis of acute myocardial infarction as
defined by the World Health organisation and recently revised by the Joint European
Society of Cardiology/American College of Cardiology committee is shown in Table
1.7.1 63.
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Table 1.7.1. Criteria of the World Health Organization and the Joint European
Society ofCardiology/American College of Cardiology
World Health Organization criteria for MI
Definite acute Ml
1. Definite ECG or
2. Symptoms typical or atypical or inadequately described, together with probable ECG or
abnormal enzymes or
3. Symptoms typical with abnormal enzymes with ischaemic or non-codable ECG or ECG
not available or
4. Fatal case, whether sudden or not, with naked eye appearance of fresh MI, recent
coronary occlusion found at necropsy, or both
Joint European Society of Cardiology/American College of Cardiology criteria
Criteria for acute, evolving, or recent MI—one of the following:




c. ischaemic ECG changes
d. coronary artery intervention
2. Pathological findings of an acute MI
Criteria for established MI—any of the following:
1. Development of new pathological Q waves on serial ECGs
2. Pathological findings of a healed or healing MI
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Despite these guidelines, the detection of perioperative myocardial injury remains
imprecise. Landesberg and colleagues reported that during 11,132 patient hours of
ambulatory ECG monitoring after surgery, 38 of 185 consecutive patients had 66
transient ischaemic events, but only 12 patients (6.5%) sustained perioperative Mis
64. Furthermore, Kirwin and coworkers were unable to correlate silent myocardial
ischaemia on preoperative continuous ambulatory monitoring with perioperative Mis
65. The use of symptomatology in the diagnosis of perioperative cardiac events is
confounded by the fact that many symptoms are atypical or absent in as many as
75% of patients who have objective evidence ofMI60. Traditional cardiac
biomarkers such as creatine phosphokinase and its isoenzymes lack specificity for
myocyte injury and are also released from skeletal muscle during surgical
intervention or an ischaemia-reperfusion insult.
Cardiac troponins are calcium regulatory proteins of the thin actin filaments of the
cardiac muscle 66. Release of these proteins is now recognized to be a highly
sensitive and specific marker of myocardial injury. Cardiac troponins are detected
using monoclonal antibodies against several different epitopes of the troponin T or I
molecule 66. These antibodies, in particular Troponin I, have negligible cross
reactivity with skeletal muscle 68. Cardiac troponins start to rise within 3-4 hours
after myocardial infarction and remain raised for 4-10 days because of a gradual
degeneration of myofibrils with release of the troponin complex 69'70. The joint
committee of the European Society of Cardiology, the American College of
Cardiology, and the American Heart Association have recently accepted their
measurement in serum as the standard biomarker for the diagnosis of acute
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myocardial infarction 63. Similarly, Andrews and colleagues have demonstrated that
Troponin I levels are accurate in the detection ofmyocardial ischaemia in patients
undergoing vascular surgery 71.
In patients with acute coronary syndromes, elevation of cardiac troponins confers
prognostic information in terms of cardiac morbidity and mortality. Patients with
raised troponins have a risk of death that is several times greater than patients
without elevated troponins 63'67. Its use in immediate cardiac risk stratification is
even advocated in the emergency setting. Interestingly, troponins have also been
shown to predict overall mortality in patients whose primary pathology is non-
cardiac in origin. This is true of populations as disparate as patients with sepsis,
patients with renal failure and patients undergoing elective vascular and other non
cardiac surgery 6 .
Data for patients undergoing elective vascular surgery have shown that perioperative
elevation of cardiac troponin, even at low cutoff levels, is an independent predictor
of both short-term and long-term outcomes 72~74. These include both perioperative
myocardial infarction and subsequent all-cause mortality. Specific analysis in
patients undergoing elective aortic surgery has shown that between 15-29% will have
a perioperative elevation in serum troponin 15,16. These elevations correlate with the
occurrence of cardiac complications. The impact of emergency aortic surgery on
troponin release is less well documented though preliminary data suggests that up to
half of patients will suffer myocardial injury76. The impact of these findings on
subsequent outcome is unknown.
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1.8. Inflammation
As discussed earlier, inflammation is integral to the pathobiology of aortic
aneurysms. Its local manifestation is highlighted by the inflammatory cell infdtration
seen on histological examination ofAAA tissue. However, the impact of
inflammation, and in particular, a systemic inflammatory response seems to extend
beyond this and influence outcome after aneurysm rupture.
Death and postoperative morbidity in patients who undergo technically successful
repair of a ruptured aneurysm is generally attributed to the development of
multiorgan failure 62. This is due to an intense acute systemic inflammatory response
caused by the failure to maintain control of the pro-inflammatory stimuli associated
with emergency aneurysm repair 11. The activation of inflammatory pathways is
triggered by the obvious insults ofmassive haemorrhage, hypothermia and
ischaemia-reperfusion. However, inflammatory pathways may already be primed in
the build up to aortic rupture by the local inflammatory responses in the aortic wall
that have already been described.
The acute phase proteins are a family of proteins that include C-reactive protein
(CRP), fibrinogen and serum amyloid A. Their concentrations change in response to
78
injurious stimuli and they are thought to facilitate the acute inflammatory response
C-reactive protein was described almost 70-years ago as a serum protein that bonded
to the C-polysaccharide ofStreptococcus pneumoniae. It is produced primarily by
hepatocytes, and to a lesser degree arterial smooth muscle cells, under the induction
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of proinflammatory cytokines such as interleukin-6 and tumour necrosis factor-a 19.
Since then, it has become established in clinical practice as a non-specific, biomarker
of systemic inflammation and the acute phase response.
As the association between inflammation and vascular disease (atherosclerotic and
aneurysmal) is increasingly accepted, it may be extrapolated that biomarkers of
inflammation will be elevated amongst patients with aneurysmal disease 80-83.
Elevated baseline levels of CRP may reflect low-grade vascular inflammation as a
consequence ofunderlying aneurysmal change. These proteins may, potentially,
represent a marker of inherent rupture risk.
Preliminary evidence exists to support such a hypothesis. Powell and colleagues have
shown that CRP is elevated among patients with AAA while Engstrom and co¬
workers have shown that patients who go on to develop aneurysmal disease have
raised serum inflammatory markers 84,85. Recently, it has been shown, from
retrospective data, that inflammatory markers, such as CRP and leucocyte count, are
elevated in patients with acutely symptomatic AAA 86. These findings have not been
reported in patients with asymptomatic aneurysms.
Data from patients with pancreatic, renal and colonic cancers have shown that raised
on
CRP levels confer prognostic information in terms of disease survival . Similar
findings are also seen in patients with critical illness 88. It is unclear whether raised
inflammatory biomarkers in patients with ruptured AAA can also be related to
outcome and survival.
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1.9. Natural history studies
There are few true natural history studies in patients with AAA; where the outcomes
for patients with treated AAA and those with untreated AAA are randomised and
compared prospectively.
Contrary to popular belief, the natural history of non-operated AAA is not one of
uniform progression to aneurysm rupture. Much available natural history data stems
from the subgroup of patients with large AAA who have been turned down for
elective repair. Szilagyi and colleagues reported on 156 patients with AAA but unfit
for surgery 89. Two-thirds of these AAA were <6cm in diameter. More than half of
their patient group died of a cardiovascular or cerebrovascular cause rather than an
aneurysm related death and 5-year survival was 17 percent.
More recently, Lederle and colleagues have reported on a multicentre study of 198
patients with AAA >5.5cm for whom elective repair was not planned due to medical
comorbidity or patient refusal90. The one-year rupture risk for AAA of 5.5 to 5.9cm
was 9.4 percent, 10.2 percent for AAA of 6.0 to 6.9cm and 32.5 percent for AAA of
>7cm. Interestingly, the risk of rupture in the smallest AAA diameter cohorts was
significantly greater than that reported in randomised controlled trials. This finding
has been reported across other studies and it is likely that patients with significant
coexistent morbidity are at a higher risk of rupture than their healthier counterparts.
Previous work from our group has also shown that patients with AAA > 5.5cm, but




So what of the rupture risk in patients with AAA fit for operation? Data on rupture
risk are less readily available and susceptible to significant selection bias. Pooled
data would suggest that AAA of 5.0-5.9cm, 6.0-6.9cm 7.0-7.9cm and >8cm have an
annual rupture rate of 3-15 percent, 10-20 percent, 20-40 percent and 30-50 percent
respectively 92"94. It is acknowledged that not all AAAs rupture at a specific diameter
and that other patient and aneurysm specific variables influence rupture risk.
Variables, apart from aneurysm diameter, that have been reported to increase risk are
female sex, hypertension, chronic obstructive pulmonary disease (COPD), cigarette
smoking, familial history ofAAA and saccular or eccentric aneurysms 92'95>96.
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1.10. Outcome of ruptured AAA
As already described, the incidence of AAA and emergency AAA related hospital
admissions have steadily increased over the past 20-years. Consequently, the crude
mortality rates for aneurysm related deaths have also increased. These developments
have taken place during a time in which there have been significant improvements in
perioperative care and anaesthesia. It is intuitive to expect these factors to have had a
positive impact on outcomes after ruptured AAA. In general, a contemporary
operative mortality rate of 40% continues to be quoted for ruptured AAA repair '.
However, there are conflicting data within the literature and mortality rates varying
from 21% to 94% are reported 97'98. Twenty-five years ago, Fielding and colleagues
reported on 174 patients with ruptured aneurysms operated on between 1960 and
1978. In this historical series, operative mortality was 42% ". Why should there be
such variability in reported mortality data and have outcomes over the past three
decades genuinely failed to improve significantly?
Variation in reported mortality rates after AAA surgery are not confined to
emergency repair alone. Similar discrepancies are seen in the reporting of results
after elective aortic surgery too 10°. This has been blamed on the different types of
study design used, i.e. prospective versus retrospective and hospital-based versus
population-based. Blankensteijn and colleagues have proposed a methodology for the
classification of evidence as illustrated in Table 1.10.1 10°.
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Table 1.10.1. Blankensteijn's modified classification of levels of evidence.
Level of evidence Definition
Level la Prospective population-based studies
Level lb Prospective hospital-based studies
Level 2a Retrospective population-based studies
Level 2b Retrospective hospital-based studies
Level 2c Retrospective hospital-based studies
concerning selected groups
In their review ofmortality after elective AAA repair, they concluded that there was
a consistent disagreement in mortality rates between hospital based and population
based studies. Nevertheless, prospective population based studies are recommended
for their inclusion of large sample sizes with narrow confidence intervals, and
prospective hospital based studies permit more detailed, accurate observations. The
weaknesses of level 2 studies are numerous and relate to the inevitable biases
associated with retrospective observational studies. These findings are clearly not
restricted to elective AAA repair and are likely to be even more heightened in the
context of emergency aneurysm surgery.
In determining contemporary mortality figures for ruptured AAA repair, the recent
meta-analysis by Bown and colleagues provided useful data 1. These authors
reviewed all English language publications reporting on operative mortality after
ruptured AAA repair from 1966 to 1998. They were able to identify 171 articles that
met their selection criteria. Of these, 12 were prospective studies. However, careful
analysis revealed that four of these studies were in fact retrospective analyses.
Extension of their search of the literature up to 1st January 2005 identified a further
16 studies reporting on ruptured aneurysm operative mortality, ofwhich only two
were prospective. Thus, over a period of almost 40-years, there have been only 10
prospective English language studies published describing mortality after ruptured
AAA repair (Table 1.10.2) 101-110- The total number of patients studied in these series
was 879 patients and the median (range) operative mortality rate from these ten
studies was 42 (22-60) %.
27
Table 1.10.2. Ten prospective studies reporting operative mortality after ruptured
AAA repair
Author Year of Publication Number of
patients
Deaths (°/
Boyle 101 2003 79 26(33)
Hsiang 102 2001 134 71 (53)
Magee 103 1997 35 13 (37)
Koskas & Keiffer 104 1997 158 73(46)
Lazarides 105 1997 40 22 (55)
Passke 106 1994 36 8(22)
Johnston 107 1994 147 73(50)
Scott108 1992 63 19 (30)
Collin 109 1989 75 27 (36)
Amundsen 110 1987 103 62(60)
Bown's analysis reports an overall published operative mortality of 48%. Meta-
regression analysis over the study period demonstrated a gentle decline in mortality
with time. Mortality in 1960 was in the region of 55%, for 1980 it was 48% and for
2000 it is 41% '. The average operative mortality reported in the ten prospective
studies from 1966 to 2005 of 42% was in keeping with this figure. The authors do
point out the striking heterogeneity in the results. Mortality ranged from 0 - 94%,
though these outlying results generally stemmed from small sample sizes.
Bown and colleagues cautioned against potential biases that may have influenced
their meta-analysis. In particular, they were able to detect considerable bias in the
reporting of intraoperative mortality from single centre reports. This together with
publication bias against, what may be perceived, as bad results due to poor surgical
performance are likely to down play true mortality rates. It is interesting to note that
of the 10 prospective studies available, those with the lowest mortality rates are from
one or two collaborative centres, while those series with the highest mortality are
true multicentre data.
In summary, operative mortality after ruptured AAA remains prohibitively high.
Although there appears to have been a slight improvement in outcome over the past
40-years, operative mortality continues to lie in the region of 40-50%.
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1.11. Predicting mortality after ruptured AAA
Most surgeons practice a selective policy of operative intervention for patients with
ruptured AAA . This approach is underpinned by the rapid assessment of the
patient's clinical condition on presentation and premorbid health and functional
status to determine if attempted operation is appropriate, and associated with a
realistic chance of survival. It aims to ensure healthcare resources are utilised
appropriately and avoid futile attempts at intervention in patients with prohibitive
risk. In clinical practice, this patient selection is largely based upon subjective
criteria. However, to ensure that selection is objective, a system that can accurately
predict outcome in patients with ruptured AAA is crucial.
Many authors have attempted to identify variables capable of predicting mortality in
patients with ruptured AAA. There is much heterogeneity in the nature and quality of
results and the methods used for reporting. A few series have gone further, and have
performed statistical modelling on predictive variables to design scoring systems that
can forecast outcome. However, many systems have not utilised sound methodology
in their design. Furthermore, only the minority have undergone robust audit, let alone
prospective validation. A previous review has recognised that these limitations would
render meta-analytical techniques unsuitable1. The following systematic review
considers existing scoring systems and existing literature on variables predictive of
outcome in patients with ruptured AAA.
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1.11.1. Hardman Index
The Hardman scoring system is, probably, the best known of the available scoring
systems for use in patients with ruptured AAA. Originally described in 1996, this
retrospective series reviewed 154 non-consecutive patients who underwent operation
for ruptured aneurysm between 1985 and 1993 at a single Australian tertiary vascular
centre111. Sixty-seven preoperative variables on 136 patients were subjected to
univariate analysis for their association with death in hospital, or within 30-days of
surgery. Continuous variables significantly associated with mortality were
categorized into quartiles, and the mortality of each category examined. All variables
related to postoperative death were further analysed alongside data from another 18
patients to develop a multivariate model. The significant multivariate risk factors
were then assessed for their cumulative effect when weighted equally.
Five independent variables were identified on multivariate analysis: preoperative
haemoglobin of less than 9g/l, serum creatinine of more than 190umol/l,
electrocardiographic evidence of myocardial ischaemia, in-hospital loss of
consciousness and age greater than 76 years. No single risk factor had a predictive
value in isolation, but the cumulative predictive value of the risk factors is shown in
Table 1.11.1. Although each variable was given equal weighting, odds ratios ranged
from 2.90-6.63. The presence of three or more of the five risk factors was associated
with a 100% mortality rate Table 1.11.2.
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Table 1.11.1. Multivariate model ofHardman Index variables independently
associated with mortality
Variable P value Odds ratio 95% CI
Age >76 years 0.001 4.69 1.93-11.5
ECG ischemia 0.004 6.63 1.81-24.3
Cr >190 umol/L 0.005 4.07 1.54-10.8
Loss of consciousness 0.020 5.37 1.30-22.2
Hb <9 g/1 0.032 2.90 1.10-7.71
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Table 1.11.2. Mortality of patients with multivariate model of five equally weighted
Hardman Index variables according to number of variables present











Following its conception, the Hardman score was commended for its simplicity and
practicality in the acute setting. Validation of the system has been performed at
various levels. To date, there have been five studies that have assessed the
performance of the Hardman system 1 >n1"4. These are illustrated in Table 1.11.3.
Figure 1.11.1 CT image of ruptured AAA
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Table 1.11.3. Operative mortality (%) in five series examining the presence of
Hardman variables in patients with ruptured AAA and relationship with death.
Hardman Variables
Series
Hardman et al. Ill
154 patients
Prance et al. 112
69 patients
Neary et al. 113
188 patients



























* Mortality for 3 risk factors only. For 4 risk factors, mortality was 100%
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On initial inspection, these results seem to support the original data ofHardman and
colleagues. Of the five series, 3 or more positive variables are uniformly associated
with perioperative death in three studies. However, it is disconcerting that two of the
reports contain patients with 3 or more variables who survived operative repair.
Although it has been widely concluded that the presence ofmore than 3 Hardman
variables is a good predictor of death, it would seem that this is not universally true.
More critical analysis of these data reveals that all but one review is retrospective in
nature and the only prospective data are compiled from two centres101. These data do
add some credibility to the validity of the Hardman scoring system, they do highlight
that the instrument is not as sensitive as initially reported and do emphasise the need
for further prospective validation before its use in clinical practice can be supported
unanimously.
1.11.2 Glasgow Aneurysm Score
The Glasgow Aneurysm Score (GAS) was first reported in 1994115. This instrument
was originally developed as a tool for prognostic scoring in patients undergoing
repair of either intact or ruptured AAA. A retrospective, multi centred, non-
consecutive sample of 500 patients undergoing aneurysm repair at general surgical
units in Glasgow between 1980 and 1990 was examined for risk factors associated
with death. Using multivariate analysis, the following independent risk factors were
identified: age (P = 0.02), shock (P - < 0.001), myocardial disease (P - 0.02),
cerebrovascular disease (P = 0.02) and renal disease (P = 0.003). Myocardial disease
is typified by documented myocardial infarction and/or on-going angina.
Cerebrovascular disease refers to all grade of stroke including transient ischaemic
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attacks. Renal disease is a history of chronic or acute renal failure and/or urea greater
than 20mmol/l and/or creatinine over 150pmol/l at presentation. Rounding of the
regression coefficients created a simple risk score: risk score = (age in years)+(17 for
shock)+(7 for myocardial disease)+(10 for cerebrovascular disease)+(14 for renal
disease). Appraisal of the scoring system showed that mortality rate increased in
proportion to score. The same authors went on to evaluate prospectively their system
in a subsequent multicentered study116. Again, they reported similar results to the
original analysis used in developing the score. Mortality was found to correlate well
with GAS and scores of >95 were related to a mortality rate of >80%.
There has been little further validation of this generic scoring system for patients
undergoing repair of an aortic aneurysm. Given its simplicity, ease of use and
apparent predictive power, this seems surprising. However, recently, a Finnish group
have examined the performance of the GAS in a retrospective review of 836 patients
with ruptured AAA admitted to 21 hospitals and included in a large national vascular
registry117. These data were able to confirm that GAS was independently associated
with postoperative death. In this series there was no cut-off score that predicted a
postoperative mortality rate of 100 %, though a score of >98 was associated with a
mortality rate of approximately 80%. It would appear that the GAS is a useful tool in
predicting outcome after AAA rupture but, again, further evaluation is needed.
1.11.3. POSSUM
The Physiological and Operative Severity Score for the enumeration ofMortality
and morbidity (POSSUM) was described and prospectively validated by Copeland
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and colleagues in 1991118. Its primary function was as a scoring system for general
surgical audit, to allow for the effects of case-mix, rather than as an instrument to
predict individual case outcome. It represents a risk-prediction model based on a
physiology score derived from 12 preoperative variables, independently predictive of
adverse postoperative outcome on multivariate analysis, and an operative score
derived from six variables. Each of the variables is graded and scored exponentially
as 1, 2, 4 or 8. The combined physiology and operative scores were subjected to
logistic regression analysis to generate risk equations that convert the scores into a
predicted percentage morbidity and mortality. However, attempted validation in both
general and subspecialty surgery has reported a lack of calibration of the initial
model and suggestions for remodelling of the regression equation have been
proposed U9~122. This led to the Vascular Surgical Society ofGreat Britain and
Ireland developing a risk equation specific for vascular surgery (V-POSSUM) 123.
Furthermore, specific evaluation of the POSSUM system in ruptured AAA repair
demonstrated that the equation performed poorly in emergency aortic surgery 105.
Subsequently, two further equations (one incorporating both physiology and
operative scores, while the other only used the physiology score) specifically for
ruptured AAA were derived from a retrospective series of 106 patients 124. Initial
validation was performed by the authors on a further set of 107 patients with
ruptured AAA. The physiology only equation, though effective, was found to have a
lack of fit at a certain risk range. However, the ruptured AAA POSSUM (RAAA-
POSSUM) equation that combined physiology and operative scores was more
successful at accurately predicting outcome. There have been two further series that
have examined the validity ofboth RAAA-POSSUM systems. Retrospective data on
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188 patients from Gloucester with ruptured AAA were subjected to both
equations113. Interestingly, both systems performed well with no difference in
observed and expected mortality results. A further non-consecutive, retrospective
series of 68 patients who survived for more than 24h after repair of a ruptured AAA
from Leicester also confirmed that although the two systems tended to slightly over-
predict mortality, there was no statistically significant lack of fit125. However, the
limitations of this highly selected data set are obvious.
To date, there has been no prospective validation of the RAAA-POSSUM systems.
Alhough the existing evidence suggests that they perform well, the utility of the
POSSUM system in clinical decision-making is questionable. It is important to
reiterate that the POSSUM methodology is principally for comparative audit. The
need for operative variables renders most POSSUM equations impractical for
preoperative risk prediction. The data required for the physiology RAAA-POSSUM
tool are easily recorded, though the need for complex mathematical equations can
make its utility cumbersome in the clinical setting. The system allows for more
precise risk stratification of patients than some of the other systems already
described. This level of accuracy may introduce even more complexity to clinical
decision-making. In the Gloucester study, one of 16 patients with a predicted
mortality risk of more than 80% survived and three of 21 with a risk of 70-80%
survived "3. Using this system, the absolute prediction of operative futility would
appear unfeasible.
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1.11.4. Vancouver Scoring System
Of scoring systems applicable to patients with ruptured AAA, the Vancouver system
is probably the least well known and utilised. Also reported in 1996, this
retrospective series examined 147 patients who underwent repair of a ruptured
aneurysm between 1984 and 1993 l26. Perioperative demographic and physiological
variables significantly associated with death on univariate analysis were subject to
further multivariate analyis.
Univariate analysis identified age, reduced conscious level, preoperative cardiac
arrest, history ofmyocardial infarction and a history of collapse as being associated
with postoperative death. After multivariate logistic regression analysis, age, reduced
conscious level and preoperative cardiac arrest remained as significant predictors of
death Table 1.11.4.
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Table 1.11.4. Vancouver scoring system predictive variables
Variable Category Coefficient Odds ratio P value
(Constant= -3.44) (95% CI)
Consciousness Conscious -1.14 3.1 (2.2-4.4) <0.01
Unconscious 1.14
Age 0.062 x age 1.9(1.5-2.3) <0.01
Cardiac arrest Yes 0.60 1.8(1.4-2.4) 0.03
No -0.60
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These variables could be entered into a predictive model equation on the basis of the
coefficients from the logistic regression model. The probability of death is estimated
using the equation ex / 1 + ex, where e is the base of the natural logarithm and x is the
constant + sum of coefficients for the significant variables.
The Vancouver group have also attempted to validate their statistical model. They
evaluated the performance of the instrument on a prospective series of 134 patients
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drawn from two tertiary centres . The authors contend that their system is accurate
at predicting patients at extreme risk (patients with a predicted mortality >90%).
However, the instrument seems to perform less well at lower levels ofmortality risk
(patients with a predicted mortality >80%). The group concluded that their tool was
of use in informing clinical decisions in patients with ruptured AAA, though unable
to identify a 100% mortality rate. Despite their assertion, this scoring system does
not seem to have gained support and been utilised by other centres. No further
independent validation is identifiable in the literature. Reasons for this may be
related to the cumbersome nature of the model. Though the variables utilised are
easily obtained, the need for coefficients and complex mathematical formula renders
it less practicable in the acute situation. The derivation of a percentage risk of death
is similar to the GAS and POSSUM systems. It may be that this instrument has a
utility for risk stratification for the purposes of audit, though more robust validation
is needed to assess its credentials. Its use in clinical decision-making in the acute
setting may be hampered by its complexity.
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1.11.5. Otherpredictive variables
Interest in the prediction of clinical outcome in patients with AAA rupture is
highlighted by the publication ofmore than 60 independent series investigating the
subject in the last 20 years alone. Though the preceding scoring systems are, perhaps,
the most sophisticated and well cited of these articles, the remainder also offer
potentially useful data to inform clinical judgement.
Of these further articles, eight report negative results and were unable to identify any
preoperative variables predictive of death after aneurysm rupture (Table 1.11.5)
125,127-33 jhggg studies, on 710 patients from European and North American centres,
are all retrospective in design. The median (range) sample size and mortality was 92
(33-140) and 49% (32%-64%) respectively. These data provide compelling evidence
for the argument that absolute prediction of outcome, in this disease, is impossible. It
is argued that withholding an operation on the basis of any predictive variables is
unsound and ethically unjustified 129. Some of the most highly regarded authorities in
vascular surgery have championed this thesis 134. It may also be assumed that there is
an even greater body of similar unpublished data in existence owing to the nature of
publication bias.
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Table 1.11.5. Series failing to identify variables predictive of death after operation.
Author Year of Number of Deaths 1
publication patients
Campbell127 1986 52 56
Vohra 128 1988 92 39
Harris 129 1991 113 64
Meesters 130 1994 99 49
Barry 131 1997 140 52
Hatori132 2000 33 39
Bown 125 2003 139* 32
Sultan 133 2004 42 60
Excludes patients who died within 24h of operation
However, examination of the available data generates some concerns. Of the three
series that study more than 100 patients, one excluded patients who died within the
first 24h of operation and another shared a dataset with a further publication, that a
year later reported female gender, preoperative hypotension, low haemoglobin and
19S 1^1
thrombocytopenia as being predictors ofmortality ' . Critics also have
questioned whether 'cardiac arrest' in these series simply represented an inability to
palpate pulses due to hypotension or arrhythmia rather than true cardiac asytole.
Nevertheless, irrespective of these deficiencies, such data cannot be ignored.
The remaining 54 series all describe one or more preoperative variables that were
predictive of outcome in 80944 patients (Table 1.11.6). The median (range) number
of patients studied was 119 (18-67751) and median (range) mortality was 47% (13%-
75%). It is noteworthy that only two studies were prospective in design 104il°7. Most
data have been subjected to multivariate statistical tests, where appropriate, though
some large series have only undertaken univariate analysis. Apart from Hardman, no
other group has robustly identified preoperative variables, either individually or in
combination, that are capable of defining a group with such a prohibitive risk of
death as to preclude intervention. Even patients with preoperative cardiac arrest, a
subgroup, intuitively, at extreme-risk ofmortality, are reported to have survival rates
158of up to 33% in certain series
Nevertheless, 10 variables regularly appear as significant predictors of death. If one
takes haematocrit and serum haemoglobin as analogous variables, six of these appear
more frequently than others. These six include hypotension, advanced age, cardiac
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arrest, raised serum creatinine, low haemoglobin/haematocrit and a history of
ischaemic heart disease. These variables or their correlates are all represented in the
established scoring systems described earlier. Though the risk factors of hypotension,
cardiac arrest, raised creatinine, low haemoglobin, loss of consiousness and ECG
ischaemia have retained independent statistical significance on multivariate analysis;
they are all implicated in the development, or a manifestation of systemic shock.
Furthermore, more than halfof these 54 publications identified hypotension as a
predictor ofmortality. Of the reported risk factors, female gender is, perhaps, the
most difficult to interpret. Four of the five datasets that describe this finding are
North American and have considerable sample sizes. The overrepresentation of
women in elective and emergency AAA mortality statistics is well described though
reasoning remains uncertain 180.
The existing literature suggests that there are preoperative variables associated with
perioperative death after AAA rupture. However, there is much to be desired in terms
of the quality and level of available evidence. In the past 20 years, there have been
no more than two published, prospective attempts to investigate risk factors
associated with death after aneurysm rupture. At present, no scoring system, or
variables, in combination or on its own, can be persuasively recommended as being
predictive of perioperative death and be utilised to influence treatment decisions. Of
the scoring systems in existence, none have been adequately validated to be of use in
dictating therapy or justifying clinical decision-making. At best, they are useful to
risk stratify patients for the purposes of audit and act as an adjunct to supplement
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clinical intuition. Until a scoring system that utilises sound methodology and robust
validation is available, experienced clinical judgement will remain of foremost
importance in the selection of patients for ruptured AAA repair.
Figure 1.11.2. Perioperative photo of completed open repair ofAAA
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A risk scoring system aims to consider a patient's characteristics and generate a
treatment independent risk of death. It attempts to rationalise and quantify a number
of patient related variables into a single number whose value corresponds to the
severity of the condition. Independent variables are selected using statistical
modelling techniques of which multiple logistic regression is the most common. The
use of scoring systems extends from comparative audit and research to clinical
decision-making. If a scoring system is to be put into clinical practice, it is essential
that it has undergone appropriate and robust validation. Furthermore, scoring systems
can evolve with time as further analysis and remodelling can improve their predictive
power.
The prediction of outcome for a given patient is subtly distinct from illness severity
scoring. Scoring systems aim to describe outcome as a statistical probability, ranging
from 0 to 1, that is derived from a measure of illness severity181. Therefore, it is
almost impossible for scoring systems to make absolute predictions of outcome.
Rather, it is possible to make predictions based on the assumption that that there is an
acceptable level of uncertainty. Thereby, if a 95% threshold of uncertainty is chosen,
it is assumed that probabilities equal or greater than 0.95 are associated with certain
prediction. It is rare for a scoring system to achieve such a high level of sensitivity
that major decisions on treatment withdrawal and limitation can be made safely.
Furthermore, there are certain intrinsic mathematical weaknesses with the
development of risk scoring systems. These flaws undermine, to an extent, the
reliability and predictive value of existing systems.
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Multiple logistic regression techniques are the most common statistical tool used in
the development of outcome prediction models. However, this technique is based
upon two assumptions that are not strictly fulfilled in outcome prediction. In a
regression analysis, it is best for the outcome variable to be continuous. Clearly, in
outcome prediction the variables are death or survival and are categoric in nature.
Secondly, an assumption is made that there is a linear relationship between the
dependent and independent variables. Again, it is unusual for mortality to display
such a linear association and a sigmoid relationship is more typical. This is illustrated
in Figure 1.12.1.
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Figure 1.12.1. The sigmoid shaped curve of risk ofhospital mortality against the
Simplified Acute Physiology Score II 182
SAPS II Score
Selection bias in the recruitment of patients to the original dataset, upon which a
scoring system is derived, can impair performance. Bias may also arise as a result of
small sample size or inadequate case-mix. This may be the case if a dataset is limited
to a single centre. In such cases, further validation in independent institutions is
necessary. It is also acknowledged that generic scoring systems underperform when
utilised in specific patient subgroups i.e. burns patients, paediatric patients. As a
result disease-specific scoring systems are preferable where possible. However, in
conditions with a low prevalence, it may be difficult to acquire a satisfactory sample
dataset on which to develop a scoring system.
The outcome measures that are used most frequently are in-hospital or 30-day
mortality. However, to a patient, their functional status on discharge is of great
important. Nonetheless, this outcome measure and its prediction is largely neglected.
In severe illness, the variables that may influence these outcomes are not confined to
those that are at play at the point of initial presentation and assessment.
Unfortunately, it is usually these initial variables that are utilised to score illness and
predict outcome. Sequential scoring may circumvent this problem but may result in
large amounts of conflicting data of little prognostic value.
Predictors for scoring system are generally selected from a combination of
demographic, physiological and therapeutic variables. It is ideal to try and generate
the most accurate value of risk scoring from the least number of predictors by
excluding variables that do not influence outcome. The selection of these variables is
performed by a combination of statistical modelling and on the basis of expert
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opinion. However, even the selection of variables for statistical assessment itself
introduces a subjective influence. Subjective judgement is also essential to select
predictors that can be easily measured and are practicable.
Statistical selection is performed using backwards elimination and forward selection.
An F statistic is generated to measure the contribution of variables to outcome.
Variables with little influence are discarded. Forward selection then adds the
variables with the strongest correlation coefficients until the most recently added
variable falls below a critical value. The weakness of these techniques is their
inability to assess indirect influences and variables with small effects. As a
consequence, predictive variables may be excluded and contribute to the weakness of
the instrument in making absolute judgements on outcome l83.
There are certain universal deficiencies common to the application of all scoring
systems. As already described, selection bias may be introduced from the sample
population that is used to derive a scoring system. Further bias may arise from the
method of recording variables, and in variation in reporting clinical signs or
symptoms. The desirable features in the application of a scoring system are data that
can be easily accessed and recorded, but can also be collected consistently and
accurately. This accuracy relates to any inter or intra observer variability. This has
been highlighted by reports demonstrating a higher severity illness scores when
automated information systems were used as opposed to manual recording 184.
Similarly, missing data may cause detection bias, and misclassification may occur
when rapid patient assessment is needed.
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With time, updating and modification of scoring systems may occur. Furthermore,
systems may be adapted to suit specific patient subgroups or populations. The
performance of a scoring system works best when it is customised to the behaviour
of a local environment and population. This limits the applicability of the system
across centres and hampers comparative audit. It also makes external validation
difficult. Nevertheless, even with customisation, it is difficult for a scoring system to
allow absolute predictions of outcome for an individual patient 185.
Any scoring system requires formal validation to assess its performance. Validation
may be described in four stages. Firstly, the performance is assessed in the original
development dataset. The instrument's performance is then assessed on a new but
separate dataset from the same institution. If performance is maintained, the model
can be applied to data from a separate centre. The instrument can then be compared
against other predictive tools that are regarded as the 'gold standard' to determine if
its performance is superior and it represents an advance l81. Finally, the scoring
system must have a useful clinical application.
Medical futility is regarded as having four independent aspects m. The first is
physiological and involves a condition that is refractory to therapy. The second is
imminent demise where, despite support, the patient's physiological stability cannot
be restored and the patient succumbs. The third is a patient with a uniformly lethal
condition (i.e. metastatic cancer) and the fourth where a patient's perception of their
quality of life after therapy is deemed unacceptable and potential benefit is
57
outweighed by risk. It is the first and second that are most relevant in the patient with
a ruptured aneurysm. This may be illustrated in the scenario of a patient who despite
resuscitative measures and urgent surgical repair does not regain physiological
stability and progressively deteriorates. A scoring system that could accurately aid in
the identification of such patients would be a useful prognostic tool and adjunct to
clinical judgement.
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1.13. Quality of life
The traditional measures of surgical outcome have been in terms of perioperative
morbidity and mortality. However, the importance of health-related quality of life
(HRQoL) in the assessment of outcome has gained increased recognition. The
rationalisation of health care finances has motivated the need to quantify outcomes of
medical interventions and in the evaluation of cost, quality of life issues must be
considered. Evaluation of a clinical intervention must not only take into account the
traditional primary outcomes of death, disability or cure but also the patient's
perspective of outcome. To assess the benefit of an intervention, evidence for the
impact on the patient in terms of health status and HRQoL is essential l87.
The efficacy and durability of elective AAA repair in terms of perioperative
morbidity and mortality, long-term survival, quality of life and cost-effectiveness are
well-established 188"190. The increase in the number of elective AAA repairs
performed has not resulted in an associated decline in the incidence of ruptured AAA
191. Despite advances in perioperative care, repair of ruptured AAA continues to be
associated with an operative mortality rate of 45% and high attendant financial cost
and resource utilisation ',192. Though survivors are reported to attain the same rates of
survival as the normal population, functional outcome in terms of HRQoL is
1Q"}
uncertain .
Clearly, it is impossible to assess HRQoL before RAAA surgery. However,
prospective follow-up of survival and functional recovery is entirely feasible.
Computerized and manual searches of the literature identified 14 studies
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investigating quality of life in patients who had survived operative repair of ruptured
AAA 194'206 (Table 1.13.1). Three articles from the original searches may be excluded
from review, as they do not undertake objective HRQoL assessment 204"206. All are
retrospective-observational studies in design. The limitations of retrospective study
are well established.
Of the 11 remaining studies, the time point between operation and HRQoL
assessment ranged between nine and 156-months. Functional recovery displays a
close temporal association and analogous studies of recovery following elective
repair of AAA have shown that HRQoL returns to preoperative levels or better six-
months after surgery . The considerable variation in follow-up period between
studies renders direct comparison difficult. With the progress of time following
ruptured AAA repair, patients become increasingly selected in that they have
survived to reach hospital, survived operative repair, survived their postoperative
recovery and agreed to HRQoL assessment. It may be argued that this process
specifically selects patients who are biologically more robust and predisposed to
achieve good functional outcomes.
Of the 11 studies reviewed, 10 report good functional outcomes for survivors of
ruptured AAA. Three of these 10 utilised HRQoL instruments designed by the
authors and though they provide interesting data, the usefulness and sensitivity in
determining functional outcome must be questioned.
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Of the seven studies that used validated HRQoL instruments and failed to establish a
difference in HRQoL after ruptured AAA repair, one used the Hopkins Symptom
Checklist and General Health Questionnaire, two were based on the Self-evaluation
of life scale instrument and four utilised the SF36 or RAND 36. All four tools are
generic instruments for HRQoL assessment and have been extensively used in
theassessment of functional outcome. In particular, the reliability, validity,
acceptability and consistency of the SF36, and its derivative the RAND 36, have
been confirmed. The SF36 is the most widely used quality of life instrument in the
medical literature and its use, as a quality of life measure in the assessment of
vascular disease, has been previously recommended 207.
Though generic instruments are designed to be used for all kinds of disease, generic
health questionnaires are disadvantaged in that they tend to lack sensitivity. Disease
specific instruments are designed to assess HRQoL in specific patient populations
assessing domains directly related to the impairments caused by the disease process
208. Disease specific instruments are thereby likely to be more sensitive to changes
between patients. However, to date no disease specific HRQoL instrument exists for
use in AAA and functional outcome remains largely assessed using generic tools.
Only one study reported significantly reduced HRQoL in survivors of ruptured AAA.
Magee and colleagues demonstrated a significant deterioration in functional outcome
following ruptured AAA repair when compared to elective repair l97. They noted a
fall in HRQoL from near perfect health preoperatively to considerable disability at
postoperative follow-up. Such a conclusive finding has not been reproduced in any
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other series reporting on ruptured AAA survivors. However, previous prospective
studies in patients surviving intensive care have shown similar reductions in HRQoL
209,210 jf sucj1 a fmciing were true for survivors of ruptured AAA repair, arguments
for aneurysm screening and elective repair would be further supported.
In the United Kingdom, the financial cost of ruptured AAA repair has been reported
to be almost double that of elective repair with an average cost of approximately
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£8000 . Nevertheless, cost-analyses of surgical repair of ruptured AAA have
shown that surgical treatment remains a cost-effective intervention 212. The
attainment of normal life expectancy after successful repair of ruptured AAA versus
the alternative of immediate death is the predominant reason for such a finding.
However, these analyses fail to consider outcome in terms of HRQoL and functional
outcome following repair of ruptured AAA remains largely uncertain. If survivors of
ruptured AAA were returned to a significant level of functional disability despite a
near-normal life expectancy, the benefit of intervention becomes less apparent.
Indeed, an intervention that encompasses a postoperative quality of life that will be
unacceptable to the patient may be regarded as futile 213. This concept has important
implications where a selective policy in the management of ruptured AAA is
employed; it could be argued that quality-adjusted survival rather than absolute
survival should be used to guide operative selection 200.
Current evidence suggests that the majority of survivors of RAAA may expect to
regain their preoperative quality of life. However, a proportion will experience
postoperative deterioration of their functional status. No reports exist to inform
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whether postoperative functional outcome can be correlated to preoperative risk
factors. The ability to predict patients at risk of impaired quality of life following
repair of ruptured AAA may have significant implications in preoperative patient
selection. Prospective studies with larger sample sizes are needed to clarify the
HRQoL outcomes of survivors of ruptured AAA repair and identify variables
predictive of functional disability.
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1.14. Aims
This thesis aims to:
• Examine potential predictors of mortality and assess current peri-operative
outcomes for ruptured AAA through retrospective study.
• Prospectively study patients presenting with ruptured AAA to determine novel
and established preoperative predictors of outcome.
• Validate existing scoring systems on a prospective cohort of patients and devise a
novel prognostic scoring instrument.
• Examine functional outcome status in patients who survive ruptured AAA repair.
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2. Glasgow Aneurysm Score andHardman Index
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2.1. Introduction
It has been proposed that the only means by which to improve outcomes after open
repair of ruptured AAA is to operate only on patients with reasonable operative risk.
Similarly, situations exist where it may be futile or even unethical to perform surgery
or to continue treatment in patients with prohibitive risk. However, no robustly
validated methods exist by which to identify those patients predisposed to mortality
following aneurysm repair and patient selection is frequently performed on the basis
of subjective assessment criteria.
As described in Chapter 1, the Glasgow Aneurysm Score (GAS) and Hardman Index
are two practicable, objective predictive scoring systems recommended for use in
patients with ruptured AAA in'115. This study aimed to assess their validity on a
contemporary series of patients from a single, high-volume centre.
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2.2. Methods
All patients admitted to the Edinburgh Vascular Surgical Service for repair of AAA
over a two-year period (January 2000 to December 2001) were identified from a
prospective database and included in a retrospective observational study. The
database, together with hospital records, provided demographic details, and clinical
and operative information, for all patients undergoing attempted repair of ruptured
AAA. Operation was defined as the delivery of an anaesthetic with the intention of
performing AAA repair. Ruptured aneurysm was defined as the presence of
retroperitoneal and/or intraperitoneal blood in the absence of any other identifiable
cause for haematoma other than an aneurysm 2I4. All patients were operated on by
one of six consultant vascular surgeons. The GAS and Hardman Index were recorded
for each patient and related to subsequent clinical outcome.
Methodology for the calculation of the Glasgow Aneurysm Score and Hardman
Index have been described in Chapter 1 and may be also found in Appendix 1.
Statistical analysis was performed using SPSS for Windows Release 11.0.0 (SPSS
Inc., Chicago, Illinois, USA). The receiver-operator characteristic (ROC) curve and
Chi squared test for trend was used to evaluate the performance of the GAS and
Hardman Index respectively in predicting postoperative death. Differences between
groups for non-parametric continuous variables were determined by the Mann-
Whitney U test; P < 0.05 was considered significant.
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2.3. Results
One hundred patients were admitted with ruptured AAA during the study period. Of
these, 18 (18%) patients were deemed unfit for aneurysm repair due to prohibitive
co-morbidity. There were 11 men and seven women of median (range) age 81 (66-
97) years. Eight patients had been previously assessed and deemed unsuitable for
elective repair. Reasons for non-operative management are listed in Table 2.1.
Median (range) GAS in patients who did not undergo operation was 102 (84-127).
These patients, in general, were not subject to a full remit of baseline investigations
on admission to allow accurate Hardman Index scoring.
The remaining 82 patients underwent attempted repair of ruptured AAA and are
included in the present analysis. There were 68 men and 14 women of median
(range) age 73 (54-87) years. Thirty (37%) patients died after operation while of all
patients admitted to hospital with a ruptured AAA during the study period, 48 (48%)
died.
Glasgow Aneurysm Score:
The GAS was a poor predictor ofmortality after ruptured AAA repair. The mortality
rates in terms of tertiles of GAS distribution are shown in Figure 2.1. The median
(range) GAS was not significantly different in patients who survived operative repair
and those who did not: 93 (57-125) versus 96 (71-115). Analysis of the ROC curve
showed that the GAS had an area under the curve of 0.606 (95% C.I. 0.483 - 0.729;
S.E. 0.063; P=0.112) for predicting perioperative death (Figure 2.2).
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Hardman Index:
There was no significant association between Hardman Index score and operative
mortality (P=0.211) (Table 2.2). Analysis of the ROC curve showed that the HI had
an area under the curve of 0.599 (95%CI 0.478 - 0.719) for predicting perioperative
death (Figure 2.2). Patients with no Hardman risk factors appeared to be at low risk
with an operative mortality of 15 per cent. However, of nine patients with three or
more Hardman risk factors, six survived aneurysm repair. The distribution of
Hardman risk factors in this subgroup is shown in Table 2.3. Of the six survivors,
four were discharged home, one was discharged to a spinal rehabilitation unit, due to
perioperative cord ischaemia, and one was discharged to a community rehabilitation
hospital. Median (range) survival in this group was 35.5 (1-53) months (Table 2.4).
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Table 2.1. Primary reason for refusal of surgery in 18 patients.
Reason for refusal Number of patients
Cardiorespiratory comorbidity 7
Cardiac arrest / Refractory LOC 3
Malignancy 3
Age related comorbidity 3
Dementia 2
LOC - Loss of consciousness
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Table 2.2. Distribution and mortality rates in 82 patients according to Hardman
Index.
Hardman Index 0 12 >3
No. of patients 26 (32%) 31 (38%) 16 (20%) 9 (11%)
No. of deaths 4(15%) 17(55%) 6(38%) 3(33%)
Values in parentheses are percentages
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Table 2.3. Distribution of risk factors in nine patients with three or more Hardman
Index variables.

















Values are median (range) unless otherwise stated
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Table 2.4. Long-term survival following hospital discharge in six patients with three
or more Hardman risk factors.








Table 2.5. Operative mortality according to Hardman index in four reported series.
Hardman Index
Series 0 12 >3
Hardman et al.4 16% 37% 72% 100%
154 patients
Prance et al. 7 18% 28% 48% 100%
69 patients
Neary et al. 12 35% 55% 74% 90%
188 patients
Boyle et al. 13 8% 24% 55% 100%
79 patients
Edinburgh 15% 55% 38% 33%
85 patients
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Glasgow Aneurysm Score tertiles
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Figure 2.2. Receiver operator characteristic curve of Glasgow Aneurysm Score and
Hardman Index and death
ROC Curve
1 - Specificity
Diagonal segments are produced by ties.







Subjecting patients at extreme operative risk to futile attempts at repair of ruptured
AAA has significant implications not only in terms of resource utilisation but also
from an ethical standpoint. It is for these reasons that the majority of vascular
surgeons in Great Britain and Ireland advocate the use of a selective policy in the
management of patients with ruptured AAA . A scoring system that could precisely
identify patients with ruptured AAA in whom operative intervention would be
unsuccessful would be a valuable tool for the practising vascular surgeon. To date
such an instrument remains elusive. To deny operation to a patient based on an
imprecise predictive tool would represent suboptimal practice. For this reason, any
proposed scoring system requires comprehensive and robust validation.
From the present data, both the GAS and Hardman Index appear to lack validity. The
GAS has recently been shown to demonstrate good validity when applied to elective
AAA repair 215-216. However, validation in patients with ruptured aneurysms is less
robust. Samy and colleagues have previously reported on 92 patients with ruptured
lesions from three centres "6. They concluded that scores over 95 were associated
with a mortality rate of 80%. From the present series, scores of 99 and more were
associated with an approximately 40% operative mortality. Indeed, it is impossible to
identify any score that confers extreme-risk and even in 14 patients with scores of
110 or more, operative mortality did not exceed 50 per cent. The Finnvasc Study
Group have recently reported on a nine-year, retrospective series of 836 patients with
ruptured AAA from 21 hospitals. This group showed the GAS to accurately predict
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postoperative mortality, but were unable to distinguish a cut-off for patients at
extreme risk 111.
The GAS was originally derived from an analysis of preoperative variables in
patients with intact or ruptured AAA. Though it displays good-fit as a predictive tool
for elective AAA repair, it seems to be less reliable when used solely in patients with
ruptured aneurysms, as seen in the present series. Its poor performance not only
questions its use in outcome prediction, but also as a risk-stratification tool for
comparative audit of ruptured AAA mortality.
Until now, the Hardman Index has been reported to show good validity and has been
recommended by four independent series (Table 2.5) 101'11M13_ its appeal is
heightened by its simplicity and ease of use. It has been unanimously concluded that
the presence of three or more Hardman risk factors in a patient, represents a
uniformly fatal prognosis. Combining these four series, of 32 patients with three or
more positive variables who underwent attempted aneurysm repair, all died apart
from one patient who survived to hospital discharge but succumbed six-weeks later
in a nursing home.
It is surprising that both scoring systems display such poor performance in the
current data. If the Hardman Index had been utilised as a means of selecting patients
for operation in the present series, six patients would have been denied life saving
operation. This is particularly alarming as four of these patients were successfully
discharged back to their home environment. There are several possible reasons for
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such a discrepancy compared to the previous series. Though the present data are
retrospective and susceptible to bias, so too are three of the four former reports that
have attempted to validate the Hardman Index. The current series reports from a
single high-volume centre, on consecutive patients operated on by a group of six
surgeons during a contemporary two-year study period. The operative mortality from
the current series is consistent with that regularly reported from our centre for
ruptured AAA repair and may influence the under-performance of both the Hardman
Index and GAS 214.
In contrast, preceding retrospective series have been drawn from prolonged study
periods or reported on non-consecutive patients ni"113. The two prospective
evaluations available in the literature pooled data from multiple centres 101,116.
Furthermore, the relationship between hospital and surgeon-volume and improved
outcome is established in elective aortic aneurysm repair and is likely to be present in
ruptured AAA repair 217,218. This may explain the superior performance of the GAS
in the Finnvasc Study Group data; where the majority of centres operated on fewer
than 10-ruptured aneurysms each year - high-risk patients may be more likely to
survive when managed in a high-volume centre 117.
The findings from the present study question the validity of both the GAS and
Hardman Index as predictive tools in patients with ruptured AAA. Both scoring
systems do not accurately predict mortality in high-risk patients and neither can be
recommended for routine use in clinical decision making. Further risk modelling
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with prospective validation is required in order to identify accurately and objectively
those patients in whom operative intervention may be inappropriate.
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3. Edinburgh RupturedAneurysm Score
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3.1. Introduction
Although the incidence of ruptured AAA is increasing in Europe, there is conflicting
evidence on which variables may be used to inform outcome prediction in patients
with ruptured AAA 8'101-145'219. The previous chapter from this thesis has shown that
the two most popular preoperative risk-scoring methods (Hardman Index and
Glasgow Aneurysm Score) lack validity and this finding has now been confirmed by
other centres 220,221. Reasons for this lack of fit may be related to the fact that the
existing models are derived from clinical data that are mostly two decades old and
which were accumulated over long study periods. Furthermore, they include results
from low-volume institutions. Their use cannot be recommended for the purpose of
clinical decision-making. The present study aimed to examine preoperative variables




All patients admitted to the Edinburgh Vascular Surgical Service who underwent
repair of ruptured AAA over a 31-month period (January 2000 to July 2002) were
identified from a prospective database and included in an observational study. The
database, together with hospital records, provided demographic details, and clinical
and operative information, for all patients undergoing attempted repair. Operation
was defined as the delivery of an anaesthetic with the intention of performing AAA
repair. Ruptured aneurysm was defined as the presence of retroperitoneal and/or
intraperitoneal blood in the absence of any other identifiable cause for haematoma
other than an aneurysm 214. All patients were operated on by a group of seven
vascular surgeons. Fifty-three preoperative variables, identified in other studies, or
suspected on clinical grounds, to be associated with mortality, were recorded for
each patient and related to subsequent outcome.
Loss of consciousness was defined as an in-hospital event and Glasgow Coma Scale
(GCS) was defined as the best recorded level in hospital. Cardiac symptoms were
typified by previous myocardial infarction, anginal symptoms or symptoms of
congestive cardiac failure. Respiratory symptoms were defined by dyspnoea at rest
or on exertion, and peripheral arterial disease was defined by a history of intermittent
claudication or critical limb ischaemia. Electrocardiographic (ECG) ischaemia was
typified by greater than 1 mm ST segment depression or an associated T-wave
change on the admission ECG.
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Statistical analysis was performed using SPSS for Windows Release 13.0.0 (SPSS
Inc., Chicago, Illinois, USA). Univariate differences between categoric variables
were compared using the chi-squared test with Yate's correction or Fisher's exact
test. Univariate differences between groups for parametric and non-parametric
continuous variables were determined by the unpaired student-t test and Mann-
Whitney U test respectively. P < 0.05 was considered significant. Multivariate
modelling examining the simultaneous and independent effect of the significant
demographic and clinical characteristics was then carried out using logistic
regression. Variables significant at the 10% level on univariate analysis were
included in the multivariate model. A stepwise (forwards-backwards) variable
selection procedure was adopted. Clinically relevant variables predictive of death
were then modeled to develop a prognostic risk score for ruptured AAA. The chi-
squared test for trend was used to compare the trend in actual mortality rate as related
to increasing risk score.
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3.3. Results
One hundred and twenty-nine consecutive patients were admitted with ruptured
AAA during the study period. Of these, 105 (81%) underwent attempted open repair
and 24 (19%) were deemed unsuitable for operation due to prohibitive co-morbidity.
Of the 105 patients undergoing attempted open repair, 91 were men and 14 were
women. The mean (SD) age of the study population was 72 (7) years. Forty-seven
(45%) patients were transferred from another hospital and the remainder were
referred directly to the vascular surgical service by their general practitioner, the
Emergency Department or by another specialty within our institution.
Nineteen patients required a secondary intervention following their aneurysm repair.
Twelve (58%) of these patients needed a further laparotomy for haemostasis, three
(16%) needed colonic resection and five (25%) needed some other form of
intervention; one patient required two secondary interventions. There were 39 (37%)
deaths in-hospital or within 30-days of operation. Sixteen (41%) of these patients
died during surgery of massive haemorrhage or cardiac arrest. Eighteen (46%) died
of multiorgan failure, and five (13%) died of other causes. Of 66 surviving patients,
61 (92%) suffered one or more postoperative complications as defined by the
Committee on Reporting Standards of the Society for Vascular Surgery and the
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North American Chapter of the International Society for Cardiovascular Surgery
Preoperative variables predictive of death after attempted repair of ruptured AAA are
listed in Tables 3.1 and 3.2. Of the continuous variables only haemoglobin and blood
pressure were predictive of perioperative death. These continuous variables were
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stratified to create categoric variables for further univariate analysis. Of all categoric
variables, loss of consciousness, cardiac arrest, haemoglobin of <9g/dl,
BP<90mmHg and GCS <15 were associated with perioperative death. However, loss
of consciousness and cardiac arrest were observed in only eight and five patients
respectively.
On logistic regression analysis of these five variables, none reach significance at the
5% level. Exclusion of the variables loss of consciousness and cardiac arrest yields
the multivariate model seen in Table 3.3. The remaining variables were retained to
determine the cumulative effect ofmultiple risk factors in a scoring system. With risk
factors equally weighted, three probands of risk were established (Table 3.4). There
was a significant association between actual mortality and cumulative risk factors
(P=0.003).
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Table 3.1. Univariate analysis of preoperative continuous variables
Variable Number of Mean (SD) or Mean (SD) or P value
missing median (range) of median (range)
cases survivors of non survivors
Age 71.9(7.4) 73.6 (6.7) 0.250
Duration of symptoms (h) 6 6 (0-240) 4(1-72) 0.218
Haemoglobin (g/dl) 1 12.0 (2.5) 10.7 (3.1) 0.038
White cell count (xl09/l) 1 13.8(6.5-33.7) 13.8 (5.2-31.1) 0.989
Platelets (xl09/l) 3 195 (90-569) 207 (71-522) 0.353
Prothrombin time (s) 23 10(8-31) 11 (9-62) 0.256
Aptt*(s) 25 32 (24-52) 32 (24-210) 0.206
Fibrinogen (g/1) 25 3.5 (1.5) 3.2(1.5) 0.386
Urea (mmol/1) 1 7.6(3.2-10.3) 7.0 (3.2-13.7) 0.688
Creatinine (pmol/1) 1 124 (78-498) 141 (84-263) 0.169
Albumin (g/1) 20 36(19-51) 35 (17-45) 0.118
Sodium (mmol/1) 1 138 (124-148) 139 (122-148) 0.089
Potassium (mmol/1) 1 4.0 (0.7) 4.0 (0.5) 0.996
Alanine Transaminase (u/1) 20 14(6-221) 12(5-154) 0.205
Highest pulse rate (bpm) 9 95 (55-190) 99 (60-130) 0.794
Lowest BP (mmHg) 5 80 (50-165) 73 (0-135) 0.003
Highest BP (mmHg) 10 150 (33) 135 (36) 0.049
*Activated Partial Thromboplastin Time
Table 3.2. Univariate analysis of preoperative categoric variables
Variable Number of Number of Number of P value
missing observations observations
cases (Survivors) (Non survivors)
Age >=75 years 24 20 0.196
Female sex 8 5 l.OOOf
Inter hospital transfer 28 19 0.672
Loss of consciousness 6 2 6 0.022f
Cardiac arrest 0 5 0.006t
ECG ischaemia 7 22 16 0.313
Hb <9g/dl 1 7 11 0.038
Creatinine >190 pmol /I 1 8 3 0.742
BP <90mmHg 5 33 29 0.036
GCS <15 5 14 17 0.016
Diabetes 5 4 0 0.310f
Cardiac symptoms 6 24 12 0.921
Respiratory symptoms 4 30 17 l.OOOf
Peripheral arterial disease 4 7 0.095|
Previous vascular intervention 0 1 0.371 f
Warfarin therapy 0 2 0.136f
Beta blocker therapy 19 8 0.480
Steroid therapy 2 1 l.ooot
Anti-platelet therapy 32 15 0.710
Anti-anginal therapy 10 3 0.363|
Preoperative inotropes 1 3 0.143t
t Fisher's exact test
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Table 3.4. Mortality ofpatients with three equally weighted risk factors






















Many authors have attempted to identify preoperative variables that predict outcome
and which might define the group of patients at extreme risk who would not benefit
from operation after AAA rupture. However, there has been little consistency in
reported findings and poor reproducibility among differing patient populations.
Furthermore, data from the preceding chapter showed that two well-established
scoring systems, the Hardman Index and the Glasgow Aneurysm Score, widely held
to be credible instruments in risk prediction, lack validity. There are several possible
reasons for the poor performance of the present data, when applied to existing
scoring models. In contrast to much of the existing data, the present series represents
a large number of patients accumulated over a short contemporary study period and
operated on exclusively by a small group of specialist vascular surgeons. This is
likely to minimise some of the bias associated with other retrospective analyses.
These data come from a high volume tertiary unit serving a Scottish population of
approximately 1 million individuals. Scoring systems will always reflect the specific
population and study period from which they were designed and modelled. For this
reason, although a scoring system may hold true for one population, it must not be
assumed to do so for other populations without appropriate, and ongoing, validation
223. While it may be argued that the current data are vulnerable to selection bias, as
some patients were palliated and not subjected to attempted operation, there is no
other ruptured AAA risk scoring system that has been modelled on patients treated
by a specialist vascular service over the last decade.
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Of the well-known predictive instruments for ruptured AAA, all include age as a risk
factor. In contrast, age was not found to be a significant risk factor in the present
series. Age may be considered an indirect marker of physiological status, and from
these data seemed to lack sensitivity as a predictor of adverse outcome. However, it
may also be considered surprising that renal function, as represented by serum
creatinine, was not identified as a predictive variable when it too is included in both
the Hardman and Glasgow scores. Preoperative creatinine >130pmol/l is recognised
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as a perioperative risk factor for adverse outcome in non-cardiac surgery
However, overall median (range) creatinine in the current series was 129 (78-498)
p.mol/1. This may imply that the majority of patients with ruptured AAA had
evidence of preoperative renal dysfunction and so creatinine might lack predictive
value in this circumstance. Review of existing literature reveals much conflicting
data and there is no consensus on the usefulness of creatinine as a risk factor for
perioperative death.
From the present data, the goal of a scoring system that can accurately predict all
patients in whom attempted repair will prove futile seems unrealistic. Although five
significant risk factors were identified on univariate analysis, these all failed to retain
significance at the 5% level when subjected to multivariate modelling. Of the five,
in-hospital loss of consciousness and cardiac arrest may be disregarded as useful
predictive variables because of their low observed frequency. The two were only
observed in eight and five patients respectively and are vulnerable to a type I error.
Preoperative loss of consciousness was associated with death in six of the eight
patients and cardiac arrest was invariably associated with death; a naturally intuitive
finding. However, previous work has shown that unconsciousness and cardiac arrest
are not always fatal after aneurysm rupture 158,172. Although they have been
frequently cited as useful risk factors predicting death after ruptured AAA, and one is
a component of the Hardman Index, it is unlikely that there is any single preoperative
variable that in isolation can predict unsuccessful outcome across different patient
populations.
The remaining three variables noted on univariate analysis were retained for analysis
in a multivariate model. Alhough they all lose significance at the 5% level, there is a
trend to significance at an alpha level of 10%. The variables of haemoglobin <9g/dl,
shock (BP<90mmHg) and GCS <15 are sensitive markers of physiological condition
- haemoglobin level and blood pressure being directly proportional to tissue oxygen
delivery, and GCS an indicator of adequate cerebral perfusion. All three variables
have odd ratios of approximately two. When applied to an equally weighted,
cumulative model of risk scoring, there are three clearly identifiable tiers of risk.
Although even the most extreme band of risk is still associated with a 20% chance of
survival, the instrument provides a useful method of assigning patients to a low,
medium or high risk category prior to attempted operation. Furthermore, all three
variables in the proposed model can be measured within a few minutes of a patient's
arrival in the emergency department. The risk score can then be used to inform
patients, and relatives, objectively of their illness severity and operative risk.
These data represent a novel predictive risk model for patients with ruptured AAA
from a single UK tertiary centre. Though this instrument cannot be recommended
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for use in patient selection at present, its potential utility in comparative audit and
supporting clinical judgement warrants further prospective validation.
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The Glasgow Aneurysm Score (GAS), Hardman Index, and Physiological and
Operative Severity Score for the enumeration of Mortality and morbidity
(POSSUM) risk equations are predictive scoring systems recommended for use in
patients with ruptured AAA 11 '115'118. a previous chapter in this thesis describes the
Edinburgh Ruptured Aneurysm Score (ERAS), a further novel prognostic index that,
in contrast to other scores, was derived from a contemporary dataset. However, none
of these scoring systems have been adequately validated to be of use in dictating
therapy or justifying clinical decision-making.
This prospective study examined preoperative variables predictive of death after
AAA rupture and assessed the validity of existing scoring systems.
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4.2. Methods
Local Research Ethics Committee approval was obtained for this research. All
patients admitted to the Edinburgh Vascular Surgical Service for repair of a ruptured
AAA over a two-year period (August 2002 to December 2004) were included.
Operation was defined as the delivery of an anaesthetic with the intention of
performing AAA repair. Ruptured aneurysm was defined as the presence of
retroperitoneal and/or intraperitoneal blood in the absence of any other identifiable
cause for haematoma other than an aneurysm 214. All patients were operated on by a
group of five consultant vascular surgeons. Fifty-three preoperative variables,
identified in other studies, or suspected on clinical grounds, to be associated with
mortality, the GAS, Hardman Index V-POSSUM and RAAA-POSSUM (physiology
only) scores and ERAS were recorded for each patient and related to subsequent
clinical outcome. Surgical intervention was generally not undertaken if the patient
declined operation, if the patient had a known serious comorbidity such as advanced
malignancy, or if the patient was otherwise unsuitable, such as refractory loss of
consciousness or cardiac arrest, severe dementia or poor functional status.
Methodology for the calculation of the Glasgow Aneurysm Score, Hardman Index
and POSSUM scores have been described in Chapter 1 and may also be found in
Appendix 1. The ERAS is decribed in the preceding chapter and is also found in
Appendix 1.
Statistical analysis was performed using SPSS for Windows Release 13.0.0 (SPSS
Inc., Chicago, Illinois, USA). The receiver-operator characteristic (ROC) curve and
Chi squared test for trend was used to evaluate the performance of the GAS,
Hardman Index and ERAS in predicting postoperative death. POSSUM predicted
mortality was compared by means of the chi-squared test, using the methods




One hundred and eleven patients were admitted with ruptured AAA during the study
period. Of these, 27 (24%) patients were deemed unfit for aneurysm repair due to
prohibitive co-morbidity. There were 17 men and 10 women of median (range) age
79 (58-92) years. Reasons for non-operative management are listed in Table 4.1.
Risk scores (GAS, HI, V-POSSUM and RAAA-POSSUM mortality scores and
ERAS) in the 11 patients who were turned down for surgery on the basis of
comorbidity (apart from malignancy) are shown in Table 4.2.
The remaining 84 patients underwent attempted repair of ruptured AAA and are
included in the present analysis. There were 74 men and 10 women of median
(range) age 73 (53-87) years. Thirty-seven (44%) patients died after operation while
of all patients admitted to hospital with a ruptured AAA during the study period, 63
(57%) died. (One patient who did not undergo attempted repair survived her ruptured
AAA and was discharged to a nursing home.)
Glasgow Aneurysm Score:
The mortality rates in terms of tertiles of GAS distribution are shown in Figure 4.1.
The GAS was statistically related to mortality after attempted repair of ruptured
AAA. The median (range) GAS was significantly lower in patients who survived
operative repair than those who did not: 90 (61-127) versus 99 (66-126) (P=0.027).
Analysis of the ROC curve showed that the GAS had an area under the curve of 0.64
(95% CI 0.52-0.76) for predicting perioperative death (Figure 4.2).
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Hardman Index:
There was a significant association between HI score and operative mortality
(P=0.010) (Table 4.3). Analysis of the ROC curve showed that the HI had an area
under the curve of 0.685 (95%CI 0.568 - 0.802) for predicting perioperative death
(Figure 4.2).
Edinburgh Ruptured Aneurysm Score:
There was a significant association between ERAS score and operative mortality
(P<0.001) (Table 4.4). Analysis of the ROC curve showed that the ERAS had the
largest area under the curve of 0.72 (95%CI 0.61-0.83) for predicting perioperative
death (Figure 4.2).
POSSUM:
There was a significant association between POSSUM physiology score and
operative mortality (P=0.002). ROC curve analysis showed that the physiology score
had an area under the curve of 0.70 (95%CI 0.59 - 0.82) for predicting perioperative
death (Figure 4.2). Table 4.5 shows the predicted risk of death and observed
mortality rate for each of the POSSUM models used. The V-POSSUM (physiology
only) model did not demonstrate a lack of fit (P=0.086). However, the RAAA-
POSSUM (physiology only) model demonstrated a significant lack of fit (P=0.009).
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Table 4.1. Primary reason for refusal of surgery in 27 patients.
Reason for refusal Number of patients
Cardiac arrest / Refractory LOC 13
Cardiorespiratory comorbidity 6
Age related comorbidity 5
Patient wishes 2
Malignancy 1
LOC - Loss of consciousness
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Table 4.2. Risk scores in 11 patients who were palliated due to comorbidity.















renal failure 83 121 3 88 91 2
4 Cardiac









disease 80 97 1 31 63 1
7 Previous
disabling
stroke 71 120 2 79 87 2
8 Preexisting
severe brain
injury 76 100 1 31 63 2
9 Severe
dementia 76 110 2 45 72 2
10 Extreme
age 92 116 2 71 83 3
11 Extreme
age 92 119 1 15 49 2
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Table 4.3. Distribution and mortality rates in 84 patients according to Hardman
Index.
Hardman Index 0 12 >3
No. of patients 21 (25%) 34 (40%) 18 (21%) 11(13%)
No. of deaths 6(29%) 11(32%) 12(67%) 8(73%)
Values in parentheses are percentages
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Table 4.4. Distribution and mortality rates in 84 patients according to Edinburgh
Ruptured Aneurysm Score.
Edinburgh Ruptured <1 2 3
Aneurysm Score
No. of patients 46(55%) 27 (32%) 11(13%)
No. of deaths 12(26%) 16(59%) 9(82%)
Values in parentheses are percentages
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Table 4.5. Predicted and observed mortality according to V-POSSUM (physiology








































































Glasgow Aneurysm Score tertiles
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Figure 4.2. Receiver operator characteristic curve of Hardman Index, Glasgow




Diagonal segments are produced by ties.








Although there have been several attempts to devise a prognostic score with which to
predict outcome in patients with ruptured AAA, few have undergone robust
validation. An earlier chapter has shown from retrospective data, that two of the most
well known scoring systems lack validity. The use of an imprecise predictive tool to
justify clinical-decision making is open to question.
The GAS was derived from an analysis of preoperative variables in patients with
intact or ruptured AAA admitted to general surgical units in Glasgow in the 1980s
115 prevjous validation of this instrument has come from prospective data on 92
patients pooled from three Scottish centres, retrospective data on 836 patients from
the multi-centre Finnvasc database, retrospective data on 181 patients from a tertiary
vascular centre in Rome and 84 patients from our own institution 116'117'221 Apart
from the Edinburgh data, the other datasets commend the GAS for its predictive
power and validity. The Italian data described an area under the curve on ROC
analysis of >0.9 whereas the Finnvasc group reported an area under the curve of 0.75
117'221. Interestingly, the more recent data from Rome noted that no patient with a
GAS of >100 survived while the Finnish data describe a mortality rate of
approximately 80% for patients with a score of >98 ll7'221- Similarly, the original
Glasgow authors reported that scores of >95 were associated with a mortality rate of
80% 116.
The present prospective data contradict the findings of these three previous series.
Though the GAS was statistically associated with mortality, the observed area under
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the curve of 0.641 is much more modest and supports our previously reported
retrospective data. Though the GAS does appear to perform better in the current
prospective series, it does not appear to stratify patients into useful tiers of risk.
Patients with scores of <90 are at low risk, but it appears difficult to identify the
group ofmost interest; those patients at extreme-risk. Of the 19 patients with a score
of 110 or more, only 11 (58%) died. Reasons for the contrasting performance of the
GAS when applied to our data have already been described. The majority of the
preceding data stemmed from low-volume institutions that operated on fewer than
20-ruptured AAA patients each year. It seems likely that the relationship between
hospital and surgeon-volume and improved outcome is likely to play a significant
part ,79<226.
The Hardman Index is, perhaps, the most well-known predictive instrument in
patients with ruptured AAA. To date, including data from this thesis, there have been
10 series examining validity; only one has been prospective 101-n 1-114,220,221,227,228
Initial reports and consensus was that the Hardman Index accurately predicted
mortality after ruptured AAA. The presence of 3 or more variables was widely held
to be fatal 101>"2. However, more recent data have shown that the instrument may not
perform as well as initially reported, and that the presence of 3 or more variables is
not always associated with death 220>221>22s_ The present prospective data confirm that
the Hardman Index may not display as convincing validity as initially reported.
Though increasing score is associated with death, its predictive ability is, again, only
moderate with an area under the curve of 0.684; less than previously reported.
Patients with none or 1 positive variable were at low-risk with an observed mortality
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of approximately 30% for both groups. However, the Index does not clearly identify
the group of patients who are at extreme-risk. Of 11 patients with three or more
variables, only eight (73%) died, while of the 18 patients with 2 variables, 12 (67%)
died. These data confirm that the score cannot define a group of patients in whom
attempted operation is futile. The merits of the present data are not only its
prospective nature, but the fact that only one patient had an incomplete set of scoring
data. In the existing literature, data have been unavailable for up to 42% of patients
228. Indeed, in the only other reported prospective study, data were missing on almost
a third of patients 101.
The POSSUM score is a tool that was designed to support comparative audit. It is
important to recognize that it is not recommended for the prediction of outcome.
There has been no prospective validation of the POSSUM risk equations
recommended for vascular surgery when applied to patients with ruptured AAA. Of
the existing retrospective literature, both the RAAA-POSSUM and V-POSSUM
equations were shown accurately to predict risk when applied to preoperative data on
191 patients from Gloucester 113. From the present preoperative data, both equations
do not perform well, though only the RAAA-POSSUM model demonstrated a
significant lack of fit. The RAAA-POSSUM model over predicted risk while the V-
POSSUM model tended to under predict risk at the lower bands of predicted risk.
This lack of fit raises concerns about its use as a risk-stratification tool for
comparative audit of ruptured AAA mortality. Reasons for the discrepancy are
unclear but further validation of this model is clearly needed. Nevertheless, the
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complex nature of POSSUM risks equations, and the need to obtain 12 different
variables renders the score less practicable for use in the acute setting.
The ERAS was modelled on retrospective data from patients presenting to our
institution with ruptured AAA over a two-year period. It has had no internal or
external validation and cannot be recommended for clinical use at present. When
applied to the present data, the score was significantly associated with perioperative
death. The appeal of this scoring system is its simplicity and the ease with which the
3 components of the score can be obtained and applied, even haemoglobin
concentration can be rapidly assessed using point of care testing. Furthermore, as
observed on the intitial dataset, three tiers of risk were discernible. None or one
variable was associated with an approximately 30% risk of death while the presence
of all three variables was associated with an 80% risk. Two variables were associated
with an intermediate risk of between 50-60%. The limitations of this scoring system
are acknowledged. It has been specifically modelled on a unique dataset and may not
be applicable or show validity on external data.
These are the first prospective data to evaluate comprehensively the main scoring
instruments recommended for use in ruptured AAA repair. The GAS and HI both did
not perform as well as predictive instruments as reported previously. Furthermore,
the V-POSSUM and RAAA-POSSUM also did not demonstrate compelling validity
when applied to these data. The ERAS is an easily applied scoring system that allows
patients to be quickly allocated to a low, medium and high-risk of perioperative
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death. However, it does not enable the prediction of surgical futility. Further external





Death and postoperative morbidity in patients who undergo technically successful
repair of a ruptured aneurysm are generally attributed to the development of
multiorgan failure, thomboembolic events and myocardial infarction 62. Nevertheless,
myocardial injury remains a frequently under recognised complication in the
perioperative period.
Cardiac troponin I (cTnl) is a highly sensitive and specific marker for myocardial
injury. In surgical patients cTnl has been shown to identify perioperative myocardial
infarction (MI) more accurately than the conventional creatinine kinase-MB fraction
isoenzyme 229. In non-surgical patients with acute coronary syndromes, even small
elevations of cTnl are associated with an increased risk ofmortality and reinfarction
9"3f) 'J *3 1
'
. However, the implications of perioperative myocardial injury in terms of
clinical outcome and its role as a risk-stratification and prognostic tool are uncertain.
It is unclear whether perioperative myocardial injury after emergency aortic surgery,
diagnosed on the basis of cTnl, confers the same prognostic implications as
traditional markers ofmyocardial infarction.
This study examined the relationship between early perioperative myocardial injury,




Local Research Ethics Committee approval was obtained for this study. Patients
undergoing attempted operative repair of ruptured AAA over a 22-month period
(October 2002 to July 2004 inclusive) and who survived for more than 24h were
included in a prospective observational cohort study. Ruptured aneurysm was
defined as the presence of retroperitoneal and/or intraperitoneal blood in the absence
of any other identifiable cause of haematoma other than an aneurysm214.
Demographic and clinical variables for all patients were recorded. Preoperative
cardiac and postoperative physiological risk stratification was carried out using the
Detsky cardiac risk index and the Acute Physiology and Chronic Health Evaluation
9-39 9-3-3
II (APACHE II) score respectively ' . All patients were operated on by a group of
five consultant vascular surgeons.
Blood was sampled for cTnl on the patients' admission to the emergency room and
on the first and second days after operation. These time points were chosen as
representing the period of greatest risk of cardiac complications after vascular
surgery 234. Samples were collected in sterile, lithium heparin tubes (Sarstedt AG &
Co. Ntimbrecht, Germany) and analysed in the Clinical Biochemistry Laboratory of
the Royal Infirmary of Edinburgh. Sample analysis was performed with an
automated immunometric assay (Ortho-Clinical Diagnostics, Amersham, Bucks,
UK). The 10% coefficient of variation level was 0.3 pg/L.
Primary outcomes assessed were postoperative mortality, defined by death in-
hospital or within 30-days of operation, and perioperative cardiac dysfunction.
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Cardiac dysfunction was determined on the following clinical and
electrocardiographic grounds: prolonged cardiac chest pain, signs or symptoms of
congestive heart failure, and electrocardiographic changes indicating ischaemia or a
new persistent arrhythmia. Echocardiography was performed only when clinically
indicated. Secondary outcomes included duration of mechanical ventilation, duration
of critical care unit stay (intensive care unit or high dependency unit), and total
hospital stay.
Statistical analysis was performed using SPSS for Windows Release 11.0.0 (SPSS
Inc., Chicago, Illinois, USA). Univariate analyses between groups were determined
by i or Fisher's exact test for categoric variables and Mann-Whitney U test for non-
parametric continuous variables; P < 0.05 was considered significant.
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5.3. Results
Eighty consecutive patients were admitted with ruptured AAA during the study
period. Of these, 62 (78%) underwent attempted open repair and 18 (22%) were
deemed unsuitable for operation due to prohibitive co-morbidity. Of the 62 patients
undergoing operation, 11 (18%) died during surgery and one (2%) died soon after
admission to the intensive care unit. Preoperative cTnl levels were normal in these
12 patients. The remaining 50 (80%) patients survived for 24h or more and all but
one survived for more than 48h. There were 44 men and six women of median
(range) age 71 (53-87) years. Forty-two (84%) patients had a contained
retroperitoneal rupture and eight (16%) had free intraperitoneal blood at laparotomy.
Twelve (24%) patients required temporary cross clamping of the suprarenal aorta
while the remainder were managed with control of the infrarenal aorta. Thirty-eight
patients (76%) had an aortic tube graft inserted and 12 (24%) required a bifurcated
graft. No patient was dialysis dependent before operation but 19 (38%) had evidence
of pre-existing renal insufficiency (serum creatinine >150pg/L) on admission.
Twenty-three (46%) patients had a detectable cTnl level at one or more time points
during the first 48h after operation. Of these, only two (4%) patients had an elevated
cTnl on admission, both of whom had a preoperative serum creatinine >150pg/L.
Twenty-two (96%) of the 23 patients had elevated cTnl levels by the first
postoperative day. There were no significant differences in Detsky cardiac risk index
or APACHE II scores between patients with, and without, a perioperative cTnl
elevation. The distribution of demographic and clinical variables between both
groups is shown in Table 5.1.
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Of the 23 patients with an elevated cTnl, 11 had clinical or electrocardiographic
evidence of acute cardiac dysfunction during the first 48h after operation. The
remaining 12 did not have any clinically apparent cardiac events despite elevated
cTnl levels. Patients with occult cardiac dysfunction had significantly lower median
(range) cTnl levels than those with a clinically evident cardiac event (0.52 (0.28-
1.65) pg/L versus 12.7 (1.31-67.5) pg/L; P<0.001).
Thirteen (26%) of 50 patients died in the postoperative period. Ten (77%) of the 13
had an elevated cTnl at one or more time points in the first 48h - five (45%) deaths in
11 patients with elevated cTnl and clinical evidence of a cardiac event, and five
(43%) deaths in 12 patients with elevated cTnl but no apparent cardiac dysfunction.
There were only three (11%) deaths in the 27 patients who had no perioperative
elevation of cTnl, significantly fewer than both groups of patients with elevated cTnl
levels (P=0.031 and P=0.043 respectively). Of these three deaths, one patient died on
the fourth postoperative day from multi-organ failure, one on the 38th postoperative
day from respiratory failure, and one on the 46th postoperative day from an aorto-
enteric fistula. Causes of death are shown in Table 5.2.
Patients with elevated cTnl levels who survived spent a significantly longer period in
the intensive care and high dependency units than those with no perioperative cTnl
elevation (P=0.038). Total in-hospital stay and duration of mechanical ventilation
were not significantly different between the two groups (Table 5.3).
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Table 5.1. Demographic and clinical variables in 27 patients without and 23 patients
with perioperative cardiac troponin I (cTnl) elevation.
Variable cTnl -ve cTnl +ve P value
Female sex 3 (11%) 3 (13%) 0.834f
Age (years) 69 (53-87) 75 (63-82) 0.031*
Detsky cardiac 15 (10-30) 15 (10-65) 0.147*
index
Preop. creatinine 6 (26%) 13 (57%) 0.013+
>150pg/L
Suprarenal aortic 4(15%) 8 (35%) 0.183+
clamp
Blood loss (ml) 3000(1325-8500) 4600(1070-21000) 0.062*
Bifurcated graft 4(15%) 8 (35%) 0.183f
APACHE II score 16(18-33) 19(10-30) 0.065*
Values are median (range) or number of patients (%)
*
- Mann-Whitney Utest; ' - Fisher's exact test
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Table 5.2. Causes of death in three patients without and 10 patients with
perioperative cardiac troponin I (cTnl) elevation.
Cause of death cTnl -ve cTnl +ve
Multiorgan failure 1 7
Respiratory failure 1 3
Aortoenteric fistula 1
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Table 5.3. Outcomes in 27 patients without, and 23 with, perioperative cardiac
troponin I (cTnl) elevation.
Outcome
Critical care stay -Survivors
and non-survivors
Duration of ventilation -
Survivors and non-survivors
Total hospital stay -
Survivors and non-survivors
Critical care stay - Survivors




Values are median (range) days
Mann-Whitney U test
cTnl -ve cTnl +ve P value
3 (1-38) 6(1-46) 0.031
1 (1-38) 2.5 (1-43) 0.008
14(4-56) 12 (1-58) 0.711
3 (1-11) 5 (1-42) 0.038
1 (1-5) 1 (1-38) 0.199
14(7-56) 18 (8-58) 0.202
122
5.4. Discussion
A previous non-consecutive series of selected patients undergoing ruptured AAA
repair in this hospital had an incidence of perioperative myocardial injury in excess
of 50% 76. Present data confirm that around half the patients who survive repair of a
ruptured AAA sustain a detectable perioperative myocardial injury. Of these, roughly
halfwill have a clinically silent event, with low-level cTnl elevation. In comparison,
approximately a quarter of the patients who undergo a major vascular surgical
operation develop perioperative myocardial injury as determined by raised cardiac
troponins 229. The incidence of myocardial injury in critically ill patients on intensive
care units is similarly reported to be between 15 and 40% 235"7. It may be inferred that
patients with ruptured AAA are subject to a greater risk of perioperative cardiac
injury. This is likely to reflect the impact of massive haemorrhage and transfusion,
compounded by the attendant burden of cardiovascular comorbidity that is common
in this patient population. However, it is of interest to note in the present series that
preoperative cardiac status, as assessed by the Detsky risk index, was not associated
with postoperative myocardial injury. It is acknowledged that the sample size of this
series does not permit a more meaningful multivariate analysis of perioperative
variables associated with myocardial injury and outcome.
Cardiac troponins are recommended as the standard biomarker for the diagnosis of
myocardial infarction and as a risk-stratification tool in patients with acute coronary
syndromes 63-238. Cardiac troponins may also be elevated in other clinical conditions
and confer similar prognostic value in patients with sepsis, renal failure and
pulmonary embolism 66. It is now acknowledged that even minor elevations of
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cardiac troponin, below the diagnostic criteria for myocardial infarction, are
oiq
indicative of increased clinical risk . The present series demonstrates that slight,
clinically silent elevations of cTnl within the first 48h after operation confer an
increased risk of postoperative death. In contrast, only one of 27 patients without a
cTnl rise died within 30-days of operation. In terms of secondary outcomes, patients
with raised cTnl also required significantly longer stays on the critical care unit.
Though total hospital stay was not significantly different between patients with, and
without, cTnl elevations, it is recognised that hospital stay, unlike critical care unit
stay, may be influenced by circumstances unrelated to a patient's clinical condition.
Are raised cTnl levels a marker of the severity of the patients' critical illness and its
consequent adverse outcome, or is there a causal relationship between myocardial
dysfunction and subsequent morbidity and mortality? The proposed mechanisms of
raised cardiac troponin, apart from myocardial necrosis, include leakage of cardiac
proteins from myocyte cell membranes 66. Tumour necrosis factor-a (TNF-a) is
known to increase endothelial permeablility and may be implicated at the cardiac
myocyte level too 240'241. Patients who survive initial repair of ruptured AAA develop
a postoperative systemic inflammatory response syndrome with associated elevation
in circulating TNF-a 77,242. It has been reported that high levels of TNF-a are
associated with poor outcome after ruptured AAA repair. Thus, cTnl elevation and
myocardial dysfunction may be an effect of an underlying systemic inflammatory
response. In support of a causal association, most patients in the present series with a
cTnl elevation had detectable levels within the first 24h after operation. Furthermore,
organ dysfunction, as determined by postoperative APACHE II score, was not
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associated with the development of cardiac injury. It is intuitive that any degree of
myocardial dysfunction may compromise a patient's potential for recovery and be
associated with prolonged critical care unit stays and adverse outcome. The
correlation of raised cTnl levels and adverse outcome noted in different studies
across a variety of patient subgroups, some with lesser potential for systemic
77 770 77A 777
inflammation, also favours a causal relationship ' ' ' . Nonetheless, the
interplay between systemic inflammation and perioperative myocardial injury
requires further investigation.
The present study confirms that perioperative cardiac injury after ruptured AAA
repair is common and often clinically silent. Even modest levels of cTnl elevation
are predictive of short-term adverse outcome. Such a marker of increased risk in the





Inflammation is an integral factor in the pathogenesis of abdominal aortic aneurysms
(AAA), histologically characterised by a transmural infiltration ofmacrophages and
lymphocytes. These cells are thought to elicit an inflammatory cytokine cascade,
culminating in the degeneration of aortic connective tissue 37. Interestingly, patients
with AAA have elevated serum markers of inflammation and the acute phase
response when compared with healthy controls and controls with coexistent vascular
disease 84'85. Furthermore, serum concentrations of inflammatory cytokines are
associated with aneurysm diameter and rate of expansion 243. However, the precise
relationship between systemic markers of inflammation, the acute phase response
and aortic aneurysms is uncertain.
C-reactive protein (CRP) is an acute-phase protein that is a strong, independent risk
factor for atherosclerosis 80. It may also predict survival in critically ill patients and
patients with underlying neoplasia 87'88. It is unclear whether inflammatory
biomarkers have any such prognostic significance in patients undergoing AAA
repair. Systemic inflammatory proteins may have a role as a diagnostic tool or as a
means of preoperative risk-stratification.
This study compares easily measured preoperative inflammatory biomarkers in




Local Research Ethics Committee approval was obtained for this research.
Consecutive patients admitted for open repair of intact or ruptured AAA were
included in a prospective observational cohort study over a 20-month period (January
2003 - September 2004). Those with intact AAA were further stratified into an
asymptomatic group undergoing elective repair, and an acutely symptomatic group
requiring urgent operation. An acutely symptomatic aneurysm was typified by severe
back and/or abdominal pain, haemodynamic stability and a tender AAA on palpation.
Ruptured aneurysm was typified by the presence of retroperitoneal and/or
intraperitoneal blood at laparotomy in the absence of any other identifiable cause
other than an aneurysm214. Patients were diagnosed as having an inflammatory AAA
by operative appearance. An inflammatory AAA was characterised by the presence
of a thickened aneurysmal wall, perianeurysmal fibrosis and adhesions to adjacent
structures214. Demographic and clinical variables for all patients were recorded.
Preoperative physiological status was stratified according to the Physiological and
Operative Severity Score for the enumeration ofMortality and morbidity
(POSSUM) "8. All patients were operated on by one of five consultant vascular
surgeons.
Blood was sampled for the following biomarkers of inflammation: CRP, platelet
count, white blood cell count, fibrinogen and albumin. Plasma samples were
collected on the time of admission in sterile, lithium heparin, potassium EDTA, or
sodium citrate tubes (Sarstedt AG & Co. Niimbrecht, Germany) and analysed in the
Clinical Biochemistry and Haematology Laboratories of the Royal Infirmary of
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Edinburgh. C-reactive protein analysis was performed with an automated
immunoturbidimetric assay (Abbott TDX, Abbott Laboratories, Maidenhead, UK). A
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systemic inflammatory response was defined by a CRP level of >10mg/l . Primary
outcome was assessed in terms of postoperative mortality, defined as death in-
hospital or within 30-days of operation.
Statistical analysis was performed using SPSS for Windows Release 13.0 (SPSS Inc.,
Chicago, Illinois, USA). Univariate analyses between groups were determined by
chi-squared or Fisher's exact test for categoric variables and Kruskal-Wallis and
Mann-Whitney U test for non-parametric continuous variables. Spearman's rank
correlation coefficient was calculated to assess the strength of association between
continuous variables. P < 0.05 was considered significant.
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6.3. Results
Fifty-one consecutive patients (39 asymptomtatic and 12 acutely symptomatic)
underwent attempted repair of an intact aneurysm, and 61 had repair of a ruptured
aneurysm, during the study period. Demographic and clinical variables are shown in
Table 6.1.
There was no statistically significant difference in age (P=0.876), gender (P=0.275),
aneurysm diameter (P=0.871) or POSSUM physiology score (P=0.201) between
patients with an asymptomatic or symptomatic intact AAA. Patients with ruptured
AAA had larger aneurysms on selectively utilised computed tomography (CT) or
ultrasound scan (P=0.007) and higher POSSUM physiology scores (PO.OOl), than
those with asymptomatic lesions; age (PO.470) and gender (P=0.609) distribution
were, however, similar.
There were no statistically significant differences in age (P=0.457), gender (P=0.257)
or AAA size (P=0.197) between patients with ruptured AAA and those with
symptomatic intact aneurysms; however, POSSUM physiology scores (P=0.001)
were greater in the former group. No patient had clinical evidence of a significant
coexistent inflammatory disease and the distribution of inflammatory AAAs, as
determined at laparotomy, is shown in Table 6.1.
There were significant differences in CRP level, fibrinogen level, WBC count and
platelet count across the three groups of patients (Table 6.2). Asymptomatic intact
AAAs were associated with a lower CRP level (PO.OOl), fibrinogen level (PO.022)
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and WBC count (P=0.036), and with a higher serum albumin (P=0.017) than
symptomatic intact aneurysms; platelet counts were similar (P=0.152).
Asymptomatic lesions were also associated with lower CRP level (P=0.002) and
WBC count (P<0.001), and with higher serum albumin (PO.OOl), than ruptured
AAA. However, patients with asymptomatic AAA had greater platelet counts
(P=0.026) and fibrinogen levels (P=0.005) than those with ruptured aneurysms.
Patients with symptomatic intact AAA had higher CRP levels (P=0.042) but a lower
WBC count (P=0.04) than those with ruptured lesions. Platelet count (P=0.011) and
fibrinogen levels (P=0.01) were higher with symptomatic intact aneurysms. There
was no difference in serum albumin between groups (P=0.171). Analysis of all
patients with AAA failed to demonstrate any correlation between age (r=0.139,
P=0.157) or aneurysm size (r=0.010, P=0.930) and CRP. However, POSSUM
physiology score correlated with CRP (r=0.283, P=0.004). The distribution of
systemic inflammatory response as defined by serum CRP levels is shown in Table
6.3. Patients with symptomatic or ruptured AAA were more likely to have a systemic
inflammatory response than asymptomatic patients (P<0.001).
There were three (8%), two (17%) and 21 (41%) perioperative deaths in the
asymptomatic, symptomatic and ruptured AAA groups respectively. Causes of
deaths are shown in Table 6.4. There was no statistically significant difference
between survivors and non-survivors ofAAA repair in terms of systemic
inflammatory response, CRP level, WBC or serum albumin in any of the three
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groups. Those who survived ruptured AAA repair had higher platelet counts
(P=0.006) and serum fibrinogen levels (P=0.002) than those who died.
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Values are median (range) or number (%)
* Selectively performed preoperative imaging
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Table 6.2. Inflammatory biomarkers in 112 patients with AAA
Asymptomatic Symptomatic Ruptured
P value
AAA (n=39) AAA (n=12) AAA (n=61)
CRP (mg/L) <5 (<5-22) 22 (5-103) 7(<5-168) <0.001
WBC x109/L 7.0(4.4-13.7) 8.8(5.4-19.2) 13.2 (4.4-24.0) <0.001
Platelets xl09/L 209 (125-320) 240(123-428) 186(89-462) 0.008
Fibrinogen (g/L) 3.6(2.1-6.0) 4.6(2.1-6.7) 2.8 (0.2-5.5) <0.001
Albumin (g/L) 41 (34-47) 37 (27-47) 33 (18-47) <0.001
Values are median (range). Kruskal-Wallis test
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Table 6.3. Presence (CRP >10mg/) or absence (CRP <10mg/l) of a systemic




CRP<10mg/l 31(86%) 2(18%) 32(54%)
CRP>10mg/l 5(14%) 9(82%) 27(46%)
Values are number (%).
135
Table 6.4. Causes of perioperative death in 30 patients
Asymptomatic Symptomatic Ruptured
AAA AAA AAA
Multiorgan failure 1 1 11
Intraoperative death 1 - 11
Myocardial infarction 1 - 2
Respiratory failure - 1 1
Aorto-enteric fistula - - 1
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6.4. Discussion
The systemic inflammatory response is typified by the synthesis of proteins by the
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liver . The effect is mediated by proinflammatory cytokines. Proteins such as CRP
and fibrinogen increase, while others such as albumin fall. Most AAAs exhibit
features of inflammation on histological examination, and increased expression of
local and circulating proinflammatory cytokines is well-documented in patients with
aneurysms 43'8 ' . Controversy persists about the extent to which this cytokine up
regulation evokes a systemic inflammatory response and about the influence of
aneurysm symptomatology on this process 243.
This study shows that patients with symptomatic intact or ruptured AAA have
elevated markers of systemic inflammation before operative intervention. Both CRP
level and WBC were significantly higher than those encountered in patients with
asymptomatic AAA. The stimulus for this inflammatory response is uncertain.
Clearly, ruptured AAA causes acute haemorrhage and hypovolaemic shock as
inflammatory triggers. However, symptomatic intact lesions do not result in such a
profound physiological insult; a lower POSSUM physiology score reflects this.
However, pain is a cardinal feature of inflammation and in acutely symptomatic
AAA is thought to relate to a sudden expansion in aneurysm size 244. This lesser
trigger seems capable of evoking systemic changes in circulating inflammatory
biomarkers too. This elevation of easily measured serum markers of inflammation
supports their utility as diagnostic tools in patients with acute aortic pathology. While
non-specific, their use in conjunction with clinical evaluation may prove a valuable
indicator of impending or established aneurysm rupture. Interpretation of changes in
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the other inflammatory markers is confounded by a number of factors. Acute blood
loss and the dilutional and volume redistribution effects of intravenous fluid
resuscitation may influence changes in platelet count and fibrinogen level 245. The
use of these inflammatory markers as diagnostic or prognostic tools is limited by
such factors.
Despite similar physiological scoring, and the integrity of the aneurysm being
preserved, patients with symptomatic lesions had an operative mortality rate more
than twice that of patients undergoing repair of an asymptomatic AAA. Reasons for
the increased operative mortality associated with symptomatic aneurysms, though
well described, remain unresolved 246. However, it is possible that elevated systemic
inflammatory proteins in symptomatic patients may be implicated.
Multiple organ failure is a major cause of perioperative death after AAA repair 247.
Excessive activation of inflammatory pathways and release of inflammatory
cytokines underpin organ dysfunction. An initial inflammatory stimulus, such as
acute AAA expansion or rupture, may cause priming of inflammatory pathways. A
subsequent stimulus, such as ischaemia-reperfusion injury during aneurysm repair,
causes an inflammatory response greater than expected if it occurred in isolation 242.
Such a phenomenon might partly account for the increased mortality rates found in
patients with acute AAA.
If a primed inflammatory response were related to perioperative death in patients
with acute AAA, it would be anticipated that raised CRP levels would be associated
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with death. However, the present data have shown that neither CRP level nor a
systemic inflammatory response provide prognostic information in terms of survival
after AAA repair. In contrast, Schillinger and colleagues have reported that
admission CRP levels predict poor outcome 86. Their retrospective series, combined
patients with thoracic and abdominal aortic disease, including both aortic dissections
and aneurysm. Despite the heterogeneity of their sample population, they concluded
that CRP level was useful for risk prediction in acute aortic disease. The absence of
such an association in the present series is surprising considering the positive
correlation between preoperative physiological status, as reflected by POSSUM
score, and CRP level (patients with greater physiological compromise had higher
CRP levels). It is possible that the failure ofCRP to predict mortality in the present
data is a reflection of small sample size. Alternatively, the use of newer high
sensitivity CRP assays may have yielded greater prognostic information.
Furthermore, analysis of the temporal changes in inflammatory markers in the
postoperative period may also have conferred useful prognostic information.
These data highlight the presence of an early elevation in inflammatory biomarkers
and the systemic inflammatory response in patients before elective and emergency
aortic aneurysm repair. This inflammatory process and upregulation of the acute





The cost of ruptured abdominal aortic aneurysm (AAA) repair in financial terms and
resource utilisation is significant212. Although survivors may return to a normal life
expectancy, their functional outcome, in terms of health related quality of life
(HRQoL), remains uncertain. In properly assessing the value of a surgical
intervention, functional outcome must be examined alongside the more traditional
outcome measures of operative morbidity and mortality. If a survivor of ruptured
AAA was returned to a significant level of functional disability despite a near-normal
life expectancy, the benefit of intervention would become less apparent. To quantify
the efficacy of ruptured AAA repair with accuracy, HRQoL analysis is essential.
Published data on HRQoL after aneurysm rupture are limited. While it has been
suggested that survivors of ruptured AAA repair regain their preoperative quality of
life, this rests on retrospective data of uncertain validity ,93"206. This study examines
the postoperative HRQoL of survivors of ruptured AAA repair when compared to
that of patients undergoing elective AAA repair and of the general population.
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7.2. Methods
Local Research Ethics Committee approval was obtained for this study. Patients
undergoing open operative repair of a ruptured AAA over the 18-month period
September 2002 to March 2004 were included in a prospective observational case-
control study. Patients were selected for operative intervention and operated on by a
group of five vascular surgeons. Ruptured aneurysm was defined as the presence of
retroperitoneal and/or intraperitoneal blood in the absence of any other identifiable
cause of haematoma other than an aneurysm at laparotomy. A control group of age
and sex-matched patients undergoing elective open repair of asymptomatic AAA
during the study period was also identified. Endovascular aortic repair was not
utilised as a therapeutic option for either intact or ruptured AAA during the study
period. Demographic and clinical variables for both groups were recorded. Severity
of illness was scored using the Simplified Acute Physiology Score II (SAPS II)
recorded during the first 24h after operation l82. Patient survival was confirmed using
hospital and general practice records.
The Short Form-36 Health Survey (SF-36) (QualityMetric Inc., Lincoln, Rhode
Island, USA) is a generic HRQoL instrument and comprises 36 questions studying
eight domains of health: physical functioning, social functioning, role limitations due
to physical problems, role limitations due emotional problems, mental health, pain,
vitality and general health perception. Each domain scores from 0 to 100, with higher
scores representing a better quality of life. The reliability, validity and consistency of
the SF-36 have been confirmed, and its use in the assessment of vascular and
aneurysm disease has been recommended 188-207
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The self-administered United Kingdom version of the SF-36 was sent to all patients
6-months after aneurysm repair. This time point was chosen as representing the time
by which patients undergoing elective AAA repair regain their preoperative levels of
HRQoL l88. Repeat questionnaires were sent after 2-weeks if no reply was received.
Questionnaires were scored according to the methodology described by Ware and
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colleagues . Mean scores and standard deviations were calculated for each group
and compared. Further comparison was made between the age and sex-matched
general population data for the United Kingdom 249.
Statistical analysis was performed using SPSS for Windows Release 11.0.0 (SPSS
Inc., Chicago, Illinois, USA). Between groups differences were determined by the
unpaired t-test or Mann-Whitney U test for parametric and non-parametric
continuous variables respectively; P < 0.05 was considered significant.
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7.3. Results
Seventy-three consecutive patients were admitted with a ruptured AAA during the
study period, of whom 57 (78%) underwent attempted aneurysm repair. Reasons for
non-operative management are listed in Table 7.1. Of these 57, 30 (53%) survived to
discharge from hospital and were included in this study. There were 26 men and four
women of median (range) age 68 (53-85) years. Twenty-two of the 30 patients had
haemodynamic instability, as defined by a preoperative blood pressure of <90mmHg,
before operation. During the same period, 78 patients underwent elective repair of an
asymptomatic aneurysm and 19 underwent urgent repair of an acutely symptomatic
aneurysm. Thirty patients with asymptomatic AAA were selected as suitable age and
sex-matched controls. The median (range) age of the 26 male and four female control
patients was 70 (59-83) years (P=.440). Patients who had repair of a ruptured
aneurysm had a median (range) hospital stay of 14 (7-59) days, while patients
undergoing elective operation stayed for a median (range) of 11 (7-37) days
(P=.048). Median (range) SAP II score for patients undergoing ruptured AAA repair
was 30 (18-52) and for patients who had elective repair it was 16 (12-30) (P<.001).
At 6-month follow-up, all patients in both the study and control groups were still
alive. Twenty-eight of the 30 patients who survived ruptured aneurysm repair had
been discharged to their homes, while one patient required nursing home care and
one remained in a geriatric rehabilitation unit. All patients in the control group were
discharged home. The SF-36 questionnaire was self-administered by all but one
patient who required the aid of a proxy. All patients from both groups returned a
completed form.
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Comparison of SF-36 scores of the ruptured AAA, elective AAA and normal
populations are shown in Tables 7.2-4. There was no statistically significant
difference between patients who had undergone ruptured aneurysm repair or an
elective aneurysm repair in any of the health domains. However, when HRQoL in
survivors of aneurysm rupture was compared to that of the matched normal
population, the former group had significantly worse outcomes in terms of role
limitations due to physical and emotional problems were apparent. There were no
statistically significant differences in the other six health domains. In contrast,
comparison of functional outcome between patients who underwent elective repair
and the normal population showed the former group to have significantly worse
outcomes in the domains of physical function, bodily pain and social functioning, as
well as role limitations due to physical and emotional problems.
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Table 7.1. Primary reason for refusal of surgery in 16 patients.
Reason for refusal Number of patients
Cardiac arrest / Refractory LOC 7




LOC - Loss of consciousness
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Table 7.2. Mean (SD) SF-36 scores in 30 patients after ruptured AAA repair and 30
patients after elective AAA repair
Health domain Ruptured AAA Elective AAA P value
repair repair
Physical function 65 (27) 55 (30) 0.222
Role limitations physical 58 (29) 57 (33) 0.855
Bodily pain 69 (28) 60 (28) 0.196
General health 62 (24) 63 (22) 0.770
Vitality 55 (23) 54 (24) 0.911
Social functioning 78(32) 71 (31) 0.441
Role limitations emotional 68 (33) 71 (35) 0.733
Mental health 77(19) 76(17) 0.782
Mental summary score 49 (12) 49(12) 0.842
Physical summary score 44(11) 40(11) 0.297
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Table 7.3. Mean (SD) SF-36 scores in 30 patients after ruptured AAA repair and the
age and sex-matched normal population
Health domain Ruptured AAA Normal P value
repair population
Physical function 65 (27) 72 (9) 0.162
Role limitations physical 58 (29) 72 (5) 0.016
Bodily pain 69 (28) 77 (3) 0.167
General health 62 (24) 64 (2) 0.638
Vitality 55 (23) 62 (4) 0.116
Social functioning 78 (32) 83 (4) 0.339
Role limitations emotional 68 (33) 87 (4) 0.004
Mental health 77(19) 79 (2) 0.521
Table 7.4. Mean (SD) SF-36 scores in 30 patients after elective AAA repair and the
age and sex-matched normal population
Health domain Elective AAA Normal P value
repair population
Physical function 55 (30) 72 (9) 0.007
Role limitations physical 57 (33) 72 (5) 0.019
Bodily pain 60 (28) 77 (3) 0.003
General health 63 (22) 64 (2) 0.926
Vitality 54(24) 62 (4) 0.098
Social functioning 71 (31) 83 (4) 0.043
Role limitations emotional 71 (35) 87 (4) 0.018
Mental health 76(17) 79 (2) 0.253
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7.4. Discussion
Postoperative quality of life is a frequently neglected outcome measure in the
assessment of surgical interventions. In contrast, oncological interventions have been
routinely subjected to HRQoL analysis and the UK Medical Research Council has
9S0 9S 1
introduced HRQoL measures in their guidelines for clinical trials ' . Ruptured
AAA repair, and subsequent recuperation, is associated with a major physical and
psychological insult. Nevertheless, there are few data on functional outcomes in this
situation. The present series contains the first prospective data examining HRQoL
outcomes following ruptured aneurysm repair. While the limitations of the data are
acknowledged in as much as preoperative assessment of HRQoL is absent and the
sample size is relatively small, the nature of ruptured AAA does not allow the former
and only three retrospective series have individually reported more patients 196>197-203-
Multivariate analysis on current data to identify independent predictors of functional
outcome has not been carried out as the small sample size renders such analysis
vulnerable to statistical error.
Present data show that the quality of life of survivors of ruptured AAA is no different
from that of patients who have undergone elective aneurysm repair. Furthermore, this
recovery in functional performance is apparent within 6-months of operation. It is
interesting that functional recovery is so similar between two groups that are clearly
different in terms of illness severity and hospital stay. The 30 patients with ruptured
aneurysm are a highly selected group who have survived to reach hospital, have been
selected for operative intervention, survived operation, and survived to 6-month
follow-up. Survival after aneurysm rupture is influenced by good preoperative
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physiological status, and this may predispose these patients to achieving good
functional outcomes 1I3. Existing studies of HRQoL after elective open repair of
AAA have shown that patients regain their preoperative functional status within 3 to
6-months of operation 188,252. It would appear, from the present data, that recovery of
HRQoL after ruptured aneurysm repair follows a similar time course. However, if
HRQoL assessment had been performed at an earlier time point from operation,
differences in functional outcome may have been apparent.
Eight previously published series compare HRQoL outcome after ruptured and
elective AAA repair l93'194'196"8'200'205>206- All are retrospective and have a varying
duration of follow-up rendering them vulnerable to an even greater selection bias. In
contrast, the present prospective data describe a consecutive series of patients with
ruptured AAA with a fixed follow-up interval. All but one of the preceding
retrospective studies have concluded that ruptured aneurysm survivors regain a
quality of life similar to that of patients undergoing elective AAA repair. Magee and
colleagues are the only authors to have demonstrated a significant deterioration in
functional outcome following ruptured AAA repair compared to elective repair 197.
They reported a fall from near perfect HRQoL to considerable disability after
ruptured aneurysm repair. However, in their series patients who underwent elective
repair were not matched for age, and, in fact, were much younger than the patients
with ruptured AAA. It is noteworthy that there is relative consistency in SF-36 health
domain scores between the present data and the three other studies that have used
this instrument 199-2 •• 2t Such a finding across different series supports the
conclusion that survivors of ruptured AAA do regain a good quality of life. Though a
151
selective policy of operative intervention has governed this series, the good
functional outcomes attained do justify an aggressive policy of surgical intervention
for ruptured aneurysm.
The present series shows that survivors of ruptured aneurysm have poorer outcomes
in terms of role limitations due to physical and emotional problems when compared
to the general population. It is, perhaps, unsurprising that they have some functional
disability after such major surgical intervention. However, no other differences were
demonstrated in the other health domains. It is interesting to note that functional
outcome after elective aneurysm repair displayed poorer outcomes in more health
domains - physical functioning, bodily pain and social functioning. Taking these
results at face value, one would infer that patients who survived ruptured aneurysm
repair had a better functional outcome than those who had an elective operation.
This, clearly, is counterintuitive. It is likely that this discrepancy is related to the
selection of biologically robust individuals for emergency operation and that they
survive to have a good functional recovery after surgery. A possible alternative is
that a near-death experience has a positive impact on an individual's perception of
his or her functional performance, resulting in a higher rating ofHRQoL.
This study provides benchmark HRQoL data for patients who survive open repair of
ruptured AAA. In the future, functional outcomes after endovascular repair of intact






Twenty years ofpreceding clinical research have failed to clarify whether outcome in
patients with ruptured AAA can be accurately predicted in the preoperative period.
Furthermore, patient selection for attempted operative repair may have been justified
on the basis of unsound risk scoring instruments. The aims of the present thesis were
to document contemporary outcomes and examine risk factors thought to relate to
poor outcome in patients with ruptured AAA, to validate existing scoring systems
and to demonstrate whether the prediction of death after aneurysm rupture is feasible.
The Hardman Index and Glasgow Aneurysm Score are well cited scoring instruments
that have been recommended as predictive scoring tools for patients with ruptured
AAA. In particular, the Hardman Index has been validated by a number of
retrospective series-it was proposed that the instrument could accurately identify
patients who would not survive any attempt at operative intervention. However, data
from this thesis question the validity and accuracy of these instruments as both
predictive tools and risk-scoring instrument for comparative audit for the first time.
These findings have now been supported by retrospective data from other centres. It
now appears to be indisputable that the Hardman Index is an imprecise tool for the
prediction of outcome after aneurysm rupture. Most importantly, the model does not
allow the identification of any patients in whom attempted AAA repair is futile. The
Glasgow Aneurysm score demonstrated poor validity when applied to retrospective
and prospective data from this centre. In contrast, other centres have reported good
validity and predictive ability for this tool. It remains unclear whether the Glasgow
score is of clinical use but further study is needed.
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POSSUM methodology was never designed for use as a tool to predict outcome.
Rather, its use was confined to risk stratification of patients to support comparative
audit. However, the preoperative (physiology score only) risk equations that have
been derived for application in arterial surgery (V-POSSUM) and, specifically,
ruptured aneurysm (RAAA-POSSUM) performed poorly when applied to the current
series. The RAAA-POSSUM demonstrated a significant lack of fit when applied and
the V-POSSUM equation tended towards lack of fit and seemed to underpredict
mortality at the lowest bands of risk. Whether this lack of fit is confined to the
preoperative model only is unclear. Nevertheless, these are the first data to question
the performance of the RAAA-POSSUM model, though the validity of the V-
POSSUM equation has been reported to underperform in a selected group of patients
with ruptured AAA before.
In an attempt to develop a model for predicting outcome after AAA rupture,
preoperative variables from both a retrospective and prospective dataset were
analysed. On multivariate logistic regression analysis, no variable retains
independent statistical significance. However, certain variables were significant on
univariate analysis and tended towards significance on multivariate analysis. In
particular, these included the triad of preoperative haemoglobin concentration <9g/dl,
best in-hospital Glasgow Coma Scale <15 and a systolic blood pressure of
<90mmHg. When compiled to form a cumulative risk score with equal weighting,
these variables demonstrated good predictive power. The accumulated score can be
translated to one of three bands ofmortality risk-low (<30%), medium (-50%) and
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high (-80%). When prospectively validated on our own data, the model performed
well and retained a high level of statistical significance. This novel risk scoring
instrument appeared to have better validity and easier applicability than existing
models. It now requires external validation to confirm its performance.
The fact that the present data stemmed from a high volume tertiary centre may
account for the lack of fit of pre-existing scoring systems. The majority of existing
analyses have come from centres that do not have a high volume experience in the
management of ruptured AAA. As a result, our risk modelling was unique and highly
specific towards our data. If applied to data from other centres, it may not
demonstrate the same good fit. However, there is an increasing drive, in the UK,
towards the centralisation of emergency vascular services in high volume centres. It
might be anticipated that our risk model will continue to perform well in such units.
The primary aim of this thesis was to develop a method of accurately identifying
patients who are unsalvageable despite attempted operation for ruptured AAA.
Analysis of the data has failed to demonstrate a robust and reproducible method of
achieving this aim. Even extreme preoperative variables, such as unconsciousness
and cardiac arrest, have been confirmed as not being uniformly fatal. It may be
concluded patients in whom surgical intervention would be futile are impossible to
identify preoperatively. Therefore, where a selective policy of operative intervention
is utilised, each case must be taken on its own individuals merits. Although
attributing patients to the highest level of risk, using our novel prognostic index, will
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help to objectively justify non-operative management, experienced clinical
judgement will have to remain at the forefront of any decision making.
Cardiac troponins have revolutionised the diagnosis and management ofmyocardial
injury. Previously undetectable myocardial injury is now quantifiable and permits
earlier intervention when indicated. From the current series, it is noted that about half
of all patients who survive initial repair of ruptured AAA will suffer a detectable
myocardial injury. Around halfof these will be clinically silent. Interestingly, even a
minor elevation in cardiac troponin in the early perioperative period confers an
increased risk of postoperative death, and is associated with a prolonged stay on the
intensive care unit. It is acknowledged that a number of non-cardiac causes, found in
patients with ruptured AAA, may cause an elevation of cardiac troponin. The early
elevations seen in the present data (within 24hrs) suggest that it is a primary cardiac
injury that is responsible for the elevation in troponin and the attendant increase in
mortality and morbidity. The practical application of such a finding is less obvious.
Once elevated cardiac troponins have been detected, there are limited opportunities
for remedial intervention. However, it may be that more aggressive cardiorespiratory
support or pharmacological intervention to optimise cardiac function may improve
outcome in this subgroup of patients. Alternatively, it identifies a group of patients
who are at increased risk of postoperative complication and may help rationalise
treatment. Further work is needed to investigate both these issues and the impact of
raised perioperative troponins in the longer term. Existing data have shown that
elevation of cardiac troponins confers prognostic information, in terms of survival,
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beyond one year . Alternatively, the interplay between myocardial injury and the
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systemic inflammatory response that is evoked postoperatively in patients with
ruptured aneurysms needs more consideration.
C-reactive protein (CRP) has been reported to be an accurate predictor of outcome in
an array of clinical situations. These include acute coronary syndrome, cancer and
the critically ill on intensive care units. Whether CRP has prognostic value in acute
AAA patients remains uncertain. From the current data, it is apparent that there is an
upregulation of the systemic inflammatory response, as measured by CRP, in patients
with acutely symptomatic and ruptured AAA. However, the present study has been
unable to relate this upregulation to outcome, as assessed by mortality. The presence
of a systemic inflammatory response is likely to influence clinical outcome. It may
be that a larger study based on these pilot data will be able to demonstrate the impact
of raised CRP on survival. Further investigation may also examine the prognostic
value of the newer high-sensitivity CRP assays. CRP remains a novel potential
prognostic biomarker in patients with acute aneurysmal disease.
Outcome after aneurysm rupture has always been largely considered in the black and
white terms of survival or death. Interest in perioperative morbidity does exist but is
less well described in the literature. This was the first prospective study of functional
outcome in survivors of ruptured AAA. Interestingly, despite the greater severity of
illness encountered in patients undergoing emergency AAA repair, they achieve a
similar functional outcome to age and sex-matched patients undergoing elective
aneurysm repair within 6-months. Furthermore, when compared to the age-matched
general population, survivors of aneurysm rupture achieve similar functional
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outcomes. These data support an aggressive policy ofmanagement for patients with
ruptured AAA. Though it is not possible to predict which patients will obtain the best
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• Haemoglobin of less than 9g/l,
• Creatinine ofmore than 190umol/l,
• Electrocardiographic ischaemia,
• In-hospital loss of consciousness
• Age greater than 76 years
The presence of 3 or more variables is reported to be uniformly fatal
Glasgow Aneurysm Score
Risk score = (age in years)+(17 for shock)+(7 for myocardial disease)+(10 for
cerebrovascular disease)+(14 for renal disease).
Myocardial disease - documented myocardial infarction and/or on-going angina.
Cerebrovascular disease - all grade of stroke including transient ischaemic attacks.
Renal disease - history of chronic or acute renal failure and/or urea greater than
20mmol/l and/or creatinine over 150pmol/l at presentation "5.
196
POSSUM physiological and operative variables
Physiological Operative
Age (years) Operation category (minor, intermediate,
major, major+)
Cardiac signs No. of procedures
Respiratory signs Total blood loss (ml)
Systolic blood pressure (mmHg) Peritoneal soiling
Pulse rate (per min) Malignancy





White cell count (x 10y/l)
Electrocardiogram
Mortality Risk equations (R is the risk ofmortality):
POSSUM: In (R/l-R) = -7.04 +(0.13 x physiological score) + (0.16 x operative
severity score)
V -POSSUM: In (R/l-R) = -8.0616 + (0.1552 x physiological score) + (0.1238 x operative
severity score)
V -POSSUM (Physiology score only): In (R/l-R) = -6.0386 + (0.1539 x physiological score)
RAAA -POSSUM: In (R/l-R) = -4.9795 + (0.0913 x physiological score) + (0.0958 x
operative severity score)




Variable Category Coefficient (Constant—
3.41)
Age 0.062 x age




Probability of death= ex /1 + e\ where e is the base of the natural logarithm and x
• *102the constant (-3.44) + sum of coefficients for the significant variables
Edinburgh Ruptured Aneursym Score
• Haemoglobin of less than 9g/dl,
• Glasgow Coma Scale <15 in-hospital,
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REVIEW
Quality of Life After Repair of Ruptured Abdominal Aortic
Aneurysm
A. L. Tambyraja,* S. C. A. Fraser, J. A. Murie and R. T. A. Chalmers
E Edinburgh Vascular Surgical Service, Royal Infirmary of Edinburgh, Lothian EH16 4SA, UKBackground. Ruptured abdominal aortic aneurysm (AAA) continues to be associated with high operative mortality.Though survivors can expect to return to a normal life expectancy, their postoperative health related quality of life (HRQoL)remains uncertain. This review examines HRQoL foll wing oper tive repair of ruptured AAA.
f Methods. PreMedline, Medline and Embase databases were searchedfor clinical studies relating to quality of life followingrepair of ruptured AAA. Reference lists of relevant papers were also reviewed.
Results. Fourteen retrospective-observational studies ofpostoperative quality of lifefollowing repair of ruptured AAA were
identified. Both validated and non-validated tools for generic HRQoL assessment were used. All but one study showed no
significant difference in overall HRQoL following ruptured AAA repair when compared to both the normal age-adjusted
population and patients undergoing elective repair of intact AAA. However, survivors of ruptured AAA did exhibit
significant reductions in the isolated domains of physical function, social behaviour and general well-being.
Conclusions. There arefew studies ofHRQoLfollowing repair of ruptured AAA. These reports are retrospective, have small
sample sizes and use generic instrumentsfor HRQoL assessment. Thefindings suggest that survivors of ruptured AAA may
attain a similar functional outcome to patients undergoing elective AAA repair and the age-matched healthy population.
However, these results must be interpreted with caution and further prospective study is required.
Key Words: Quality of life; Abdominal aortic aneurysm; Functional outcome.
Introduction
2 traditional measures of surgical outcome have
:n in terms of perioperative morbidity and mor-
ity. However, the importance of health-related
ality of life (HRQoL) in the assessment of outcome
5 gained increased recognition. The rationalisation
health care finances has motivated the need to
antify outcomes of medical interventions and in the
tluation of cost, quality of life issues must be
asidered.
The prevalence of abdominal aortic aneurysm
AA) is increasing in the United Kingdom and
•rently accounts for approximately 8000 deaths per
mm. The efficacy and durability of elective AAA
>air in terms of perioperative morbidity and
>rtality, long-term survival, quality of life and cost-
^ctiveness are well established.2-4 However, despite
irresponding author. Mr A. L. Tambyraja, Clinical and Surgical
inces (Surgery), Royal Infirmary of Edinburgh, 51 Little France
■scent, Edinburgh, Lothian EH16 4SA, UK.
advances in perioperative care, repair of ruptured
AAA continues to be associated with an operative
mortality rate of 45% and high attendant financial cost
and resource utilisation.5. Though survivors are
reported to attain the same rates of survival as the
normal population, functional outcome in terms of
HRQoL is uncertain.7 Such data are essential to
quantify the efficacy of current intervention for
ruptured AAA.
Method
The Medline and PreMedline (January 1966 to July
2003) and Embase (January 1980 to July 2003)
electronic databases were searched. The Ovid search
engine (version 16.2.0; Ovid Technologies, New York,
USA) was employed. The search strategy used the
keywords 'quality of life' and 'aneurysm', with the
Boolean operator 'and'. Criteria for inclusion were
studies assessing postoperative quality of life in
8-5884/030229 + 05 $35.00/0 © 2004 Elsevier Ltd. All rights reserved.
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tients undergoing operative repair of ruptured
^A. Manual searching of reference lists from articles
rieved by electronic searching was also used,
tides retrieved were restricted to those published
English. All identified articles were obtained
■ough local library collections and The British
jrary.
Results
urteen studies investigating quality of life in
ients who had survived operative repair of rup-
id AAA were identified from computerized and
nual searches.7-20 (Table 1). Three articles from the
pnal searches were excluded, as they did not
lertake quantitative HRQoL assessment.18-20
3f the 11 remaining papers, all were retrospective-
ervational studies. Publications dates ranged from
"6 to 2003, with study periods ranging from 1962 to
■3. Three papers reported quality of life specifically
selected groups of patients (octogenarians) but are
luded in the present review.8'9,12 Two studies
nbined patients with symptomatic, intact AAA
dergoing emergency repair with patients with
ptured AAA.12,1 Three studies used non-validated
itruments to assess quality of life while eight articles
ed validated, generic HRQoL instruments.
Non-validated health related quality of life assessment
these three studies, all utilised self designed
lestionnaires to assess quality of life.8,9,12 The mid-
ne point of all three reports was earlier than 1985.
/o studies on survivors of ruptured AAA concluded
at preoperative physical status was regained in the
ajority of patients within one-year.8,9 The remaining
idy analysed functional outcome in patients aged
er 80 years who had survived emergency repair of
ith intact and ruptured AAA.12 Though it is
ncluded that octogenarians surviving emergency
\A surgery enjoy a reasonable quality of life, specific
itcomes of patients undergoing ruptured AAA
rgery are not extractable.
Validated health related quality of life assessment
ght studies used validated instruments for HRQoL
sessment. Rohrer and van Ramshorst applied
odified versions of the Self-evaluation of function
ale to their cohorts of ruptured AAA survivors.7,10
\ese reports used patients who had undergone
ictive AAA repair as controls. Both series failed to
demonstrate differences in overall HRQoL between
the ruptured and elective AAA groups. However,
Rohrer reported a statistically significant reduction in
the domain of general sense of well-being amongst
patients with ruptured AAA. Similarly, van Ramshorst
noted that patients undergoing elective AAA repair
tended to be significantly more active in the domain of
social behaviour than their counterparts with ruptured
lesions.
Magee and co-workers used the York quality of life
questionnaire with Rosser index classification on
patients who underwent ruptured AAA repair and
their counterparts undergoing elective repair.11
Patients undergoing elective repair were noted to
have improved HRQoL scores after operation while
those undergoing emergency repair reported a dimin¬
ished quality of life.
Hennessy studied patients who survived ruptured
AAA repair compared to matched patients under¬
going elective repair.14 It is unclear whether this
patient cohort represents a selected group of patients
surviving ruptured AAA repair or a consecutive
series. No significant differences, in terms of HRQoL,
were elicited.
Four studies, reported between 1998 and 2003, used
the generic Medical Outcomes Study Short Form 36
(SF36), or its derivative the RAND 36-Item Health
Survey (RAND36), to assess quality of life.13,15-17
These instruments comprise 36 questions covering
eight health domains.
Joseph and colleagues studied SF36 results from
survivors of ruptured AAA compared to age-matched
healthy controls.16 The majority of patients were
reported to have the same quality of life compared to
controls. No significant differences or trends between
groups, in terms of physical functioning, were
identified.
Eskandari's and Bohmer's comparisons of survi¬
vors of ruptured AAA and the age-matched general
population also revealed no significant differences in
SF 36 scores between the two groups.13,15 However,
survivors of ruptured AAA trended towards lower
functional outcome scores in six of the eight domains,
including those of physical function, in Eskandari's
report and lower physical function scores in Bohmer's
series.
In the largest study to date, Korhonen and
colleagues administered the RAND36 questionnaire
to 82 survivors of ruptured AAA compared to the age
and sex-matched general population.17 Again, signifi¬
cant differences in physical functioning were demon¬
strated between ruptured AAA patients and their
healthy counterparts. No other differences, in terms of
r J Vase Endovasc Surg Vol 28, September 2004
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RQoL, were identified between the study and
jntrol populations.
Discussion
;spite an increase in the number of elective AAA
oairs performed, an associated decline in the
:idence of ruptured AAA has not been borne out.21
rthermore, recent advances in perioperative care
_ve failed to make a significant impact on survival
flowing operative repair of ruptured aneurysm and
Hptality remains around 40%.5 Within the constraints
Hinite health care resource, there is a need to assess
Hi compare the outcomes of medical interventions.
^Rluation of a clinical intervention must not only take
Ha account the traditional primary outcomes of
;ath, disability or cure but also the patient's
rspective of outcome. To assess the benefit of an
Invention, evidence for the impact on the patient in
^Pns of health status and HRQoL is essential.22
■Of the 11 studies presently reviewed, all have
■ficiencies in their design. The small number of
idies, sample sizes, methodology and variation in
low-up period do not permit meaningful meta¬
analysis and render direct comparison awkward. In
jrticular, studies that utilised non-validated HRQoL
struments and those that amalgamate data from
■rjtients with intact and ruptured AAA must be
terpreted with caution. Furthermore, all series
ere retrospective in design and are susceptible to
as. With the progress of time following ruptured
A.A repair, patients become increasingly selected in
ot they have survived to reach hospital, survived
perative repair, survived their postoperative recovery
ad agreed to HRQoL assessment. It may be argued
tat this process specifically selects patients who are
iologically more robust and predisposed to achieve
ood functional outcomes. Similarly, some patients
ith ruptured AAA will have been deemed unfit for
ective repair and again are less likely to attain good
mctional recovery when compared to patients under¬
ling elective repair.
Of the seven studies that used validated HRQoL
struments and failed to establish a difference in
RQoL after ruptured AAA repair, all used generic
RQoL instruments. In particular, the reliability,
ilidity and consistency of the SF36, and its derivative
e RAND 36, have been confirmed. The SF36 is the
ost widely used quality of life instrument in the
edical literature and its use, in the assessment of
tscular disease, has been previously recommended.23
Generic tools require large sample sizes to demon-
rate statistically significant HRQoL differences, due
to the large standard deviations of health profiles.24 Of
the four articles that used the SF36 or RAND 36
instruments, only one study included more than 30
patients. Interestingly, this report on 82 patients by
Korhonen was the only one to detect significant
reductions, in the isolated domain of physical func¬
tioning, amongst ruptured AAA survivors.
Overall perception of HRQoL, in the three studies
that utilised generic instruments other than the SF36 or
RAND 36, was not significantly different between
patients undergoing emergency or elective AAA
repair. However, the absence of differences may be
attributable to small sample sizes and use of a generic
HRQoL tool. It is noteworthy that significant
reductions in the domains of general well-being and
social behaviour were detected amongst ruptured
AAA survivors.
Magee and colleagues demonstrated a significant
deterioration in functional outcome following rup¬
tured AAA repair when compared to elective repair.
They noted a fall in HRQoL from near perfect health
preoperatively to considerable disability at postopera¬
tive follow-up. Such a conclusive finding has not been
reproduced in any other series reporting on ruptured
AAA survivors. However, prospective studies in
patients surviving intensive care admission have
described similar reductions in HRQoL.25,26 If such a
finding were true for survivors of ruptured AAA
repair, arguments for aneurysm screening and elective
repair would be further supported.
In the United Kingdom, the financial cost of
ruptured AAA repair has been reported to be almost
double that of elective repair.27 Nevertheless, cost-
analyses of surgical repair of ruptured AAA have
shown that surgical treatment remains a cost-effective
intervention.28 The attainment of normal life expect¬
ancy after successful repair of ruptured AAA versus
the alternative of immediate death is the predominant
reason for such a finding. However, these analyses fail
to consider outcome in terms of HRQoL and functional
outcome following repair of ruptured AAA remains
largely uncertain. If survivors of ruptured AAA were
returned to a significant level of functional disability
despite a near-normal life expectancy, the efficacy of
intervention becomes less apparent. Indeed, an inter¬
vention that encompasses a postoperative quality of
life that will be unacceptable to the patient may even
be regarded as futile.29 This concept has important
implications where a selective policy in the manage¬
ment of ruptured AAA is employed; it might be
argued that quality-adjusted survival rather than
absolute survival should be used to guide operative
selection.14 With the introduction of endovascular
repair for ruptured AAA, any comparison of outcome
ur J Vase Endovasc Surg Vol 28, September 2004
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th conventional repair should also consider post-
erative functional status.
The limited current evidence suggests that the
ijority of survivors of RAAA may expect to regain
;ir preoperative quality of life. However, a pro-
rtion will experience postoperative deterioration of
ir functional status. No existing reports inform
ether postoperative functional outcome can be
related to preoperative risk factors. Further pros-
tive studies are needed to clarify the HRQoL
comes of survivors of ruptured AAA repair.
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Background: The Glasgow Aneurysm Score and the Hardman Index have been recommended as
predictors of outcome after repair of ruptured abdominal aortic aneurysm (AAA). This study aimed to
assess their validities.
Methods: Patients admitted to a single unit with a ruptured AAA over a 2-year interval (2000-2001) were
identified from a prospectively compiled database. Hospital records of all patients undergoing attempted
operative repair were reviewed. The Glasgow Aneurysm Score and the Hardman Index were calculated
retrospectively and related to clinical outcome.
Results: One hundred patients were admitted with a ruptured AAA. Of these, 82 underwent attempted
operative repair and were included in the study: 68 men and 14 women, of median age 73 (range
54-87) years. Thirty (37 per cent) patients died after the operation. The Glasgow Aneurysm Score was
a poor predictor ofpostoperative mortality. The area under the Receiver-Operator Characteristic curve
was 0-606 (P = 0-112, 95 per cent c.i. 0-483-0-729). Similarly, the Hardman Index failed to predict
postoperative mortality accurately (P = 0-211, x2 for trend). Of nine patients in this series with three or
more Hardman criteria, generally held to be fatal, six survived.
Conclusion: Contrary to previous reports, The Glasgow Aneurysm Score and the Hardman Index were
poor predictors of postoperative mortality after repair of a ruptured AAA in this study.
Presented to the Association of Surgeons of Great Britain and Ireland Annual Meeting, Harrogate, UK, 2004, and
published in abstract form as BrJ Surg 2004; 91 (SI): 103
Paper accepted 26 October 2004
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Introduction
The incidence of abdominal aortic aneurysm (AAA) is
increasing in the UK and at present AAA accounts for
approximately 8000 deaths each year1. Despite advances in
perioperative care, outcome after ruptured AAA repair has
remained relatively unchanged over the past 40 years, with
an operative mortality rate in excess of 40 per cent2.
It has been suggested that the outcome after open repair
of a ruptured AAA could be improved by operating on
patients with a reasonable operative risk. Similarly, it may
be futile or even unethical to perform surgery or to continue
treatment in patients with prohibitive risk.
However, no robustly validated methods exist by which
to identify patients unlikely to survive emergency aneurysm
repair and selection is frequently subjective.
Copyright © 2U05 British Journal of Surgery Society Ltd
Published by John Wiley & Sons Ltd
The Glasgow Aneurysm Score (GAS) and the Hardman
Index are two practical, objective, predictive scoring
systems recommended for use in patients with a ruptured
AAA3,4. This study aimed to assess their validity in a series
of patients from a high-volume centre.
Patients and methods
All patients admitted to the Edinburgh Vascular Surgical
Service with a ruptured AAA over a 2-year interval
(January 2000 to December 2001) were identified from
a prospective database and included in a retrospective
observational study. The database, together with hospital
records, provided demographic details as well as clinical
and operative information for all patients undergoing
British Journal ofSurgery 2 005; 92: 570-573
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ittempted repair of a ruptured AAA. Operation was defined
is the delivery of an anaesthetic with the intention of
lerforming AAA repair. Ruptured aneurysm was defined
is the presence of retroperitoneal or intraperitoneal blood
)r both from an aortic aneurysm. All patients were operated
in by one of six consultant vascular surgeons. The GAS
nd the Hardman Index were recorded for each patient
nd related to subsequent clinical outcome.
The GAS was calculated using the following formula:
sk score = age in years +17 for shock + 7 for myocardial
Ijsease+10 for cerebrovascular disease+14 for renalisease3. Shock was defined on clinical grounds by[chycardia, hypotension, pallor and sweating. Myocardial
.isease was previously documented myocardial infarction,
ingoing angina or both. Cerebrovascular disease referred
:o all grades of stroke including transient ischaemic attacks,
tenal disease was one or more of a history of chronic or
icute renal failure, urea over 20 mmol/1 or creatinine over
L50gmol/1 at presentation3. A score of more than 95 is
eported to correlate with a mortality rate of 80 per cent5.
The Hardman Index was derived from five preoperative
variables: age greater than 76 years, serum creatinine
iver 190 gmol/1, haemoglobin less than 9 g/dl, myocardial
schaemia on electrocardiogram and a history of loss of
:onsciousness after arrival in hospital6. A patient may
icore between 0 (no Hardman variables present) and 5
frve Hardman variables present). It has been reported that
;he presence of three or more variables is uniformly fatal7.
Statistical analysis was performed using SPSS for
Windows Release 11.0.0 (SPSS Inc., Chicago, Illinois,
LJSA). The Receiver-Operator Characteristic (ROC)
:urve and x.2 test for trend was used to evaluate
:he performance of the GAS and the Hardman Index
-espectively in predicting postoperative death. Differences
aetween groups for non-parametric continuous variables
vere determined by the Mann-Whitney U test; P < 0 05
tvas considered significant.
Results
Dne hundred patients were admitted with a ruptured
AAA during the study interval. Of these, 18 were
deemed unfit for aneurysm repair owing to prohibitive
:o-morbidity: 11 men and seven women of median age 81
'range 66-97) years. Eight patients had previously been
issessed and deemed unsuitable for elective repair. The
Drimary reasons for non-operative management in the
remainder were cardiorespiratory co-morbidity (seven),
:ardiac arrest (three), malignancy (three) age-related co¬
morbidity (three) and dementia (one). The median GAS
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Fig. 1 Postoperative mortality rates for three tcrtiles of the
Glasgow Aneurysm Score
84-127). These patients, in general, were not subject to a
full remit of baseline investigations on admission to allow
accurate Hardman Index scoring.
The remaining 82 patients underwent attempted repair
of a ruptured AAA and were included in the present
analysis: 68 men and 14 women of median age 73
(range 54-87) years. Thirty (37 per cent) patients died
after operation. Of all patients admitted to hospital with a
ruptured AAA during the study interval, 48 (48 per cent)
died.
Glasgow Aneurysm Score
The GAS was a poor predictor of mortality after ruptured
AAA repair. The mortality rates in terms of tertiles ofGAS
distribution are shown in Fig. 1. The median (range) GAS
was not significantly different in patients who survived
operative repair and those who did not: 93 (57-125)
versus 96 (71 -115) (P = 0-112). Analysis of the ROC curve
showed that the GAS had an area under the curve of 0-606
(95 per cent c.i. 0-483-0-729; s.e. 0-063; P = 0-112) for
predicting postoperative death.
Hardman Index
There was no significant association between Hardman
Index scores and operative mortality (P = 0-211) (Table I).
Patients with no Hardman Index risk factors appeared
to be at low risk, with an operative mortality of
15 percent. However, of nine patients with three or
more Hardman Index risk factors, six survived aneurysm
repair. The distribution of Hardman Index risk factors in
this subgroup is shown in Table 2. Of the six survivors,
four were discharged home, one was discharged to a
spinal rehabilitation unit because of perioperative spinal
cord ischaemia, and one was discharged to a community
rehabilitation hospital. Median survival in this group was
35-5 (range 1-53) months.
Copyright © 2005 British Journal of Surgery Society Ltd
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able 1 Distribution and mortality rates in 82 patients according
o the Hardman Index
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discussion
subjecting patients at extreme operative risk to a futile
ittempt at repair of ruptured AAA has resource and ethical
mplications. Therefore most vascular surgeons in the UK
idvocate selective management of patients with ruptured
AAA8. A scoring system that could identify patients with
l ruptured AAA in whom operative intervention would be
jnsuccessful would be valuable, but a reliable instrument
'emains elusive. To deny operation to a patient based on
in imprecise predictive tool would be a significant failing.
For this reason, any potential scoring system requires
;omprehensive and robust validation.
In the present study, both the GAS and the Hardman
Index appeared to lack validity. The GAS has recently
aeen shown to be accurate when applied to elective AAA
•epair9,10. Samy and colleagues have previously reported on
)2 patients with ruptured AAAs from three centres5. They
;oncluded that a score higher than 95 was associated with a
nortality rate of 80 per cent. In the present series, a score
af 99 and above was associated with an operative mortality
af approximately 40 per cent. Indeed, it was impossible to
Identify any score that conferred extreme risk, and even in
14 patients with scores of 110 or more operative mortality
lid not exceed 50 per cent. The Finnvasc Study Group
have recently reported on a 9-year, retrospective series of
836 patients with a ruptured AAA from 21 hospitals. They
showed that the GAS accurately predicted postoperative
mortality, but they were unable to describe a cut-off value
for patients at extreme risk11.
The GAS was originally derived from an analysis of
preoperative variables in patients with intact or ruptured
AAA. Though it displays good fit as a predictive tool for
elective AAA repair, it seems to be less reliable when used
solely in patients with ruptured aneurysms, as seen in the
present series. Its poor performance casts doubt over its
use not only in outcome prediction but also as a risk-
stratification tool for comparative audit of ruptured AAA
mortality.
Until now, the Hardman Index has been reported to be
accurate and has been recommended by four independent
series4'7'1215. Its appeal is heightened by its simplicity. It
has been concluded that the presence of three or more
Hardman risk factors in a patient represents a uniformly
fatal prognosis. Combining these four series of 32 patients
with three or more positive variables who underwent
attempted aneurysm repair, all died apart from one, who
survived to hospital discharge but succumbed 6 weeks later
in a nursing home.
It was surprising that both scoring systems displayed
such poor performance in the current data. If the Hardman
Index had heen used to select patients for operation in the
present series, six patients would have been denied a life-
saving operation; four of these patients were successfully
discharged home. There may be several reasons for these
differences. Though the present data were retrospective
and susceptible to bias, so too were three of the four
reports. The current series reported from a single high-
volume centre on consecutive patients operated on by
one of six surgeons during a contemporary 2-year study
interval. The operative mortality in the current series is
consistent with that regularly reported from this centre
for ruptured AAA repair and may have influenced the
performance of both the Hardman Index and GAS6.
In contrast, preceding retrospective series have been
drawn from longer study intervals or included non-
consecutive patients4,712. The two prospective evalua¬
tions available in the literature pooled data from mul¬
tiple centres5,15. The relationship between hospital and
surgeon-volume and improved outcome has been estab¬
lished in elective AAA repair and is likely to be a factor
in ruptured AAA repair141-1. In the Finnvasc Study Group
data, most of the centres operated on fewer than ten rup¬
tured AAAs each year; high-risk patients may be more
likely to survive when managed in a high-volume centre".
The findings from the present study cast doubt over
the validity of both the GAS and the Hardman Index
as predictive tools in patients with ruptured AAA. Both
scoring systems failed to predict mortality accurately
in high-risk patients and neither can be recommended
for routine use in clinical decision making. Further
risk modelling with prospective validation is required to
Copyright © 2005 British Journal of Surgery Society Ltd
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dentify patients in whom operative intervention may be
nappropriate.
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Background: Cardiac troponin I (cTnl) is a highly sensitive and specific marker for myocardial injury
that predicts mortality in patients with acute coronary syndromes. This study examined the relationship
between perioperative cTnl levels and clinical outcome in patients with ruptured abdominal aortic
aneurysm (AAA).
Methods: Consecutive patients who underwent operative repair of a ruptured AAA over a 22-month
interval and survived for more than 24 h were entered into a prospective observational cohort study.
Levels of cTnl were measured immediately before, and at 24 and 48 h after surgery, and related to
clinical outcome.
Results: Of 62 patients who underwent attempted operative repair of ruptured AAA, SO (81 per cent)
survived for more than 24 h and were included in this study. Twenty-three (46 per cent) of the SO had a
detectable cTnl level at one or more time points during the first 48 h. Of these, 11 patients had clinical
or electrocardiographic evidence of an acute cardiac event and 12 did not; five patients in each of these
two groups died. Of 27 patients with no increase in cTnl in the first 48 h, only three died (P = 0-031 and
P = 0-043 respectively, relative to the groups with detectable cTnl).
Conclusion: Approximately half of patients who survived repair of ruptured AAA for more than 24 h
sustained a detectable myocardial injury within the first 48 h. A perioperative increase in the level of
cTnl, with or without clinically apparent cardiac dysfunction, was associated with postoperative death.
Paper accepted 25 January 2005
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ntroduction
\bdominal aortic aneurysm (AAA) rupture continues to be
issociated with a high rate of perioperative morbidity
md mortality. In patients who undergo technically
successful repair of a ruptured aneurysm, death is
Generally attributed to the development of multiorgan
:ailure, thomboembolic events and myocardial infarction1.
Nevertheless, myocardial injury remains a frequently
.inder-recognized complication.
Cardiac troponin I (cTnl) is a highly sensitive and
specific marker for myocardial injury. In surgical patients
t has been shown to identify perioperative myocardial
infarction more accurately than the conventional creatinine
kinase MB fraction isoenzyme2. In non-surgical patients
with acute coronary syndromes, even small increases in
;TnI are associated with an increased risk of death and
reinfarction3,4. However, it remains uncertain whether
perioperative myocardial injury after emergency aortic
Copyright © 2005 British Journal of Surgery Society Ltd
Published by John Wiley & Sons Ltd
surgery, diagnosed on the basis of cTnl level, has the
same prognostic implications as traditional markers of
myocardial infarction.
This study examined the relationship between early
perioperative myocardial injury, as detected by increased
serum levels of cTnl, and clinical outcome after repair of
ruptured AAA.
Patients and methods
Local research ethics committee approval was obtained
for this study. Patients undergoing attempted operative
repair of a ruptured AAA between October 2002 and July
2004 and who survived for more than 24 h were included
in a prospective observational cohort study. Ruptured
aneurysm was defined as the presence of retroperitoneal
and/or intraperitoneal blood. Demographic and clinical
variables were recorded for all patients. Preoperative
British Journal ofSurgery 2005; 92: 824-827
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:ardiac and postoperative physiological risk stratification
vas carried out using the Detsky cardiac risk index3 and
he Acute Physiology And Chronic Health Evaluation
APACHE) II score6 respectively. All patients underwent
;urgery by one of five consultant vascular surgeons.
Blood was sampled for cTnl on admission to the
•mergency room and on the first and second days after
jperation. These time points were chosen as representing
te period of greatest risk of cardiac complications
fter vascular surgery7. Samples were collected in sterile
thium heparin tubes (Sarstedt, Niimbrecht, Germany)
ind analysed using an automated immunometric assay
Ortho-Clinical Diagnostics, Amersham, Bucks, UK). The
10 per cent coefficient of variation was 0-3 jag/1.
Primary outcomes assessed were postoperative death,
defined as death in hospital or within 30 days of
operation, and perioperative cardiac dysfunction. Cardiac
dysfunction was determined on the following clinical
ind electrocardiographic grounds: prolonged cardiac chest
tain, signs or symptoms of congestive heart failure,
md electrocardiographic changes indicating ischaemia
tr a new persistent arrhythmia. Echocardiography was
terformed only when indicated clinically. Secondary
tutcomes included duration of mechanical ventilation,
duration of critical care unit stay (intensive care or high-
dependency units) and total hospital stay.
Statistical analysis
Statistical analysis was performed using SPSS® for
Windows release 11.0.0 (SPSS, Chicago, Illinois, USA).
Univariate analyses between groups were conducted using
X.2 or Fisher's exact test for categorical variables and
Mann-Whitney U test for non-parametric continuous
variables. P < 0-050 was considered statistically significant.
Results
Eighty consecutive patients were admitted with a ruptured
AAA. Of these, 62 (78 per cent) underwent attempted
open repair; 18 (22 percent) were deemed unsuitable for
operation owing to co-morbidity. Of the 62 patients who
had an operation, 11(18 per cent) died during surgery and
one died soon after admission to the intensive care unit.
Preoperative cTnl levels were normal in these 12 patients.
The remaining 50 patients (81 percent) survived for at
least 24 h and all but one survived for more than 48 h.
There were 44 men and six women of median age 71
(range 53-87) years. Forty-two patients (84 per cent) had
a contained retroperitoneal rupture and eight (16 per cent)
had free intraperitoneal blood at laparotomy. Twelve
Copyright © 2005 British Journal of Surgery Society Ltd
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patients (24 per cent) required temporary cross-clamping
of the suprarenal aorta and the remainder were managed
with control of the infrarenal aorta. Thirty-eight patients
(76 per cent) had an aortic tube graft inserted and 12
(24 per cent) required a bifurcated graft. No patient was
dependent on dialysis before operation but 19 (3 8 per cent)
had evidence of pre-existing renal insufficiency (serum
creatinine level more than 150 gg/1).
Twenty-three patients (46 per cent) had a detectable
level of cTnl at one or more time points during the
first 48 h after operation. Only two of these patients
had a raised level of cTnl on admission, both of whom
had a preoperative serum creatinine concentration greater
than 150 pg/1. Twenty-two of the 23 patients had raised
cTnl levels by the first day after surgery. There were
no significant differences in Detsky cardiac risk index or
APACHE II scores between patients, with and without a
perioperative increase in cTnl (Table 1).
Of the 23 patients with a raised level of cTnl, 11 had
clinical or electrocardiographic evidence of acute cardiac
dysfunction during the first 48 h after operation. The
remaining 12 did not have any clinically apparent cardiac
events despite an increased cTnl level. Patients with
occult cardiac dysfunction had significantly lower median
(range) cTnl levels than those with a clinically evident
cardiac event: 0-52 (0-28-1-65) versus 12-7 (1-31-67-5) gg/l
(P < 0-001).
Thirteen (26 per cent) of 50 patients died after surgery.
Ten of these patients had a raised perioperative level of
cTnl, five of whom had clinical evidence of a cardiac
event and five with no apparent cardiac dysfunction. The
Table 1 Demographic and clinical variables in 27 patients
without, and 23 patients with raised perioperative levels of
cardiac troponin I
cTnl negative cTnl positive
(n = 27) (n = 23) P
Women 3 3 0-834*
Age (years)* 69 (53-87) 75 (63-82) 0-031*
Detsky cardiac 15(10-30) 15 (10-65) 0-147*
index*
Preoperative 6 13 0-013*
serum creatinine
> 150 pg/l
Suprarenal aortic 4 8 0-183*
clamp
Blood loss (ml) 3000 (1325-8500) 4600 (1070-21 000) 0-062*
Bifurcated graft 4 8 0-183*
APACHE II score* 16(18-33) 19(10-30) 0-065*
"Values are median (range). cTnl, cardiac troponin I; APACHE, Acute
Physiology And Chronic Health Evaluation. fFisher's exact test;
*Mann-Whitney U test.
www.bjs.co.uk British Journal ofSurgery 2005; 92: 824-827
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:ause of death was multiorgan failure in seven patients
md respiratory failure in three. There were only three
deaths among the 27 patients who had no perioperative
increase in cTnl, significantly fewer than in both groups of
Datients with raised cTnl levels (P = 0 031 and P = 0 043,
espectively). One patient died from multiorgan failure on
he fourth day after surgery, one from respiratory failure
t 38 days and one from an aortoenteric fistula at 46 days
fter operation.
Patients with raised levels of cTnl who survived spent
ignificantly longer in intensive care and high dependency
ban those with no perioperative cTnl increase (P =
)-038). Total stay in hospital and duration of mechanical
ventilation were not significantly different between the two
groups {Table 2).
-Discussion
\ previous non-consecutive series of selected patients
undergoing ruptured AAA repair in this hospital had an
incidence of perioperative myocardial injury in excess of
50 per cent8. Present data confirm that around half of the
patients who survive repair of a ruptured AAA sustain
a detectable perioperative myocardial injury. Of these,
roughly half have a clinically silent event, with a low-level
cTnl increase. By comparison, approximately a quarter of
patients who undergo a major vascular surgical operation
develop perioperative myocardial injury, as determined
by raised levels of cardiac troponins2. The incidence of
myocardial injury in critically ill patients in intensive care
is similarly reported to be between 15 and 40 per cent9-11.
Patients with a ruptured AAA are subject to a greater
risk of perioperative cardiac injury. This is likely to
reflect the impact ofmassive haemorrhage and transfusion,
compounded by the burden of cardiovascular co-morbidity
that is common in these patients. In the present series,
however, preoperative cardiac status, as assessed by the
Detsky risk index, was not associated with postoperative
Table 2 Outcomes in 27 patients without, and 23 patients with
raised perioperative levels of cardiac troponin I
cTnl negative cTnl positive p.
Survivors and non-survivors
Critical care stay (days) 3 (1 -38) 6 (1 -46) 0031
Duration of ventilation (days) 1 (1 -38) 2-5 (1-43) 0008
Total hospital stay (days) 14(4-56) 12 (1-58) 0-711
Survivors
Critical care stay (days) 3(1-11) 5 (1 -42) 0-038
Duration of ventilation (days) 1 (1-5) 1 (1 -38) 0-199
Total hospital stay (days) 14(7-56) 18 (8-58) 0-202
Values are median (range). CTnl, cardiac troponin I. *Mann-Whitney U
test.
myocardial injury. The sample size of this series did not
permit a multivariate analysis of perioperative variables
associated with myocardial injury and outcome.
Cardiac troponins are the standard bioinarker for the
diagnosis of myocardial infarction and a useful tool
for risk stratification in patients with acute coronary
syndromes12'13. Levels of cardiac troponins may also
be raised in other clinical conditions and have similar
prognostic value in patients with sepsis, renal failure
and pulmonary embolism14. It is now acknowledged that
even minor increases in cardiac troponin, below the
diagnostic criteria for myocardial infarction, are indicative
of increased clinical risk15. The present study demonstrated
that a slight, clinically silent increase in cTnl level within
the first 48 h after operation conferred an increased risk of
postoperative death. In contrast, only one of 27 patients
without a rise in cTnl died within 30 days of operation.
In terms of secondary outcomes, patients with raised cTnl
levels also required a significantly longer stay in critical
care. Although total stay was not significantly increased
in such patients, it is recognized that hospital stay, unlike
critical care, may be influenced by circumstances unrelated
to a patient's clinical condition.
The question remains whether raised cTnl levels
represent a marker of severity of critical illness and
its consequent adverse outcome, or whether there is
a causal relationship between myocardial dysfunction
and subsequent morbidity and mortality. The possible
mechanisms underlying raised cardiac troponin levels,
apart from myocardial necrosis, include leakage of
cardiac proteins from myocyte cell membranes14. Tumour
necrosis factor (TNF) a is known to increase endothelial
permeability and may also be implicated at the cardiac
myocyte level1617. Patients who survive initial repair
of a ruptured AAA develop a postoperative systemic
inflammatory response syndrome with an associated
increase in circulating TNF-a levels18,19. It has been
reported that high levels ofTNF-a are associated with poor
outcome after ruptured AAA repair19. Thus, an increase in
cTnl and myocardial dysfunction may be an effect of an
underlying systemic inflammatory response.
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Functional outcome after open repair of ruptured
abdominal aortic aneurysm
Andrew L. Tambyraja, MRCSEd, Simon C. A. Fraser, MD, FRCSEd, John A. Murie, MD, FRCSEd, and
Roderick T. A. Chalmers, MD, FRCSEd, Edinburgh, Scotland
Background: Outcome after operative repair of ruptured abdominal aortic aneurysm (AAA) has traditionally been assessed
in terms of survival. This study examines the functional outcome of patients who survive operation.
Methods: Consecutive patients who survived open repair over an 18-month period were entered into a prospective
case-control study. Age- and sex-matched controls were identified from patients undergoing elective AAA repair. The
Short Form-36 health survey was administered to both groups of patients at 6 months after operation. Results were
compared with the expected scores for an age- and sex-matched normal UK population.
Results: Fifty-seven patients underwent open repair of a ruptured AAA, and 30 survived; no patient was lost to follow-up.
There were no significant differences in quality of life between patients who had an emergency repair and those who had
an elective repair. Both of these groups had poorer health-related quality of life outcomes than the matched normal
population. Surprisingly, compared with the normal population, patients after elective repair had poorer outcomes in
more health domains than patients who survived emergency operation.
Conclusions: Survivors of ruptured AAA repair have a good functional outcome within 6 months of operation. (J Vase
Surg 2005;41:758-61.)
Open repair of ruptured abdominal aortic aneurysm
(AAA) is burdened with high perioperative morbidity and
mortality. Furthermore, its cost in financial terms and re¬
source utilization is significant.1 Although survivors may
return to a normal life expectancy, their functional out¬
come, in terms of health-related quality of life (HRQoL),
remains uncertain. In properly assessing the value of a
surgical intervention, functional outcome must be exam¬
ined alongside the more traditional outcome measures of
operative morbidity and mortality. If a survivor of ruptured
AAA were returned to a significant level of functional
disability despite a near-normal life expectancy, the benefit
of intervention would beeonte less apparent. To quantify
the efficacy of ruptured AAA repair with accuracy, HRQoL
analysis is essential.
Published data on HRQoL after aneurysm rupture are
limited. Although it has been suggested that survivors of
ruptured AAA repair regain their preoperative quality of
life, this rests on retrospective data ofuncertain validity.2'15
A recent review of HRQoL after repair of ruptured aneu¬
rysm concluded that prospective data are now needed.16
This study examines the postoperative HRQoL ofsurvivors
of ruptured AAA repair when compared with that of pa¬
tients undergoing elective AAA repair and that of the
general population.
From the Edinburgh Vascular Surgical Service, Clinical & Surgical Sciences
(Surgery), University of Edinburgh.
Competition of interest: none.
Reprint requests: Andrew L. Tambyraja,MRCSEd, Clinical & Surgical Sciences
(Surgery), Royal Infirmary of Edinburgh, 51 Litde France Crescent, Edin¬
burgh, EH16 4SA, Scodand (e-mail: andrew.tambyraja@ed.ac.uk).
0741-5214/530.00




Local Research Ethics Committee approval was ob¬
tained for this study. Patients undergoing open operative
repair of a ruptured AAA over the 18-month period from
September 2002 to March 2004 were included in a pro¬
spective observational case-control study. Patients were
selected for operative intervention and were operated on by
one of five vascular surgeons. Ruptured aneurysm was
defined as the presence of retroperitoneal and/or intraperi¬
toneal blood in the absence of any other identifiable cause
of hematoma other than an aneurysm at laparotomy. A
control group of age- and sex-matched patients undergo¬
ing elective open repair of asymptomatic AAA during the
study period was also identified. Endovascular aortic repair
was not used as a therapeutic option for either intact or
ruptured AAA during the study period. Demographic and
clinical variables for both groups were recorded. The sever¬
ity of illness was scored by using the Simplified Acute
Physiology Score II recorded during the first 24 hours after
operation.17 Patient survival was confirmed by using hos¬
pital and general practice records.
The Short Form-36 Health Survey (SF-36; Quality-
Metric Inc, Lincoln, RI) is a generic HRQoL instrument
and comprises 36 questions studying 8 domains of health:
physical functioning, social functioning, role limitations
due to physical problems, role limitations due emotional
problems, mental health, pain, vitality, and general health
perception. Each domain scores from 0 to 100, with higher
scores representing a better quality of life. The reliability,
validity, and consistency ofthe SF-36 have been confirmed,
and its use in the assessment of vascular and aneurysm
disease has been recommended.18,19
The self-administered UKversion ofthe SF-36 was sent
to all patients 6 months after aneurysm repair. This time
point was chosen as representing the time by which patients
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undergoing elective AAA repair regain their preoperative
levels ofHRQoL.18 Repeat questionnaires were sent after 2
weeks if no reply was received. Questionnaires were scored
according to the methods described by Ware et al.20 Mean
scores and standard deviations were calculated for each
group and compared. Further comparison was made be¬
tween the age- and sex-matched general population data
for the United Kingdom.21
Statistical analysis was performed with SPSS for Win¬
dows release 11.0.0 (SPSS Inc, Chicago, 111). Between-
groups differences were determined by the unpaired t test
or Mann-Whitney Utest for parametric and nonparantetric
continuous variables, respectively; P < .05 was considered
significant.
RESULTS
Seventy-three consecutive patients were admitted with
a ruptured AAA during the study period, of whom 57
(78%) underwent attempted aneurysm repair. Reasons for
nonoperative management are listed in Table I. Of these
57, 30 (53%) survived to discharge from the hospital and
were included in this study. There were 26 men and 4
women ofmedian age 68 years (range, 53-85 years). Twen¬
ty-two of the 30 patients had hemodynamic instability, as
defined by a preoperative blood pressure of less than 90 mm
Hg, before operation. During the same period, 78 patients
underwent elective repair of an asymptomatic aneurysm,
and 19 underwent urgent repair of an acutely symptomatic
aneurysm. Thirty patients with asymptomatic AAA were
selected as suitable age- and sex-matched controls. The
median age of the 26 male and 4 female control patients
was 70 years (range, 59-83 years; P = .440). Patients who
had repair of a ruptured aneurysm had a median hospital
stay of 14 days (range, 7-59 days), whereas patients under¬
going elective operation stayed for a median of 11 days
(range, 7-37 days; P = .048). The median Simplified Acute
Physiology Score II for patients undergoing ruptured AAA
repair was 30 (range, 18-52), and for patients who had
elective repair, it was 16 (range, 12-30; P < .001).
At the 6-month follow-up, all patients in both the study
and control groups were still alive. Twenty-eight of the 30
patients who survived ruptured aneurysm repair had been
discharged to their homes, one patient required nursing
home care, and one remained in a geriatric rehabilitation
unit. All patients in the control group were discharged
home. The SF-36 questionnaire was self-administered by
all but one patient, who required the aid of a proxy. All
patients from both groups returned a completed form.
Comparisons of SF-36 scores of the ruptured AAA,
elective AAA, and normal populations are shown in Tables
II to IV. There was no statistically significant difference
between patients who had undergone ruptured aneurysm
repair or an elective aneurysm repair in any of the health
domains. However, when HRQoL in survivors of aneu¬
rysm rupture was compared with that of the matched
normal population, the former group had significantly
worse outcomes in terms of role limitations due to physical
and emotional problems. There were no statistically signif-
Table I. Primary reason for refusal of surgery in 16
patients
Reason for refusal No. patients





LOC, Loss of consciousness.
Table II. Mean (SD) SF-36 scores in 30 patients after
ruptured AAA repair and in 30 patients after elective AAA
repair
Ruptured Elective
Health domain AAA repair AAA repair P value
Physical function 65 (27) 55 (30) .222
Role limitations physical 58 (29) 57 (33) .855
Bodily pain 69 (28) 60 (28) .196
General health 62 (24) 63 (22) .770
Vitality 55 (23) 54 (24) .911
Social functioning 78 (32) 71 (31) .441
Role limitations emotional 68 (33) 71 (35) .733
Mental health 77 (19) 76 (17) .782
Mental summary score 49 (12) 49 (12) .842
Physical summary score 44 (ID 40 (11) .297
SF-36, Short Form-36 Health Survey; AAA, abdominal aortic aneurysm.
icant differences in the other six health domains. In con¬
trast, comparison of functional outcome between patients
who underwent elective repair and the normal population
showed the former group to have significantly worse out¬
comes in the domains ofphysical function, bodily pain, and
social functioning, as well as role limitations due to physical
and emotional problems.
DISCUSSION
Postoperative quality of life is a frequently neglected
outcome measure in the assessment of surgical interven¬
tions. In contrast, oncologic interventions have been rou¬
tinely subjected to HRQoL analysis, and the UK Medical
Research Council has introduced HRQoL measures into
their guidelines for clinical trials.22'23 Ruptured AAA re¬
pair, and subsequent recuperation, is associated with a
major physical and psychological insult. Nevertheless, there
are few data on functional outcomes in this situation. This
series contains the first prospective data examining HRQoL
after ruptured aneurysm repair. Although the limitations of
the data arc acknowledged inasmuch as preoperative assess¬
ment of HRQoL is absent and the sample size is relatively
small, the nature of ruptured AAA does not allow the
former, and only three retrospective series have individually
reported more patients.5,6,12 Multivariate analysis on cur¬
rent data to identify independent predictors of functional
outcome has not been performed because the small sample
size renders such analysis vulnerable to type II statistical
error.
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Table III. Mean (SD) SF-36 scores in 30 patients after
ruptured AAA repair and the age- and sex-matched
normal population
Ruptured Normal
Health domain AAA repair population P value
Physical function 65 (27) 72 (9) .162
Role limitations physical 58 (29) 72 (5) .016
Bodily pain 69 (28) 77 (3) .167
General health 62 (24) 64 (2) .638
Vitality 55 (23) 62 (4) .116
Social functioning 78 (32) 83 (4) .339
Role limitations emotional 68 (33) 87 (4) .004
Mental health 77 (19) 79 (2) .521
SF-36, Short Form-36 FJealth Survey; AAA, abdominal aortic aneurysm.
Table IV. Mean (SD) SF-36 scores in 30 patients after
elective AAA repair and the age- and sex-matched normal
population
Elective Normal
Health domain AAA repair population P value
Physical function 55 (30) 72 (9) .007
Role limitations physical 57 (33) 72 (5) .019
Bodily pain 60 (28) 77 (3) .003
General health 63 (22) 64 (2) .926
Vitality 54 (24) 62 (4) .098
Social functioning 71 (31) 83 (4) .043
Role limitations emotional 71 (35) 87 (4) .018
Mental health 76 (17) 79 (2) .253
SF-36, Short Form-36 FJealth Survey; AAA, abdominal aortic aneurysm.
Present data show that the quality of life ofsurvivors of
ruptured AAA is no different from that ofpatients who have
undergone elective aneurysm repair. Furthermore, this re¬
covery in functional performance is apparent within 6
months ofoperation. It is interesting that functional recov¬
ery is so similar between two groups that are clearly differ¬
ent in terms of illness severity and hospital stay. The 30
patients with ruptured aneurysm are a highly selected
group who have survived to reach the hospital, have been
selected for operative intervention, have survived opera¬
tion, and have survived to the 6-month follow-up. Survival
after aneurysm rupture is influenced by good preoperative
physiological status, and this may predispose these patients
to achieving good functional outcomes.24 Existing studies
of HRQoL after elective open repair of AAA have shown
that patients regain their preoperative functional status
within 3 to 6 months of operation.18-25 It would seem,
from the present data, that recovery of HRQoL after rup¬
tured aneurysm repair follows a similar time course. How¬
ever, if HRQoL assessment had been performed at an
earlier time point from operation, differences in functional
outcome may have been apparent.
Eight previously published series2-3,5"7-9'14-15 com¬
pared HRQoL outcome after ruptured and elective AAA
repair. All were retrospective and had a varying duration of
follow-up, thus rendering them vulnerable to an even
greater selection bias. In contrast, the present prospective
data describe a consecutive series of patients with ruptured
AAA with a fixed follow-up interval. All but one of the
preceding retrospective studies concluded that ruptured
aneurysm survivors regain a quality of life similar to that of
patients undergoing elective AAA repair. Magee et al6 are
the only authors to have demonstrated a significant deteri¬
oration in functional outcome after ruptured AAA repair
compared with elective repair. They reported a decrease
from near-perfect HRQoL to considerable disability after
ruptured aneurysm repair. However, in their series, patients
who underwent elective repair were not matched for age
and, in fact, were much younger than the patients with
ruptured AAA. It is noteworthy that there is relative con¬
sistency in SF-36 health domain scores between the present
data and the three other studies that have used this instru¬
ment.8-10-11 Such a finding across different series supports
the conclusion that survivors of ruptured AAA do regain a
good quality of life. Although a selective policy ofoperative
intervention has governed this series, the good functional
outcomes attained do justify an aggressive policy ofsurgical
intervention for ruptured aneurysm.
The present series shows that survivors of ruptured
aneurysm have poorer outcomes in terms of role limitations
due to physical and emotional problems when compared
with the general population. It is, perhaps, unsurprising
that they have some functional disability after such a major
surgical intervention. However, no other differences were
demonstrated in the other health domains. It is interesting
to note that functional outcome after elective aneurysm
repair displayed poorer outcomes in more health do¬
mains—physical functioning, bodily pain, and social func¬
tioning. Taking these results at face value, one would infer
that patients who survived ruptured aneurysm repair had a
better functional outcome than those who had an elective
operation. This, clearly, is counterintuitive. It is likely that
this discrepancy is related to the selection of biologically
robust individuals for emergency operation; they survive to
have a good functional recovery after surgery. A possible
alternative is that a near-death experience has a positive
effect on an individual's perception of his or her functional
performance, resulting in a higher rating ofHRQoL.
This study provides benchmark HRQoL data for pa¬
tients who survive open repair of ruptured AAA. In the
future, functional outcomes after endovascular repair can
be assessed against these results.
The authors thank A. R. W. Dawson and Z. Raza for
allowing us to report on their patients.
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bstract
ackground Inflammation is integral to the pathogenesis
f abdominal aortic aneurysm (AAA). This study examines
eoperative biomarkers of systemic inflammation in pa-
ents undergoing open repair of intact and ruptured AAA.
Methods One-hundred twelve patients were entered into a
"ospective observational study. Preoperative POSSUM
tysiology score, C-reactive protein (CRP), white blood
runt (WBC), platelet count, fibrinogen, and albumin were
corded and related to clinical variables using univariate
lalysis.
esults Sixty-one patients with a ruptured AAA, 39 with
i asymptomatic intact AAA, and 12 with an acutely
/mptomatic intact AAA underwent attempted repair,
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inical evidence of coexistent inflammatory disease. Pa-
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lower serum albumin, than those with an asymptomatic
intact AAA. Patients with a ruptured aneurysm had a sig¬
nificantly greater level of CRP, higher WBC, and lower
serum albumin than those with an asymptomatic intact
aneurysm. Patients with a symptomatic intact AAA had a
significantly higher CRP level, but lower WBC, than those
with a ruptured AAA. There was no difference in CRP
level, WBC, or serum albumin between survivors and non-
survivors of attempted repair of asymptomatic, symptom¬
atic and ruptured AAA.
Conclusions Acutely symptomatic and ruptured AAAs
are associated with an early elevation in systemic inflam¬
matory biomarkers. This early activation of the inflam¬
matory response might influence perioperative outcome.
Inflammation is an integral factor in the pathogenesis of
abdominal aortic aneurysms (AAA) histologically charac¬
terized by a transmural infiltration of macrophages and
lymphocytes. These cells are thought to elicit an inflam¬
matory cytokine cascade, culminating in the degeneration
of aortic connective tissue [1], Interestingly, patients with
AAA have elevated serum markers of inflammation and the
acute phase response when compared with healthy controls
and controls with coexistent vascular disease [2, 3], Fur¬
thermore, serum concentrations of inflammatory cytokines
are associated with aneurysm diameter and rate of expan¬
sion [4], However, the precise relationship between sys¬
temic markers of inflammation, the acute phase response,
and aortic aneurysms is uncertain.
C-reactive protein (CRP) is an acute-phase protein that
is a strong, independent risk factor for atherosclerosis [5],
It may also predict survival in critically ill patients and in
patients with underlying neoplasia [6, 7], It is unclear
whether inflammatory biomarkers have any such prog¬
nostic significance in patients undergoing AAA repair.
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ystemic inflammatory proteins may have a role as a
agnostic tool or as a means of preoperative risk stratifi-
ition.
This study compares easily measured preoperative
iflammatory biomarkers in patients admitted for open
pair of intact and ruptured AAA, and their relationship
ith clinical outcome.
(aterials and Methods
ocal Research Ethics Committee approval was obtained
>r this research. Consecutive patients admitted for open
pair of intact (September 2003-September 2004) or
iptured (January 2003-September 2004) AAA were in-
uded in a prospective observational case-cohort study,
hose with intact AAA were further stratified into an
symptomatic group undergoing elective repair and an
:utely symptomatic group requiring urgent operation. An
:utely symptomatic aneurysm was typified by severe back
id/or abdominal pain, hemodynamic stability, and ten-
;rness of the AAA on palpation. Ruptured aneurysm was
pified by the presence of retroperitoneal and/or intra-
5ritoneal blood at laparotomy in the absence of any
entifiable cause other than an aneurysm. Patients were
agnosed as having an inflammatory AAA by operative
rpearance. An inflammatory AAA was characterized by
e presence of a thickened aneurysmal wall, perianeur-
;mal fibrosis, and adhesions to adjacent structures [8].
emographic and clinical variables for all patients were
corded. Preoperative physiological status was stratified
:cording to the Physiological and Operative Severity
:ore for the enumeration of Mortality and morbidity
'OSSUM) [9]. All patients were operated on by one of
ve consultant vascular surgeons.
Blood was sampled for the following biomarkers of
flammation: CRP, platelet count, white blood cell count,
orinogen, and albumin. Serum samples were collected at
e time of admission in sterile, lithium heparin, potassium
-DTA, or sodium citrate tubes (Sarstedt AG & Co.
Numbrecht, Germany) and analyzed in the Clinical Bio¬
chemistry and Haematology Laboratories of the Royal
Infirmary of Edinburgh. C-reactive protein analysis was
performed with an automated immunoturbidimetric assay
(Abbott TDX, Abbott Laboratories, Maidenhead, UK). A
systemic inflammatory response was defined by a CRP
level of > 10 mg/1 [10], Primary outcome was assessed in
terms of postoperative mortality, defined as death in-hos-
pital or within 30-days of operation.
Statistical analysis was performed using SPSS for
Windows Release 13.0 (SPSS Inc., Chicago, IL, USA).
Univariate analyses between groups were determined by
the chi-square or Fisher's exact test for categoric variables
and by the Kruskal-Wallis and Mann-Whitney U-test for
non-parametric continuous variables. Spearman's rank
correlation coefficient was calculated to assess the strength
of association between continuous variables; p < 0.05 was
considered significant.
Results
Fifty-one consecutive patients, 39 asymptomtatic and 12
acutely symptomatic, underwent attempted repair of an
intact aneurysm, and 61 of a ruptured aneurysm, during the
study period. Demographic and clinical variables are
shown in Table 1.
There was no statistically significant difference in age
(p = 0.876), gender (p - 0.275), aneurysm diameter (p =
0.871), or POSSUM physiology score (p = 0.201) between
patients with an asymptomatic or symptomatic intact AAA.
Patients with ruptured AAA had larger aneurysms on
selectively utilized computed tomography (CT) or ultra¬
sound scan (p = 0.007) and higher POSSUM physiology
scores (p < 0.001) than those with asymptomatic lesions;
age [p = 0.470) and gender (p = 0.609) distribution were,
however, similar.
There were no statistically significant differences in age
(p = 0.457), gender {p - 0.257) or AAA size (p - 0.197)
between patients with ruptured AAA and those with
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able 2 Inflammatory biomarkers in 112 patients with AAA
Asymptomatic AAA Symptomatic AAA Ruptured AAA p Value
(.n = 39) (n = 12) (n = 61)
RP (mg/1) < 5 (< 5-22) 22 (5-103) 7 (< 5-168) < 0.001
'BC x 109/1 7.0 (4.4-13.7) 8.8 (5.4-19.2) 13.2 (4.4-24.0) < 0.001
atelets xl09/l 209 (125-320) 240 (123-428) 186 (89-462) 0.008
brinogen (g/1) 3.6 (2.1-6.0) 4.6 (2.1-6.7) 2.8 (0.2-5.5) < 0.001
Tmmin (g/1) 41 (34-47) 37 (27-47) 33 (18-47) <0.001
alues are median (range). Kruskal-Wallis test
'mptomatic intact aneurysms; however, POSSUM physi-
ogy scores (p = 0.001) were greater in the former group.
0 patient had clinical evidence of a significant coexistent
flammatory disease, and the distribution of inflammatory
AAs, as determined at laparotomy, is shown in Table 1.
There were significant differences in CRP level, fibrin-
-»en level, WBC count, and platelet count across the three
oups of patients (Table 2). Asymptomatic intact AAAs
ere associated with a lower CRP level (p < 0.001),
mnogen level (p = 0.022), and WBC count (p = 0.036),
id with a higher serum albumin level (p = 0.017) than
■mptomatic intact aneurysms; platelet counts were similar
1 = 0.152). Asymptomatic lesions were also associated
ith lower CRP level (p - 0.002) and WBC count (p <
001), and with higher serum albumin (p < 0.001), than
ptured AAA. However, patients with asymptomatic AAA
id greater platelet counts (p = 0.026) and fibrinogen levels
1 = 0.005) than those with ruptured aneurysms.
Patients with symptomatic intact AAA had higher CRP
vels (p - 0.042) but a lower WBC count (p = 0.04) than
ose with ruptured lesions. Platelet count (p = 0.011) and
irinogen level (p = 0.01) were higher with symptomatic
tact aneurysms. There was no difference in serum albu-
in between groups (p = 0.171). Analysis of all patients
ith AAA failed to demonstrate any correlation between
;e (r = 0.139, p - 0.157) or aneurysm size (r = 0.010, p -
930) and CRP. However, POSSUM physiology score
irrelated with CRP (r = 0.283, p = 0.004). The distribution
systemic inflammatory response as defined by serum
*RP levels is shown in Table 3. Patients with symptomatic
ruptured AAA were more likely to have a systemic
flammatory response (p < 0.001).
ible 3 Presence (CRP > 10 mg/) or absence (CRP < 10mg/l)ofa
stemic inflammatory response in 106 patients
Asymptomatic Symptomatic Ruptured
AAA AAA AAA
IP < 10 mg/l 31 (86%) 2 (18%) 32 (54%)
iP > 10 mg/1 5 (14%) 9 (82%) 27 (46%)
Value <0.001
flues are number (%). Chi-square test
Table 4 Causes of perioperative death in 30 patients
Asymptomatic Symptomatic Ruptured
AAA AAA AAA
Multiorgan failure 1 1 11
Intraoperative 1 - 11
death
Myocardial 1 - 2
infarction
Respiratory - 1 1
failure
Aorto-enteric - - 1
fistula
There were 3 (8%), 2 (17%), and 21 (41%) perioperative
deaths in the asymptomatic, symptomatic, and ruptured
AAA groups, respectively. Causes of deaths are shown in
Table 4. There was no statistically significant difference
between survivors and non-survivors of AAA repair in
terms of systemic inflammatory response, CRP level,
WBC, or serum albumin in any of the three groups. Those
who survived ruptured AAA repair had higher platelet
counts (p - 0.006) and serum fibrinogen levels (p = 0.002)
than those who died.
Discussion
The systemic inflammatory response is typified by the
synthesis of proteins by the liver [11], The effect is med¬
iated by proinflammatory cytokines. Proteins such as CRP
and fibrinogen increase, while others such as albumin fall.
Most AAAs exhibit features of inflammation on histolog¬
ical examination, and increased expression of local and
circulating proinflammatory cytokines is well documented
in patients with aneurysms [12-14], Controversy persists
about the extent to which this cytokine upregulation evokes
a systemic inflammatory response and about the influence
of aneurysm symptomatology on this process [4].
This study shows that patients with symptomatic intact
or ruptured AAA have elevated markers of systemic
inflammation before operative intervention. Both the CRP
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id the WBC levels were significantly higher than those
icountered in patients with asymptomatic AAA. The
imulus for this inflammatory response is uncertain,
learly, ruptured AAA causes acute hemorrhage and hy-
avolaemic shock as inflammatory triggers. However,
'mptomatic intact lesions do not result in such a profound
lysiological insult; a lower POSSUM physiology score
fleets this. However, pain is a cardinal feature of
flammation and in acutely symptomatic AAA is thought
' relate to a sudden expansion in aneurysm size [15]. This
sser trigger seems capable of evoking systemic changes
circulating inflammatory biomarkers too. This elevation
"
easily measured serum markers of inflammation sup-
arts their utility as diagnostic tools in patients with acute
artic pathology. While nonspecific, their use in conjunc-
an with clinical evaluation may prove a valuable indicator
~
impending or established aneurysm rupture. Interpreta-
an of changes in the other inflammatory markers is con-
mnded by a number of factors. Acute blood loss and the
lutional and volume redistribution effects of intravenous
aid resuscitation may influence changes in platelet count
id fibrinogen level [16]. The use of these inflammatory
arkers as diagnostic or prognostic tools is limited by such
ctors.
Despite similar physiological scoring, and the integrity
'
the aneurysm being preserved, patients with symptom-
ic lesions had an operative mortality rate more than twice
at of patients undergoing repair of an asymptomatic
AA. Reasons for the increased operative mortality asso-
ated with symptomatic aneurysms, though well de-
ribed, remain unresolved [17]. However, it is possible
at elevated systemic inflammatory proteins in symptom-
ic patients may be implicated.
Multiple organ failure is a major cause of perioperative
:ath after AAA repair [18]. Excessive activation of
flammatory pathways and release of inflammatory cyto-
nes underpin organ dysfunction. An initial inflammatory
imulus, such as acute AAA expansion or rupture, may
mse priming of inflammatory pathways. A subsequent
imulus, such as ischemia-reperfusion injury during
leurysm repair, causes an inflammatory response greater
an expected if it occurred in isolation [19]. Such a phe-
amenon might partially account for the increased mor-
lity rates found in patients with acute AAA.
If a primed inflammatory response were related to
trioperative death in patients with acute AAA, it would be
iticipated that raised CRP levels would be associated with
:ath. However, the present data have shown that neither
level nor a systemic inflammatory response provides
ognostic information in terms of survival after AAA re-
lir. In contrast, Schillinger and colleagues have reported
at admission CRP levels predict poor outcome [20]. Their
trospective series combined patients with thoracic and
1213
abdominal aortic disease, including both aortic dissections
and aneurysm. Despite the heterogeneity of their sample
population, they concluded that CRP level was useful for
risk prediction in acute aortic disease. The absence of such
an association in the present series is surprising considering
the positive correlation between preoperative physiological
status, as reflected by POSSUM score, and CRP level
(patients with greater physiological compromise had higher
CRP levels). It is possible that the failure of CRP to predict
mortality in the present data is a reflection of small sample
size. Alternatively, the use of newer high-sensitivity CRP
assays may have yielded greater prognostic information.
Furthermore, analysis of the temporal changes in inflam¬
matory markers in the postoperative period may also have
conferred useful prognostic information.
These data highlight the presence of an early elevation
in inflammatory biomarkers and the systemic inflammatory
response in patients before elective and emergency aortic
aneurysm repair. This inflammatory process and upregu-
lation of the acute phase response might affect periopera¬
tive outcome.
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bstract
ackground Many surgeons adopt a selective policy of
itervention for a ruptured abdominal aortic aneurysm
AAA). This study aimed to develop an objective method
-f identifying patients suitable for attempted repair.
Methods Consecutive patients selected for attempted
epair of ruptured AAA over a 31-month period (January
000 to July 2002) were entered into an observational study,
altogether, 53 preoperative physiological and biochemical
ariables were recorded and related to operative outcome.
lesults A total of 105 patients underwent attempted
epair of a ruptured AAA. There were 39 (37%) deaths in
iospital or within 30 days of operation. On univariate
nalysis, hemoglobin <9 g/dl (p - 0.038), blood pressure
:90 mmHg (p - 0.036), and Glasgow Coma Scale <15
o = 0.016) were found to be risk factors that predicted
eath. Of 70 patients with no or one risk factor, 20 (29%)
lied. Of 30 patients with two factors, 15 (50%) died, and of
die five patients with all three factors, four (80%) died.
There was a significant association between mortality and
emulative risk factors (p = 0.003).
Conclusion These three risk factors are easily assessed in
he emergency setting and might form the basis of a scoring
system to inform the outcome of ruptured AAA.
Despite increased elective abdominal aortic aneurysm
(AAA) repair, the incidence of ruptured AAA is increasing
A. Tambyraja (El) • J. Murie • R. Chalmers
Edinburgh Vascular Surgical Service, Clinical & Surgical
Sciences (Surgery), University of Edinburgh, 51 Little France
Crescent, Edinburgh EH16 4SA, UK
;»-mail: andrew.tambyraja@ed.ac.uk
in Europe [1, 2], Disconcertingly, aneurysm rupture con¬
tinues to be associated with a prohibitive mortality rate,
with 50% of patients who reach a hospital not surviving
[3], Among them, some are already at an overwhelming
risk of death due to coexisting morbidity or irreversibly
compromised physiologic status. It is for this reason that
most surgeons in the United Kingdom adopt a selective
policy for intervention [4], However, patient selection is
largely based on subjective criteria, and there is conflicting
evidence about which variables to base objective preoper¬
ative outcome prediction in patients with a ruptured AAA
[5, 6],
Previously reported data from this center have shown
that the two most popular preoperative risk-scoring meth¬
ods (Hardman Index, Glasgow Aneurysm Score) lack
validity, and this finding has now been confirmed by other
centers [7-11], Reasons for this lack of fit may be related to
the fact that the existing models derive from clinical data
that are mostly two decades old and that were accumulated
over long study periods. Furthermore, they include results
from low-volume institutions. Their use cannot be robustly
recommended for the purpose of clinical decision-making.
The present study aimed to examine preoperative variables
associated with perioperative death in a large, contempo¬
rary series of patients from a high-volume center. These
variables were modeled to develop an objective risk-scor¬
ing instrument with which to inform patient selection.
Method
All patients admitted to the Edinburgh Vascular Surgical
Service who underwent repair of a ruptured AAA over a
31-month period (January 2000 to July 2002) were iden¬
tified from a prospective database and included in an
<£) Springer
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etrospective observational study. The database, together
/ith hospital records, provided demographic details and
linical and operative information for all patients under-
bing attempted repair. Operation was defined as the
tlivery of an anesthetic with the intention of performing
AA repair. Ruptured aneurysm was defined as the pres-
tce of retroperitoneal and/or intraperitoneal blood in the
tsence of any other identifiable cause for hematoma other
an an aneurysm [12].
All patients were operated on by one of seven consultant
tscular surgeons. An open transperitoneal repair was the
vored surgical approach. The protocols observed in our
tit did not advocate the use of endovascular aortic repair
ir emergency AAA repair during the study period,
election for operation was at the discretion of the
tending surgeon. Surgical intervention was not under-
—ken if the patient declined operation, if the patient had a
lown serious co-morbidity such as advanced malignancy,
; if the patient was otherwise unsuitable (e.g., such as
-aving refractory loss of consciousness or cardiac arrest,
aving severe dementia, or being dependent and requiring
ursing home care). There were 53 preoperative variables
-ientified in other studies, or suspected on clinical grounds,
o be associated with mortality that were recorded for each
'atient and related to subsequent outcome.
Loss of consciousness was defined as an in-hospital
vent; and the Glasgow Coma Scale (GCS) was defined as
le best recorded level in hospital. Cardiac symptoms were
ypified by previous myocardial infarction, anginal symp-
ims, or symptoms of congestive cardiac failure.
Lespiratory symptoms were defined by dyspnea at rest or
n exertion; and peripheral arterial occlusive disease
■PAOD) was defined by a history of intermittent claudi-
ation or critical limb ischemia. Electrocardiographic
-ECG) ischemia was typified by >1 mm ST segment
depression or an associated T-wave change on the admis-
ion ECG.
Statistical analysis was performed using SPSS for
Windows Release 13.0.0 software (SPSS, Chicago, IL,
JSA). Univariate differences between categoric variables
tvere compared using the chi-squared test with Yates'
;orrection or Fisher's exact test. Univariate differences
between groups for parametric and nonparametric contin¬
uous variables were determined by the unpaired Student's
f-test and the Mann-Whitney U-test, respectively. A value
of p < 0.05 was considered significant. Multivariate
modeling examining the simultaneous and independent
effect of the significant demographic and clinical charac¬
teristics was then carried out using logistic regression. A
stepwise (forward-backward) variable selection procedure
was adopted. Clinically relevant variables predictive of
death were then modeled to develop a prognostic risk score
for ruptured AAA. The chi-squared test for trend was used
to compare the trend in the actual mortality rate as related
to an increasing risk score.
Results
In toal, 129 consecutive patients were admitted with rup¬
tured AAA during the study period. Among them, 105
(81%) underwent attempted open repair, and 24 (19%)
were deemed unsuitable for operation due to prohibitive
co-morbidity. Of the 105 patients undergoing attempted
open repair, 91 were men and 14 were women. The
mean ± SD age of the study population was 72 + 7 years.
Altogether, 47 (45%) patients were transferred from
another hospital, and the remainder were referred directly
to the vascular surgical service by their general practi¬
tioner, the Emergency Department, or another specialty in
the authors' hospital.
A total of 19 patients required a secondary intervention
following their aneurysm repair: 12 (11%) patients
required a further laparotomy for hemostasis, 3 (3%) nee¬
ded colonic resection, and 5 (5%) needed some other form
of intervention; one patient required two secondary inter¬
ventions. There were 39 (37%) deaths in hospital or within
30 days of operation. Altogether, 16 (15%) patients died
during surgery of massive hemorrhage or cardiac arrest; 18
(17%) died of multiorgan failure, and 5 (5%) died of other
causes. Of 66 surviving patients, 61 (92%) suffered one or
more postoperative complications as defined by the Com¬
mittee on Reporting Standards of the Society for Vascular
Surgery and the North American chapter of the Interna¬
tional Society for Cardiovascular Surgery [13].
Preoperative variables predictive of death after attemp¬
ted repair of ruptured AAA are listed in Tables 1 and 2. Of
the continuous variables, only hemoglobin level and blood
pressure were predictive of perioperative death. These
continuous variables were stratified to create categoric
variables for further univariate analysis. Of all categoric
variables, loss of consciousness, cardiac arrest, hemoglobin
<9 g/dl, blood pressure (BP) <90 mmHg and GCS <15
were associated with perioperative death. However, loss of
consciousness and cardiac arrest were observed in only
eight and five patients, respectively.
On logistic regression analysis of these five variables,
none reach significance at the 5% level. Exclusion of the
variables loss of consciousness and cardiac arrest yields
the multivariate model seen in Table 3. The remaining
variables were retained to determine the cumulative effect
of multiple risk factors in a scoring system. With risk
factors equally weighted, three probands of risk were
established (Table 4). There was a significant association
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'able 1 Univariate analysis of
reoperative continuous
ariables in 105 patients
BC: white blood cells; APTT:
tivated partial thromboplastin
ne; BP: blood pressure
esults are the mean or the
ean and range
able 2 Univariate analysis of
reoperative categoric variables
t 105 patients
Hb: hemoglobin; GCS: Glasgow
Boma Scale; PAOD: peripheral
irterial occlusive disease
f Fisher's exact test
Variable No. of missing cases Survivors Nonsurvivors P
Age (years) 71.9 (7.4) 73.6 (6.7) 0.250
Duration of symptoms (hr) 6 6 (0-240) 4 (1-72) 0.218
Hemoglobin (g/dl) 1 12.0 (2.5) 10.7 (3.1) 0.038
WBC count (x109/L) 1 13.8 (6.5-33.7) 13.8 (5.2-31.1) 0.989
Platelets (xl09/L) 3 195 (90-569) 207 (71-522) 0.353
Prothrombin time (s) 23 10 (8-31) 11 (9-62) 0.256
APTT (s) 25 32 (24-52) 32 (24-210) 0.206
Fibrinogen (g/L) 25 3.5 (1.5) 3.2 (1.5) 0.386
Urea (mmol/L) 1 7.6 (3.2-10.3) 7.0 (3.2-13.7) 0.688
Creatinine (pmol/L) 1 124 (78^498) 141 (84-263) 0.169
Albumin (g/L) 20 36 (19-51) 35 (17-45) 0.118
Sodium (mmol/L) 1 138 (124-148) 139 (122-148) 0.089
Potassium (mmol/L) 1 4.0 (0.7) 4.0 (0.5) 0.996
Alanine transaminase (U/L) 20 14 (6-221) 12 (5-154) 0.205
Highest pulse rate (bpm) 9 95 (55-190) 99 (60-130) 0.794
Lowest BP (mmHg) 5 80 (50-165) 73 (0-135) 0.003
Highest BP (mmHg) 10 150 (33) 135 (36) 0.049
Variable No. of No. of observations P
missing cases
Survivors Nonsurvivors)
Age > 75 years 24 20 0.196
Female sex 8 5 1.000t
Interhospital transfer 28 19 0.672
Loss of consciousness 6 2 6 0.022*
Cardiac arrest 0 5 0.006+
ECG ischemia 7 22 16 0.313
Hb <9 g/dl 1 7 11 0.038
Creatinine >190 pmol /L 1 8 3 0.742
BP <90 mmHg 5 33 29 0.036
GCS <15 5 14 17 0.016
Diabetes 5 4 0 0.310t
Cardiac symptoms 6 24 12 0.921
Respiratory symptoms 4 30 17 1.000*
PAOD 4 7 0.095*
Previous vascular intervention 0 1 0.371*
Warfarin therapy 0 2 0.136+
//-Blocker therapy 19 8 0.480
Steroid therapy 2 1 1.000*
Antiplatelet therapy 32 15 0.710
Antianginal therapy 10 3 0.363t
Preoperative inotropes 1 3 0.143+
Discussion
Many authors have attempted to identify preoperative
variables that predict outcome and that might define the
group of patients at extreme risk who would not benefit
from operation after AAA rupture. However, there has
been little consistency in reported findings and poor
reproducibility among differing patient populations. Fur¬
thermore, data from the authors' center have shown that




'able 3 Multivariate model of variables related to perioperative
Bath
Variable P Odds ratio 95% CI
emoglobin <9 g/dl 0.102 2.519 0.831-7.630
—P <90 mmHg 0.148 2.020 0.779-5.241
CS <15 0.077 2.318 0.916-5.866
1: confidence interval
—able 4 Mortality of patients with three equally weighted risk fac-
irsa according to number of factors present.
o. of variables No. of patients No. of deaths % Mortality
: 1 70 20 29
30 15 50
5 4 80
Hemoglobin <9 g/dl, BP <90 mmHg, GCS <15
;id the Glasgow Aneurysm Score—widely held to be
redible instruments in risk prediction—lack validity [9].
easons for the poor performance of the present data, when
-pplied to existing scoring models, are manifold. In con-
rast to much of the existing data, the present series
epresents a large number of patients accumulated over a
-hort contemporary study period and operated on exclu-
ively by a small group of specialist vascular surgeons,
'his is likely to minimize some of the bias associated with
ther retrospective analyses.
These data come from a high-volume tertiary unit
erving a Scottish population of approximately 1.2 million
ndividuals. Scoring systems always reflect the specific
opulation and study period from which they were
esigned and modeled. For this reason, although a scoring
ystem may hold true for one population, it must not be
ssumed to do so for other populations without appropriate,
ingoing validation [14]. Although it may be argued that the
urrent data are vulnerable to selection bias, as some
ratients were palliated and not subjected to attempted
rperation, there is no other ruptured AAA risk scoring
system that has been modeled on patients treated by a
specialist vascular service during the last decade.
Of the well known predictive instruments for ruptured
AAA, all include age as a risk factor. In contrast, age was
not found to be a significant risk factor in the present series.
Age may be considered an indirect marker of physiologic
status, and based on these data it seems to lack sensitivity
as a predictor of adverse outcome. However, it is also
surprising that renal function, as represented by the serum
creatinine level, was not identified as a predictive variable
when it too is included in both the Hardman and Glasgow
scores. Preoperative creatinine >130 pmol/L is recognized
ts a perioperative risk factor for adverse outcome in
World J Surg (2007) 31:2243-2247
noncardiac surgery [15]. However, the overall median
(range) creatinine level in the current series was 129 pmol/
L (78-498) pmol /L. This may imply that most patients
with ruptured AAA had evidence of preoperative renal
dysfunction and so creatinine might lack predictive value
in this circumstance. Review of the existing literature
reveals much conflicting data, and there is no consensus on
the usefulness of creatinine as a risk factor for periopera¬
tive death.
Based on the present data, the goal of a scoring system
that can accurately predict all patients in whom attempted
repair will prove futile seems unrealistic. However, five
significant risk factors were identified on univariate anal¬
ysis. They all failed to retain significance at the 5% level
when subjected to multivariate modeling. Of the five fac¬
tors, in-hospital loss of consciousness and cardiac arrest
are not useful predictive variables for patient stratification
because of their low observed frequency. The two were
only observed in eight and five patients, respectively, and
are vulnerable to a type I error. Preoperative loss of con¬
sciousness was associated with death in six of the eight
patients, and cardiac arrest was invariably associated with
death, a naturally intuitive finding. However, previous
work has shown that unconsciousness and arrest are not
always fatal after aneurysm rupture [16, 17]. Although they
have been frequently cited as useful risk factors for pre¬
dicting death after ruptured AAA, and one is a component
of the Hardman Index, it is unlikely that there is any single
preoperative variable that in isolation can predict an
unsuccessful outcome across different patient populations.
The remaining three variables noted on univariate
analysis were retained for analysis in a multivariate model.
Although they all lose significance at the 5% level, there is
a trend to significance at an a level of 10%. The variables
of hemoglobin <9 g/dl, shock (BP <90 mmHg), and GCS
<15 are sensitive markers of the physiologic condition—
hemoglobin level and blood pressure being directly pro¬
portional to tissue oxygen delivery, and GCS an indicator
of adequate cerebral perfusion. All three variables have odd
ratios of approximately two. When applied to an equally
weighted, cumulative model of risk scoring, there are three
clearly identifiable tiers of risk. Although even the most
extreme band of risk is still associated with a 20% chance
of survival, the instrument provides a useful method of
assigning patients to a low-, medium-, or high-risk cate¬
gory prior to attempted operation. Furthermore, all three
variables in the proposed model can be measured within a
few minutes of a patient's arrival in the emergency
department. The risk score can then be used to inform
patients and relatives objectively of the illness severity and
operative risk.
These data represent a novel, unvalidated predictive risk
model for patients with ruptured AAA from a single UK
.2) Springer
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:rtiary center. The limitations of these data are that they
e highly selected in that the patients at most extreme risk
ere palliated and are not included in the analysis of
iriables predictive of perioperative death. However, such
as is unavoidable in a study of this nature, particularly
here a selective policy of surgical intervention is
nployed. Although this instrument cannot be recom-
tended for use in patient selection at present, its potential
ility in comparative audit and supporting clinical judg-
lent warrants further prospective validation.
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Prediction of outcome after abdominal aortic
aneurysm rupture
Andrew L. Tambyraja, BM, BS, John A. Murie, MD, and Roderick T. A. Chalmers, MD,
Edinburgh, United Kingdom
Background: Most vascular surgeons practice a selective policy of operative intervention for patients with ruptured
abdominal aortic aneurysm (AAA). The evidence on which to justify operative selection remains uncertain. This review
examines the prediction of outcome after attempted open repair of ruptured AAA.
Methods: The Medline and EMBASE databases and Cochrane Database of Systematic Reviews were searched for clinical
studies relating to the prediction of outcome after ruptured AAA. Reference lists of relevant articles were also reviewed.
Results: The last 20 years has seen >60 publications considering variables predictive of outcome after AAA rupture. Four
predictive scoring systems are reported: Hardman Index, Glasgow Aneurysm Score, Physiological and Operative Severity
Score for Enumeration ofMortality and Morbidity (POSSUM), and the Vancouver Scoring System. No scoring system
has been shown to have consistent or absolute validity. Of the remaining data, there are no individual or combination of
variables that can accurately and consistently predict outcome.
Conclusions: Little robust evidence is available on which to base preoperative outcome prediction in patients with
ruptured AAA. Experienced clinical judgement will remain of foremost importance in the selection of patients for
ruptured AAA repair. (J Vase Surg 2008;47:222-30.)
Most surgeons practice a selective policy of operative
intervention for patients with ruptured abdominal aortic
aneurysm (AAA).1 This approach is underpinned by the
rapid assessment of the patient's current clinical condition,
premorbid health, and functional status to determine if
attempted operation is appropriate and associated with a
realistic chance of survival. It aims to ensure health care
resources are used appropriately and avoid futile attempts at
intervention in patients with prohibitive risk. In clinical
practice, this patient selection is largely based upon subjec¬
tive criteria. However, to ensure that selection is objective,
a system that can accurately predict outcome in patients
with ruptured AAA is crucial.
Many authors have attempted to identify variables ca¬
pable of predicting death in patients with ruptured AAA.
There is much heterogeneity in the nature and quality of
results and the methods used for reporting. A few series
have gone further and have performed statistical modelling
on predictive variables to design scoring systems that can
forecast outcome. In many systems, however, sound meth¬
odology has not been used in the design; furthermore, only
a few have undergone robust audit, let alone prospective
validation. A previous review has recognized that these
limitations would render meta-analytical techniques un¬
suitable.2 The following systematic review considers exist¬
ing scoring systems and existing literature on variables
predictive of outcome in patients with ruptured AAA.
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METHOD
The Medline, EMBASE, and Cochrane Systematic Re¬
views (January 1985 to June 2006) electronic databases
were searched. The search strategy used the MeSH head¬
ings "Aortic aneurysm, abdominal" and "aortic rupture or
rupture.mp," with the Boolean operator "and." The OVID
search engine 10.3.2 (Ovid Technologies, New York, NY)
was used. Criteria for inclusion were studies assessing vari¬
ables predictive of outcome in patients before attempted
open repair of ruptured AAA. Studies that examined out¬
come in a subgroup of patients alone and those that only
assessed selected variables were excluded. Manual searching
was also done of reference lists from articles retrieved by
electronic searching. Articles retrieved were restricted to
those published in English. All identified articles were
obtained through local library collections and The British
Library.
RESULTS
Hardman index. The Hardman scoring system is
probably the most well known ofscoring systems for use in
patients with ruptured AAA. Originally described in 1996,
this retrospective series reviewed 154 nonconsccutive pa¬
tients who underwent operation for ruptured AAA be¬
tween 1985 and 1993 at a single Australian tertiary vascular
center.3 Univariate analysis was done on 67 preoperative
variables in 136 patients for their association with death
in-hospital or ^30 days of surgery. Continuous variables
significantly associated with death were categorized into
quartiles, and the mortality rate ofeach category examined.
All variables related to postoperative death were further
analyzed alongside data from another 18 patients to de¬
velop a multivariate model. The significant multivariate risk
factors were then assessed for their cumulative effect when
weighted equally.
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Table I. Operative mortality (%) according to number of Hardman variables
No. ofHardman variables
First author Tear Patients, No. 0 1 2 >3
Hardman3 1996 154 16% 37% 72% 100%
Prance4 1999 69 18% 28% 48% 100%
Neary5 2003 188 35% 55% 74% 90%
Boyle6 2003 79 8% 24% 55% 100%
Caiderwood7 2004 137 40% 46% 77% 92%*
Tambyraja8 2005 85 15% 55% 38% 33%
*Mortality for 3 risk factors only. For 4 risk factors, mortality was 100%.
Five independent variables were identified on multivar¬
iate analysis: preoperative hemoglobin level <9 g/L, serum
creatinine level >90 pmol/L, electrocardiographic isch¬
emia, in-hospital loss of consciousness, and age >76 years.
No single risk factor had a predictive value in isolation, but
the cumulative predictive value of the risk factors is sum¬
marized in Table I. Three or more of the five risk factors
were associated with a 100% mortality rate.
After its conception, the Hardman score was com¬
mended for its simplicity and practicality in the acute set¬
ting. Validation of the system has been performed at
various levels. To date, six studies have assessed the perfor¬
mance of the Hardman system.4"8 These are summarized in
Table I.
On initial inspection, these results seem to support the
original data ofHardman and colleagues. Of the five series,
three or more positive variables are uniformly associated
with perioperative death in three studies. However, it is
concerning that three of the reports contain patients with
three or more variables who survived operative repair.
Although it has been widely concluded that the presence of
more than three Hardman variables is a good predictor of
death, this would seem not to be universally true.
More critical analysis of these data reveals that all but
one review is retrospective in nature and the only prospec¬
tive data are compiled from two centers. These data add
some credence to the validity of the Hardman score system
but also highlight that the instrument is not as precise as
initially reported. This emphasizes the need for further
prospective validation before its use in clinical practice can
be unanimously supported.
Glasgow aneurysm score. The Glasgow Aneurysm
Score (GAS) was first reported in 1994." This instrument
was originally developed as a tool for prognostic scoring in
patients undergoing repair of intact or ruptured AAA. A
retrospective, multicentered, nonconsecutive sample of
500 patients undergoing AAA repair at general surgical
units in Glasgow between 1980 and 1990 was examined for
risk factors associated with death. Multivariate analysis
identified the independent risk factors of age, shock, myo¬
cardial disease, cerebrovascular disease, and renal disease.
Myocardial disease is typified by documented myocardial
infarction or on-going angina, or both. Cerebrovascular
disease refers to all grade of stroke, including transient isch¬
emic attacks. Renal disease is any combination of history of
chronic or acute renal failure, urea level >20 mmol/L, or
creatinine level >150 pmol/L at presentation.
Rounding of the regression coefficients created a sim¬
ple risk score: risk score = age in years +17 (for shock) +
7 (for myocardial disease) + 10 (for cerebrovascular dis¬
ease) + 14 (for renal disease). Appraisal of the scoring
system showed that mortality rate increased in proportion
to score. The same authors prospectively evaluated their
system in a subsequent multicentered study.1" Again, they
reported similar results to the original analysis used in
developing the score. Mortality was found to correlate well
with GAS, and scores of >95 were related to a mortality
rate of >80%.
This generic scoring system for patients undergoing
AAA repair has had little further validation. Given its sim¬
plicity, ease of use, and apparent predictive power, this
seems surprising. However, a Finnish group recently exam¬
ined the performance of the GAS in a retrospective review
of836 patients with ruptured AAA admitted to 21 hospitals
and included in a large national vascular registry.11 These
data confirmed that the GAS was independently associated
with postoperative death. This series did not have a cutoff
score that predicted a postoperative mortality rate of 100%,
although a score of>98 was associated with a mortality rate
of about 80%.
We have previously reported the results of our own
retrospective audit of the GAS.8 A surprising finding was
that the GAS performed poorly as a predictive tool. Indeed,
it was impossible to identify any score that conferred ex¬
treme risk, and even in 14 patients with scores of ^110,
operative mortality was <50%. Despite its apparent merits,
further attempts at validation have yielded conflicting re¬
sults. Until further data are available, its use in outcome
prediction and as a risk-stratification tool for comparative
audit must be questioned.
The physiological and operative severity score for
the enumeration of mortality and morbidity. The
POSSUM score was described and prospectively validated
by Copcland et al12 in 1991. Its primary function was as a
scoring system for general surgical audit to allow for the
effects of case-mix rather than as an instrument to predict
individual case outcome. POSSUM represents a risk-pre¬
diction model based on a physiology score derived from 12
preoperative variables, which are independently predictive
of adverse postoperative outcome on multivariate analysis,
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Table II. Physiological and Operative Severity Score for
Enumeration ofMortality and Morbidity (POSSUM)
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Mortality risk equations (R = risk of mortality):
POSSUM: In (R/l-R) = -7.04 + (0.13 X physiological score) + (0.16 X
operative severity score).
Vascular (V)-POSSUM: In (R/l-R) = -8.0616 + (0.1552 X physiolog¬
ical score) + (0.1238 X operative severity score).
V-POSSUM (physiological score only): In (R/l —R) = -6.0386 +
(0.1539 X physiological score).
Ruptured abdominal aortic aneurysm (RAAA)-POSSUM: In (R/l —R) =
—4.9795 + (0.0913 X physiological score) + (0.0958 X operative severity
score).
RAAA-POSSUM (physiological score only): In (R/l —R) = —2.7569 +
(0.0968 X physiological score).
and an operative score derived from six further intraopera¬
tive variables (Table II). Each of the variables is graded and
scored exponentially as 1, 2, 4, or 8.
The combined physiology and operative scores were
subjected to logistic regression analysis to generate risk
equations that convert the scores into a predicted percent¬
age morbidity and mortality. However, attempted valida¬
tion in both general and subspecialty surgery has reported a
lack of calibration of the initial model and suggestions for
remodelling of the regression equation have been pro¬
posed.13"16 This led to the Vascular Surgical Society of
Great Britain and Ireland developing a risk equation
specific for patients undergoing vascular surgery, the
V-POSSUM.17 Specific evaluation of the POSSUM system
in ruptured AAA repair demonstrated that the equation
performed poorly in emergency aortic surgery.18
Subsequently, two further equations exclusively for
ruptured AAA were derived from a retrospective series of
106 patients.19 One equation incorporated both physiol¬
ogy and operative scores and the other only used the
physiology score. Initial validation was performed by the
authors on a further set of 107 patients with ruptured AAA.
The physiology-only equation was effective but was found
to have a lack of fit at a certain risk range. However, the
ruptured AAA POSSUM (RAAA-POSSUM) equation that
combined physiology and operative scores was more suc¬
cessful at accurately predicting outcome.
Two further series have examined the validity of both
RAAA-POSSUM systems. Both equations were used to
analyze retrospective data on 188 patients with ruptured
AAA from Gloucester.9 Both systems performed well, with
no difference in observed and expected mortality results. A
further nonconsecutive, retrospective series of 68 patients
who survived >24 hours after repair of a ruptured AAA
from Leicester also confirmed that although the two sys¬
tems tended to slightly overpredict death, there was no
statistically significant lack of fit. However, the limitations
of the latter highly selected data set are obvious.20
To date, the RAAA-POSSUM systems have not been
prospectively validated. Although the existing evidence
suggests that they perform well, the utility of the POSSUM
system in clinical decision making is questionable. It is
paramount to reiterate that the POSSUM methodology is
principally for comparative audit. The need for operative
variables renders most POSSUM equations impractical for
preoperative risk prediction.
Although the data required for the physiology RAAA-
POSSUM tool are easily recorded, the need for complex
mathematical equations can make its utility cumbersome in
the clinical setting. The system allows for more precise risk
stratification of patients than some of the other systems
already described. This level of accuracy may introduce
even more complexity to clinical decision making. In the
Gloucester study, one of 16 patients with a predicted
mortality risk of >80% survived, as did three of 21 with a
risk of 70% to 80%. Using this system, the absolute predic¬
tion of operative futility would appear unfeasible.
Vancouver scoring system. Of scoring systems appli¬
cable to patients with ruptured AAA, the Vancouver system
is probably the least well known and used.21 Also reported
in 1996, this retrospective series examined 147 patients
who underwent repair of a ruptured AAA between 1984
and 1993. Perioperative demographic and physiologic vari¬
ables significantly associated with death on univariate anal¬
ysis underwent further multivariate analysis.
Univariate analysis identified age, reduced conscious
level, preoperative cardiac arrest, history ofmyocardial in¬
farction, and a history of collapse as being associated with
postoperative death. After multivariate logistic regression
analysis, age, reduced conscious level, and preoperative
cardiac arrest remained as significant predictors of death.
These variables could be entered into a predictive model
equation on the basis of the coefficients from the logistic
regression model. The probability of death is estimated
using the equation [e*/(l + ex)], where e is the base of the
natural logarithm and #is the constant ( — 3.44) + sum of
coefficients for the significant variables (Table III).
The Vancouver group has also attempted to validate
their statistical model. They evaluated the performance of
the instrument on a prospective series of 134 patients
drawn from two tertiary centers.22 The authors argue that
their system is accurate at predicting patients at extreme risk
(patients with a predicted mortality >90%); however, the
instrument seems to perform less well at lower levels of
mortality risk (patients with a predicted mortality >80%).
The group concluded that their tool was of use in inform¬
ing clinical decisions in patients with ruptured AAA, al¬
though unable to identify a 100% mortality rate.
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Table III. Risk factor coefficients from the Vancouver
scoring system
Coefficient
Variable Category (Constant = —3.41)
Age 0.062 X age
Loss of consciousness Yes 1.14
No -1.14
Cardiac arrest Yes 0.60
No -0.60
Table IV. Series failing to identify variables predictive of
death after operation
First author Tear Patients, No. Deaths, %
Campbell 23 1986 52 56
Vohra 24 1988 92 39
Harris 25 1991 113 64
Meesters 26 1994 99 49
Barry 27 1997 140 52
Hatori 28 2000 33 39
Bovvn 2H 2003 139* 32
Sultan 29 2004 42 60
* Excludes patients who died ^ 24 hours of operation.
Despite their assertion, this scoring system does not
seem to have gained support and been used by other
centers. No further independent validation is identifiable in
the literature. Reasons for this may be related to the nature
of the model. Although the variables used are easily ob¬
tained, the need for coefficients and complex mathematical
formula render it less practicable in the acute situation. The
derivation ofa percentage risk ofdeath is similar to the GAS
and POSSUM systems. This instrument may have a utility
for risk stratification for the purposes of audit, although
more robust validation is needed to assess its credentials. Its
use in clinical decision making in the acute setting is ham¬
pered by its complexity.
Other predictive variables. Interest in the prediction
of clinical outcome in patients with AAA rupture is high¬
lighted by the publication of>60 independent series inves¬
tigating the subject in the last 20 years alone. Although the
preceding scoring systems are, perhaps, the most sophisti¬
cated and well cited of these articles, the others also offer
potentially useful data to inform clinical judgement.
Eight of these further articles reported negative results
and were unable to identify any preoperative variables
predictive of death after aneurysm rupture (Table
IV).20'23"29 These studies on 710 patients from European
and North American centers are all retrospective in design.
The median sample size was 92 (range, 33 to 140) and
mortality was 49% (range, 32% to 64%). These data provide
compelling evidence for the argument that absolute predic¬
tion of outcome in this disease is impossible. It is argued
that withholding an operation on the basis ofany predictive
variables is unsound and ethically unjustified.25 Some ofthe
most highly regarded authorities in vascular surgery have
championed this thesis.30 It may also be assumed that an
even greater body of similar unpublished data exists owing
to the nature of publication bias.
Examination of the available data generates some con¬
cerns, however. Of the three series that study >100 pa¬
tients, one excluded patients who died ^24 hours of oper¬
ation,20 and another shared a data set with a further
publication that a year later reported female gender, preop¬
erative hypotension, low hemoglobin level, and thrombo¬
cytopenia as predictors of death.27 Critics also have ques¬
tioned whether "cardiac arrest" in these series simply
represented an inability to palpate pulses due to hypoten¬
sion or arrhythmia rather than true loss of cardiac output.
Nevertheless, irrespective of these deficiencies, such data
cannot be ignored.
The remaining 55 series all describe one or more pre¬
operative variables that were predictive of outcome in
81,350 patients (Table V).31-80 It must be noted that two
series have similar characteristics and are likely to represent
duplicate publication of an extended data set.77'80 The
median number of patients studied was 119 (range, 18 to
67,751), and median mortality was 47% (range, 13% to
75%). It is noteworthy that only two studies were prospec¬
tive in design.48,56 Most data have been subjected to mul¬
tivariate statistical tests, where appropriate, although some
large series have only undertaken univariate analysis. Apart
from the Hardman data, no other group has robustly
identified preoperative variables, individually or combined,
that are capable of defining a group with such a prohibitive
risk of death that intervention is precluded. Even patients
with preoperative cardiac arrest, a group that is intuitively at
an extreme risk of mortality, are reported to have survival
rates of up to 33% in certain series.59
Nevertheless, 10 variables regularly appear as signifi¬
cant predictors ofdeath. Ifone takes hematocrit and serum
hemoglobin as analogous variables, six of these appear
more frequently than others. These six include hypoten¬
sion, advanced age, cardiac arrest, raised serum creatinine
level, low hemoglobin/hematocrit, and a history of isch¬
emic heart disease. Of interest is that these variables or their
correlates are all represented in the established scoring
systems described earlier.
The risk factors of hypotension, cardiac arrest, raised
creatinine level, low hemoglobin level, loss of conscious¬
ness, and electrocardiographic ischemia have retained
independent statistical significance on multivariate anal¬
ysis, and they are all implicated in the development or a
manifestation of systemic shock. Furthermore, more
than halfof these 54 publications identify hypotension as
a predictor of mortality. Of the reported risk factors,
female gender is, perhaps, the most difficult to interpret.
Four of the five data sets that describe this finding are
North American and have considerable sample sizes. The
over-representation ofwomen in elective and emergency
AAA mortality statistics is well described, but the reason¬
ing remains uncertain.81
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Table V. Series identifying preoperative variables predictive for death after attempted repair of ruptured abdominal
aortic aneurysm
First author Tear Patients, No. Deaths, % BP, mm Hg Age, y Cardiac arrest Creatinine, [xmol/l
Donaldson31 1985 81 43 *(>76)*
Lambert32 1986 180 75 * (<80)
Morishita33 1986 20 45 • *
Nachbur34 1987 116 47 • *
Shackleton35 1987 106 40
Martin36 1988 58 26 * (<90)
Amundsen37 1989 103 59 *(<92) •(>71)
Ouriel38 1990 243 55 * (<70) *(>300)
Murphy39 1990 172 49 *(<90)* • *
Johansen40 1991 186 70 *(>80)* • *
AbuRahma41 1991 73 62 •(<90)
Gloviczki42 1992 231 42 •
Rosenthal43 1992 47 43 *(<90)* *(>75)* • *
Scott44 1992 66 30 •t
Bauer45 1993 314 29 *(<90)
McCready46 1993 208 50 * (<90) *(>70)
Katz47 1994 99 57 •
Johnston48 19941 147 49 *(>130)
Katz49 1994 1829 50 •
Panneton5" 1995 112 49 * (<90)
•
Browning51 1995 54 44 •(<85)
Marty-Ane52 1995 61 13 •
Farooq53 1996 122 56 * (<80) •
jaakkola54 1996 48 65 * (<90)
Rutledge55 1996 1480 54 • *
Chen21 1996 157 46 • •
Hardman3 1996 154 39 *(>76)
•
*(>190)
Koskas56 19971 158 47 • •
Martinez57 1997 84 57 *(<90)
•
Lazarides18 1997 40 55
Halpern58 1997 96 60 *(<90) *(>150)
Satta59 1997 51 47 • *
Subramaniam6" 1998 18* 67 • *
Barry61 1998 150 48 • *
Dardik62 1998 527 47 •
Van Dongen63 1998 309 25 *(>70)
Sasaki64 1998 27 22 * (<80)
•
Urwin65 1999 135* 63 • •
Ho66 1999 40 48 •
Kniemeyer67 2000 57 32 *(<80)
Turton68 2000 102 53 *(<90) •
Heller69 2000 67751 46 *(>70) •
Lovricevic70 2000 54 30 •t •t
Merlo71 2001 123 45 • *
Noel72 2001 413 37 •
Alonso-Perez73 2001 144 47 *(<80)
•
Gutierrez-Morlote74 2002 106 49 *(<90)
Hans75 2003 101 48 •
Piper76 2003 147 35
Markovic77 2004 229 54 *(<95)* • * *(>180)*
Lo78 2004 41 41 •
Dueck79 2004 2601 41 •
Calderwood 7 2004 137 56 *(<100) *(>76) *(>190)
Korhonen11 2004 836 47 •
Davidovic8" 2005 406 48 • * • * * (>180)*
LOC, Loss ofconsciousness; IHD, ischemic heart disease; BP, blood pressure; Hb, hemoglobin; Hct, hematocrit; APACHE II, Acute Physiology and Chronic
Health Evaluation II; TIA, transient ischemic attack; AAA, abdominal aortic aneurysm; COPD, chronic obstructive pulmonary disease.
*This variable was predictive of death.
* Univariate analysis only.
*Prospective studies.
*No statistical analysis.
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Table V. Continued
ECG Platelets
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(<10)* *(<29)* Low urine output*,
Leucocytes >14 X109/
L,* urea >11 mmol/L*
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DISCUSSION
The existing literature suggests that certain patient-
related preoperative variables are associated with perioper¬
ative death after AAA rupture. Of note, however is that
surgeon- and hospital-related variables are also known to
have a profound impact on outcome.79 Recent data have
[confirmed that outcome in terms ofdeath after ruptured AAA
repair is better in high-volume centers.82 This factor may be
implicated in the poor comparative performance of existing
scoring systems that were derived from low-volume or non-
specialist institutions. With the introduction of endovascular
repair of ruptured AAA and the potential improvements in
patient survival, risk scoring instruments may require further
remodelling or recalibration.83'84
Predictive scoring systems are derived from a combina¬
tion of demographic, physiologic, and therapeutic vari¬
ables. It is ideal to try to generate the most accurate value of
risk scoring from the least number ofpredictors by exclud¬
ing variables that do not influence outcome. The selection
of these variables is performed by a combination of statis¬
tical modelling and expert opinion. After an analysis on a
development data set, validation should be performed on a
separate data set from the same institution before being
applied to data from other centers and compared with the
performance of other predictive tools.85
There is much to be desired in terms of the quality and
level of available evidence. In the past 20 years, no more
than two prospective attempts to investigate risk factors
associated with death after AAA rupture have been pub¬
lished. Furthermore, the measure and reporting of signifi¬
cant perioperative morbidity in this group of patients con¬
tinues to lack accuracy and focus.86
CONCLUSION
At present, no scoring system or variable, in combina¬
tion or on its own, can be persuasively recommended as
being predictive of perioperative death and be used to
influence treatment decisions. The existing scoring systems
have not been adequately validated to be ofuse in dictating
therapy or justifying clinical decision making. At best, they
are useful to risk stratify patients for the purposes of audit
and act as an adjunct to supplement clinical intuition. Until
a scoring system that uses sound methodology and robust
validation is available, experienced clinical judgement will
remain of foremost importance in the selection of patients
for ruptured AAA repair.
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Prognostic scoring in ruptured abdominal aortic
aneurysm: A prospective evaluation
Andrew L. Tambyraja, BM, BS,a Amanda J. Lee, PhD,b John A. Murie, MD,a and
Roderick T. A. Chalmers, MD,a Edinburgh and Aberdeen, Scotland
Background: Prospective validation of prognostic scoring systems for ruptured abdominal aortic aneurysm (AAA) is
lacking. This study assesses the validity of three established risk scores and a new prognostic index.
Method: Patients admitted with ruptured AAA during a 26-month period (August 2002-December 2004) were recruited
prospectively. The Glasgow Aneurysm Score (GAS), Hardman Index, Physiological and Operative Severity Score for
enumeration of Mortality and Morbidity (POSSUM) scores, and the Edinburgh Ruptured Aneurysm Score (ERAS)
were recorded and related to outcome.
Results: During the study period, 111 patients were admitted with ruptured AAA. Of these, 84 (76%) underwent
attempted operative repair and were included in the study; 37 (44%) died after operation. The GAS, Hardman Index, and
the ERAS were statistically related to mortality. However, analysis by receiver-operator characteristic curve revealed the
ERAS to have an area under the curve (AUC) of 0.72 (95% confidence interval [CI], 0.61-0.83). The vascular
(V)-POSSUM and ruptured AAA (RAAA)-POSSUM models had an AUC of 0.70 (95% CI, 0.59-0.82). The Hardman
Index and GAS had an AUC of 0.69 (95% CI, 0.57-0.80) and 0.64 (95% CI, 0.52-0.76), respectively. Although the
V-POSSUM equation predicted mortality effectively (P = .086), the RAAA-POSSUM derivative demonstrated a
significant lack of fit (P = .009).
Conclusion: Prospective validation shows that the Hardman Index, GAS, and V-POSSUM and RAAA-POSSUM scores
do not perform well as predictors for death after ruptured AAA. The ERAS accurately stratifies perioperative risk but
requires further validation. (J Vase Surg 2008;47:282-6.)
The incidence of patients presenting with ruptured
abdominal aortic aneurysm (AAA) is increasing.1'2 To en¬
sure appropriate use of health care resources and avoid
futile attempts at intervention in patients with prohibitive
risk, judicious patient selection is essential. Upon presenta¬
tion, the patient's clinical condition must be rapidly as¬
sessed to determine if attempted operation is appropriate
and associated with a reasonable chance ofsurvival. For the
most part, this is largely a subjective decision; however, a
scoring system that could accurately predict outcome in
patients before operation would allow selection to be ob¬
jective and more easily justified. Appropriate risk stratifica¬
tion of patients would also support comparative audit
within and between institutions.
The Glasgow Aneurysm Score (GAS), Hardman Index,
and Physiological and Operative Severity Score for the
enumeration ofMortality and morbidity (POSSUM) risk
equations are predictive scoring systems recommended for
use in patients with ruptured AAA.3"5 Recently, our center
has developed the Edinburgh Ruptured Aneurysm Score
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(ERAS), a further novel prognostie index that, in contrast
to other scores, was derived from a contemporary data set.6
However, none of these scoring systems have been ade¬
quately validated to be of use in dictating therapy or justi¬
fying clinical decision making. This prospective study ex¬
amined preoperative variables predictive ofdeath after AAA
rupture and assessed the validity ofexisting scoring systems.
METHOD
Local Research Ethics Committee approval was ob¬
tained for this prospective study. All patients admitted to
the Edinburgh Vascular Surgical Service for repair of a
ruptured AAA during a 2-year period (August 2002-
December 2004) were included in this prospective study.
Operation was defined as the delivery of an anesthetic with
the intention of performing AAA repair. Ruptured AAA
was defined as the presence of retroperitoneal or intraperi¬
toneal blood, or both, in the absence of any other identifi¬
able cause for hematoma other than an aneurysm.7
All patients were operated on by one of five consultant
vascular surgeons. For each patient, 53 preoperative vari¬
ables, identified in other studies or suspected on clinical
grounds to be associated with mortality, the GAS, Hard-
man Index, V-POSSUM and ruptured AAA (RAAA)-
POSSUM (physiology only) scores, and ERAS were re¬
corded at the point of admission, before operation, and
related to 30-day or in-hospital mortality. The protocols
observed within our unit did not advocate the use of
endovascular aortic repair for emergencyAAA repair during
the study period. Surgical intervention was generally not
undertaken if the patient declined operation, had a known
serious comorbidity such as advanced malignancy, or was
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POSSUM, Physiological and Operative Severity Score for enumeration of
Mortality and Morbidity.
Mortality risk equations (R is the risk of mortality): V-POSSUM (Physiol¬
ogy score only): In (R/l-R) = -6.0386 + (0.1539 X physiologic score).
RAA-POSSUM (Physiology score only): In (R/l-R) = -2.7569 +
(0.0968 X physiologic score).
otherwise unsuitable, such as refractory loss of conscious¬
ness or cardiac arrest, severe dementia, or poor functional
status.
The GAS is calculated using the following formula: risk
score = age in years + 17 (for shock) + 7 (for myocardial
disease) + 10 (for cerebrovascular disease) + 14 (for renal
disease). Shock is defined on clinical grounds by tachycar¬
dia, hypotension, pallor, and sweating. Myocardial disease
is previously documented myocardial infarction or on¬
going angina, or both. Cerebrovascular disease refers to all
grades ofstroke, including transient ischemic attacks. Renal
disease is any or all of a history of chronic or acute renal
failure, urea level >20 mmol/L, or a creatinine level >150
pmol/L at presentation.3
The Hardman Index is derived from five preoperative
variables: age >76 years, serum creatinine level >190
pmol/L, hemoglobin level <9 g/dL, myocardial ischemia
on electrocardiograph, and a history of loss of conscious¬
ness after hospital arrival.4 A patient may score between 0
(no Hardman variables present) and 5 (5 Hardman vari¬
ables present). It has been reported that the presence of>3
variables is uniformly fatal.8'9
The POSSUM represents a risk-prediction model
based on a physiology score derived from 12 preoperative
variables, independently predictive ofadverse postoperative
outcome on multivariate analysis, and an operative score
derived from six further intraoperative variables. To allow
for preoperative risk scoring, the physiology score may be
subjected to risk equations developed for vascular surgery
(V-POSSUM) and ruptured AAA (RAAA-POSSUM) that
convert the scores into a predicted percentage mortality
(Table I).5'1"
The ERAS derives from three preoperative variables:
hemoglobin level <9 g/dL, a best-recorded in-hospital
Glasgow Coma Scale of <15, and a recorded in-hospital
blood pressure of <90 mm Hg. A patient may score ^1,2,
Table II. Primary reason for refusal of surgery in 27
patients
Reason for refusal Patients, No.





LOCy Loss of consciousness.
or 3, depending on the number of variables present. These
bands of risk correspond to a predicted mortality of 30%,
50%, and 80%, respectively.6
Statistical analysis was performed using SPSS 13.0.0
software (SPSS Inc, Chicago, 111). The receiver-operator
characteristic (ROC) curve and x2 test for trend was used to
compare the performance of the GAS, Hardman Index,
POSSUM models, and ERAS in predicting postoperative
death. The POSSUM-prcdicted mortality was evaluated by
means of the \2 test, using the methods described by
Hosmer and Lemeshow as appropriate,11,12 and P s .05
was considered significant.
RESULTS
During the study period, 111 patients were admitted
with ruptured AAA, and 27 (24%) were deemed unfit for
aneurysm repair due to prohibitive comorbidity. There
were 17 men and 10 women of a median (interquartile
range) age of 79 (73-84) years. Reasons for nonoperative
management are listed in Table II. Risk scores for the GAS,
Hardman Index, V-POSSUM and RAAA-POSSUM mor¬
tality scores, and ERAS in the 11 patients who were turned
down for surgery on the basis of comorbidity (apart from
advanced malignancy) are summarized in Table III.
The remaining 84 patients underwent attempted repair
of ruptured AAA and are included in the present analysis.
There were 74 men and 10 women of a median (interquar¬
tile range) age of 73 (67-78) years. Thirty-seven patients
(44%) died after operation, whereas ofall patients admitted
to hospital with a ruptured AAA during the study period,
63 (57%) died. One patient who did not undergo at¬
tempted repair survived her ruptured AAA and was dis¬
charged to a nursing home.
Glasgow Aneurysm Score. The mortality rates in
terms of tertiles of GAS distribution are summarized in
Table IV. The GAS was statistically related to death after
attempted repair of ruptured AAA. The median (interquar¬
tile range) GAS was significantly greater in patients who
survived operative repair than those who did not: 90 (82-
106) vs 99 (91-112; P — .027). Analysis of the ROC curve
showed that the GAS had an area under the curve (AUC) of
0.64 (95% confidence interval [CI], 0.52-0.76) for predict¬
ing perioperative death.
Hardman Index. The mortality rates in terms of
Hardman Index distribution are summarized in Table V.
There was a significant association between the Hardman
,84 Tambyraja et al
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-Table III. Risk scores in 11 patients who were palliated due to comorbidity





1 Cardiac dysfunction, suprarenal AAA 73 107 0 41 70 1
2 Cardiac dysfunction, suprarenal AAA 79 96 1 38 67 1
3 Cardiac dysfunction, chronic renal failure 83 121 3 88 91 2
4 Cardiac dysfunction 87 111 4 88 91 3
5 Cardiac dysfunction, chronic renal failure 89 120 3 57 77 2
6 Severe COPD 80 97 1 31 63 1
7 Previous disabling stroke 71 120 2 79 87 2
8 Pre-existing severe brain injury 76 100 1 31 63 2
9 Severe dementia 76 110 2 45 72 2
10 Extreme age 92 116 2 71 83 3
11 Extreme age 92 119 1 15 49 2
AAA, Abdominal aortic aneurysm; COPD, chronic obstructive pulmonary disease; ERAS, Edinburgh Ruptured Aneurysm Score; GAS, Glasgow Aneurysm
Score; HI, Hardman Index; POSSUM, Physiological and Operative Severity Score for enumeration ofMortality and Morbidity; V, vascular; RAAA, ruptured
abdominal aortic aneurysm.
Table IV. Distribution and mortality rates in 84 patients
according to tertiles ofGlasgow Aneurysm Score
Glasgow Aneurysm Score <89 89-105 >105
Patients, No. (%) 28 (33)





Table V. Distribution and mortality rates in 84 patients
according to the Hardman Index
Hardman Index 0 1 2 >3
Patients, No. (%) 21(25) 34 (40)





score and operative death (P — .010). Analysis of the ROC
curve showed that the Hardman score had an AUC of0.69
(95% CI, 0.57-0.80) for predicting perioperative death.
Edinburgh Ruptured Aneurysm Score. There was a
significant association between ERAS score and operative
death (P < .001; Table VI). Analysis of the ROC curve
showed that the ERAS had the largest AUC of 0.72 (95%
CI, 0.61-0.83) for predicting perioperative death.
Possum. The ROC curve analysis showed that the
POSSUM models had an AUC of 0.70 (95% CI, 0.59-
0.82) for predicting perioperative death. Table VII summa¬
rizes the predicted risk ofdeath and observed mortality rate
for each of the POSSUM models used. The V-POSSUM
(physiology only) model did not demonstrate any lack of
fit. However, the RAAA-POSSUM (physiology only)
model demonstrated a significant lack of fit (P = .009).
DISCUSSION
Although there have been several attempts to devise a
prognostic score with which to predict outcome in patients
with ruptured AAA, few have undergone robust validation.
The use of an imprecise predictive tool to justify clinical
decision making is open to question.
Table VI. Distribution and mortality rates in 84 patients
according to Edinburgh Ruptured Aneurysm Score
Edinburgh Ruptured
Aneurysm Score <1 2 3
Patients, No. (%) 46 (55) 27(32) 11(13)
Deaths, No. (%) 12 (26) 16 (59) 9 (82)
Previous validation of the GAS has come from prospec¬
tive data pooled from three Scottish centers, retrospective
data from the multicenter Finnvasc database, retrospective
data from a tertiary vascular center in Rome, and from our
own institution.13"16 Apart from the Edinburgh data, the
other data sets commend the GAS for its predictive power
and validity. Of interest is that the more recent data from
Rome noted that no patient with a GAS of >100 survived,
whereas the Finnish data describe a mortality rate of ap¬
proximately 80% for patients with a score of >98.'5,16
Similarly, the original Glasgow authors reported that scores
of >95 were associated with a mortality rate of 80%.14
The present prospective data contradict the findings of
these three previous series. Although the GAS was statisti¬
cally associated with death, the performance of the instru¬
ment is much less precise. Patients with scores of<90 are at
low risk, but it appears difficult to identify the group of
most interest: those patients at extreme risk. Potential
reasons for the contrasting performance of the GAS when
applied to our data have been described.13 Most of the
preceding data stem from low-volume institutions that
operate on <20 patients with ruptured AAA each year. It
seems likely that the relationship between hospital and
surgeon volume and improved outcome is likely to be
important.17
Ten series have examined the validity of the Hardman
Index; only one has been prospective.3'8'.9'13'16'18"22 Initial
reports and consensus was that the Hardman Index accu¬
rately predicted death after ruptured AAA. The presence of
three or more variables was widely held to be fatal8'9;
however, more recent data have shown that the instrument
I
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Table VII. Predicted and observed mortality according to V-POSSUM (physiology only) and RAAA-POSSUM
physiology only) models
Overall resultfor
Predicted risk Mortality each model
Range, % Mean, % Range, No. Predicted Observed x2 x2 P
V-POSSUM 0-31 16 44 7 13 6.61
31-50 42 17 7 7 0.01
50-70 59 12 7 9 1.21
70-100 80 11 9 8 0.32
0-100 36 84 30 37 8.16 .086 (4df)
RAAA-POSSUM
0-55 41 31 13 9 1.91
55-70 63 23 15 8 8.13
70-80 75 15 11 9 1.73
80-100 86 15 13 11 1.86
0-100 61 84 51 37 13.63 .009 (4df)
POSSUM, Physiological and Operative Severity Score for enumeration ofMortality and Morbidity; V, vascular; RAAA, ruptured abdominal aortic aneurysm.
does not perform as well as initially reported.13,1922 The
present prospective data confirm that the Hardman Index
does not display as convincing validity as initially reported.
Although increasing score is associated with death, its
predictive ability is only moderate, and the Hardman Index
does not clearly identify patients who are at extreme risk in
whom attempted operation is futile. The merits of the
present data are not only its prospective nature but also the
fact that only one patient had an incomplete set of scoring
data. In the existing literature, data have been unavailable
for up to 42% of patients.22 Indeed, in the only other
reported prospective study, data were missing on almost a
third of patients.9
The POSSUM score is a tool that was designed to
support comparative audit. It is important to recognize that
it has never been recommended for outcome prediction.
No prospective validation of the POSSUM risk equations
recommended for vascular surgery when applied to patients
with ruptured AAA has been reported. Of the existing
retrospective literature, both the RAAA-POSSUM and V-
POSSUM equations were shown accurately to predict risk
when applied to preoperative data on 191 patients from
Gloucester.18 From the present preoperative data, both
equations perform less well, although only the RAAA-
POSSUM model demonstrated a significant lack of fit. The
RAAA-POSSUM model over-predicted risk, whereas the
V-POSSUM model tended to under-predict at the lower
bands of risk. This lack of fit raises concerns about its use as
a risk-stratification tool for comparative audit ofdeath from
ruptured AAA. Reasons for the discrepancy are unclear, but
further validation of this model is needed.
The ERAS was modelled on retrospective data from
patients presenting to our institution with ruptured AAA
during a 2-year period. It has had no internal or external
validation and cannot be recommended for clinical use at
present. When applied to the present data, the score was
significantly associated with perioperative death. The ap¬
peal of this scoring system is its simplicity and the ease with
which the three components of the score can be obtained
and applied, and even the hemoglobin concentration can
be rapidly assessed using point-of-care testing. Further¬
more, as observed on the initial data set, three tiers of risk
are discernible. The limitations of this scoring system are
acknowledged. It has been specifically modelled on a
unique data set and may not be applicable or show validity
on external data.
CONCLUSION
To our knowledge, these are the first prospective data
to evaluate comprehensively the main scoring instruments
recommended for use in ruptured AAA repair. The GAS
and Hardman Index do not perform as predictive instru¬
ments as well as previously reported. Furthermore, the
V-POSSUM and RAAA-POSSUM also do not demon¬
strate compelling validity when applied to these data. The
ERAS is an easily applied scoring system that allows patients
to be quickly and accurately allocated to a low, medium,
and high risk ofperioperative death. It does not enable the
prediction of surgical futility, however; further external
assessment is required to confirm its validity.
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